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Background: Duchenne muscular dystrophy (DMD) is a rare disease that causes the progressive loss of
motor abilities such as walking. Standard treatment includes physiotherapy. No trial has evaluated whether
or not adding aquatic therapy (AT) to land-based therapy (LBT) exercises helps to keep muscles strong and
children independent.
Objectives: To assess the feasibility of recruiting boys with DMD to a randomised trial evaluating AT
(primary objective) and to collect data from them; to assess how, and how well, the intervention and trial
procedures work.
Design: Parallel-group, single-blind, randomised pilot trial with nested qualitative research.
Setting: Six paediatric neuromuscular units.
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Participants: Children with DMD aged 7–16 years, established on corticosteroids, with a North Star
Ambulatory Assessment (NSAA) score of 8–34 and able to complete a 10-m walk without aids/assistance.
Exclusions: > 20% variation between baseline screens 4 weeks apart and contraindications.
Interventions: Participants were allocated on a 1 : 1 ratio to (1) optimised, manualised LBT (prescribed by
specialist neuromuscular physiotherapists) or (2) the same plus manualised AT (30 minutes, twice weekly
for 6 months: active assisted and/or passive stretching regime; simulated or real functional activities;
submaximal exercise). Semistructured interviews with participants, parents (n = 8) and professionals (n = 8)
were analysed using Framework analysis. An independent rater reviewed patient records to determine the
extent to which treatment was optimised. A cost-impact analysis was performed. Quantitative and
qualitative data were mixed using a triangulation exercise.
Main outcome measures: Feasibility of recruiting 40 participants in 6 months, participant and therapist
views on the acceptability of the intervention and research protocols, clinical outcomes including NSAA,
independent assessment of treatment optimisation and intervention costs.
Results: Over 6 months, 348 children were screened – most lived too far from centres or were enrolled in
other trials. Twelve (30% of target) were randomised to AT (n = 8) or control (n = 4). People in the AT
(n = 8) and control (n = 2: attrition because of parental report) arms contributed outcome data. The mean
change in NSAA score at 6 months was –5.5 [standard deviation (SD) 7.8] for LBT and –2.8 (SD 4.1) in the
AT arm. One boy suffered pain and fatigue after AT, which resolved the same day. Physiotherapists and
parents valued AT and believed that it should be delivered in community settings. The independent rater
considered AT optimised for three out of eight children, with other children given programmes that were
too extensive and insufficiently focused. The estimated NHS costs of 6-month service were between £1970
and £2734 per patient.
Limitations: The focus on delivery in hospitals limits generalisability.
Conclusions: Neither a full-scale frequentist randomised controlled trial (RCT) recruiting in the UK alone
nor a twice-weekly open-ended AT course delivered at tertiary centres is feasible. Further intervention
development research is needed to identify how community-based pools can be accessed, and how
families can link with each other and community physiotherapists to access tailored AT programmes
guided by highly specialised physiotherapists. Bayesian RCTs may be feasible; otherwise, time series designs
are recommended.
Trial registration: Current Controlled Trials ISRCTN41002956.
Funding: This project was funded by the National Institute for Health Research (NIHR) Health Technology
Assessment programme and will be published in full in Health Technology Assessment; Vol. 21, No. 27.
See the NIHR Journals Library website for further project information.
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Glossary
Aetiology The causes of a disease or condition.
Ambulation Walking.
Bayesian Tradition of statistical methods distinct from mainstream ‘frequentist’ approaches.
Blinded/blinding Concealment of group allocation from individuals involved in a randomised
controlled trial.
Contractures A condition involving the shortening and hardening of muscles, tendons or other tissue,
often leading to deformity and rigidity of joints.
Contraindications Situation in which a procedure should not be used because it may be harmful.
Convergence coding/assessment Summary of similarities and differences between two sets of data.
Cytoskeleton Microscopic network of protein filaments and tubules that give living cells shape
and coherence.
Disuse atrophy Withering of muscles as a result of lack of muscle use.
Dorsiflexion Flexion between the foot and the front of the leg.
Dystrophin A protein found in skeletal muscle, which is absent in patients with Duchenne
muscular dystrophy.
Dystrophinopathy Duchenne or Becker muscular dystrophy.
Epidemiology The study of incidence, distribution and possible control of diseases.
Framework analysis Qualitative method, suited for applied policy research.
Frequentist Mainstream tradition of statistical methods.
Glucocorticoid corticosteroids A class of anti-inflammatory drugs.
Haemodialysis Kidney dialysis.
Hydrodynamic Motion of fluids and the forces acting on solid bodies immersed in fluids and in motion
relative to them.
Hydrostatic Equilibrium of liquids and the pressure exerted by liquid at rest.
Hydrotherapy Use of exercises in a pool as part of treatment for conditions. Increasingly referred to as
‘aquatic therapy’.
Hypertonia An abnormal increase in muscle tension and the reduced ability of a muscle to stretch,
caused by injury to motor pathways in the central nervous system.
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xvii
Hypertrophy Enlargement of an organ or tissue from the increase in size of its cells.
Hypotonia Low muscle tone.
Iliotibial tract/band Long fibrous connective tissue that helps the thigh muscle to extend or rotate
the hip.
Learning support assistant A person, often referred to as a teaching assistant, who supports teachers
and pupils in mainstream schools with special educational needs units and special schools.
Logic model A tool used to evaluate the implementation of a programme of care.
MEDLINE Bibliographic database.
Musculature The arrangement of muscles in a body.
Myoglobin/myoglobinuria The presence of the protein myoglobin in the urine, usually associated with
muscle damage.
Neurodevelopment The growth and development of the brain or central nervous system.
NVivo (QSR International, Warrington, UK) Computer software package for qualitative data analysis.
Orthosis An external device that may support the limbs/spine or prevent/assist movement.
Orthotics Devices such as splints and braces.
Pathology Effects of diseases.
Prognosis The probable future course of a medical condition.
Scoliosis Twisting leading to the lateral curvature of the spine.
Sequential design Sometimes referred to as cross-sequential design, defined as a combination of
longitudinal and cross-sectional design by following several differently aged cohorts over time.
Success criteria The basis on which the feasibility of a research study is to be demonstrated.
Teaching assistant See Learning support assistant.
Tertiary centre A large hospital that provides specialist health care and receives referrals from secondary
and primary care.
Thermodynamics Relationships between heat and mechanical energy.
Transmembrane Existing or occurring across a cell membrane.
Triangulation Method used by qualitative researchers to establish trustworthiness by comparing the
findings of different methods or perspectives.
Triceps surae A muscle in the calf area of the leg.
GLOSSARY
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xviii
Viscoelastic deformation The ability of some tissues to stretch and remain stretched for some time
before slowly returning to their original length.
Viscosity The body’s inhibition of quick muscle reaction as it slows contraction, preventing tearing
during loading.
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xix

List of abbreviations
6MWD 6-minute walk distance
ACTIVLIM Activity Limitations Measure
AT aquatic therapy
ATACP Aquatic Therapy Association of
Chartered Physiotherapists
CarerQoL Care-related Quality of Life
CHU-9D Child Health Utility 9D Index
CI confidence interval
CTRU clinical trials research unit
DMD Duchenne muscular dystrophy
FVC forced vital capacity
ICF-CY International Classification of
Functioning, Disability and Health –
Children and Youth version
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Plain English summary
Background
Physiotherapy is thought to help children with Duchenne muscular dystrophy (DMD) stay physically active.
Aquatic therapy (AT; also known as hydrotherapy), that is, physiotherapy in warm water, allows exercise
and stretching that are not possible on land. It is not clear that AT works, so NHS access is limited.
Objectives
To see if a full-scale controlled trial (experiment) was feasible, we wanted to enrol 40 children to a pilot
study, 20 of whom would have AT. We also tested the design and procedures.
Methods
All children were asked to do stretching and exercise at home. We planned that half would have AT in
hospital pools for half an hour, twice a week, for 6 months. We measured how well they could use their
legs at the beginning and end of the study. After this, children, parents and physiotherapists told us how
they felt about AT and the study.
Results
We screened 348 children with DMD for the study. Only 12 could enter the study. This number is too low
to show whether or not AT works. Those involved said that it should be offered nearer to their homes
than we managed. The cost to the NHS for 6 months of hydrotherapy treatment was £1970–2734
per child.
Conclusions
An insufficient number of children could be found for a full-scale study run only from hospitals. Local AT
programmes should be designed by specialist physiotherapists in liaison with children, parents, community
physiotherapists and teaching assistants. Standard trial designs may not be feasible. Other research designs
might be needed to test AT.
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Scientific summary
Background
Duchenne muscular dystrophy (DMD) is a rare disease that mainly affects boys. Among other effects, it
causes progressive skeletal muscle weakness, which results in the loss of motor abilities such as walking.
For many years, treatment has included daily physiotherapy. There is no randomised controlled trial (RCT)
evaluating whether or not adding aquatic therapy (AT) to land-based exercises helps to keep muscles
strong and boys with DMD independent.
Objectives
The primary objective was to determine the feasibility of recruitment to a full-scale trial, through recruiting
40 participants in 6 months from four centres, with two centres in reserve. The secondary objectives were
to assess how, and how well, the intervention and trial procedures work.
Design
Development and formative evaluation of a complex intervention. Two-arm, parallel-group, external pilot
randomised trial, with a 1 : 1 allocation ratio, using web-based randomisation and with only the principal
investigator and analysts blind to allocation until after the final analysis. Intervention optimisation,
qualitative research and health economic substudies.
Setting
Six paediatric neuromuscular units in the UK.
Participants
Between 24 October 2014 and 30 June 2015, 348 boys were screened for eligibility. The eligibility criteria
included having genetically confirmed DMD, a North Star Ambulatory Assessment (NSAA) score of 8–34,
being aged 7–16 years, being established on glucocorticoid corticosteroids and able to complete a 10-m
walk test with no walking aids or assistance. Thirteen boys consented and 12 were randomised (30% of
the recruitment target, n = 40) to AT plus land-based therapy (LBT) (n = 8) or LBT alone (n = 4).
Interventions
First, manualised AT, delivered by an AT-trained physiotherapist, in a 30-minute session, twice per week, in
a NHS pool heated to a temperature of 34–36 °C plus LBT. A manual provided a menu of aquatic exercises
using the properties of water (buoyancy, turbulence) including (1) active assisted and/or passive stretching
that targets key muscle groups, (2) simulated or real functional activities and (3) submaximal exercise.
Second, manualised LBT, prescribed by a specialist physiotherapist at baseline, tailored to the capability and
needs of the participant, with best practice advocating a regular stretching regime delivered by parents
(4–6 days per week, physiotherapists advised participants not to complete LBT and AT on the same day)
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targeting key muscle groups, plus a directed programme of exercises and advice on regular activity
designed to prevent disuse atrophy.
Main outcome measures
Feasibility outcomes
1. Feasibility of recruitment to the main trial [recruitment of 40 participants in 6 months from four centres,
with two in reserve (primary outcome)].
2. Decision on primary end point for main trial.
3. Feasibility of recruiting participating centres.
4. Number/characteristics of eligible patients approached, consenting, randomised and followed up, with
reasons for refusal of consent and attrition.
5. Data completeness.
6. Independent assessment of whether AT or LBT was optimised.
7. Participant, parent and physiotherapist views on the acceptability of research and intervention procedures.
Clinical outcomes
For all participants:
1. NSAA
2. 6-minute walk distance (6MWD)
3. forced vital capacity
4. Activity Limitations Measure
5. Child Health Utility 9D Index – health state utility
6. the Care-related Quality of Life (carer burden) questionnaire
7. health and social care resource use questionnaire.
For participants allocated to AT only, at the end of each session:
1. pain (visual analogue scale)
2. Children’s OMNI Scale of Perceived Exertion.
Barriers to implementation of the trial and intervention were assessed using e-mail communication and
Trial Management Group meeting minutes. Views on the acceptability of the AT and research protocols
were obtained through semistructured interviews with participants, parents (n = 8 children) and health
professionals (n = 8). Interviews were audio-recorded and transcribed verbatim with transcripts coded in
NVivo version 11 (QSR International, Warrington, UK) and analysed using Framework analysis.
An independent rater reviewed baseline data and patient records (medical, social and school history) to
determine the extent to which treatment was optimised, using attendance logs, the therapist-completed
AT exercise log and the parent-completed LBT log.
A cost analysis was performed. Quantitative and qualitative data were mixed using a triangulation exercise.
Results
Over 6 months, 348 boys were screened, most of whom lived too far from centres or were enrolled in
other trials; 13 consented and 12 were randomised (30% of target) to AT (n = 8) or control (n = 4).
Two participants withdrew from, and one was lost to follow-up in, the control arm. As a result, the
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intention-to-treat analysis involved nine (AT, n = 8; control, n = 1) participants for all outcomes, except the
routinely collected NSAA score, which was available for 10 participants.
Feasibility outcomes
Of the 349 scheduled AT sessions for which we have data, 203 (58.2%) expected sessions took place and
146 (41.8%) did not. Where the reasons for session cancellation were reported (10% of sessions were
unaccounted for), there was a fairly even split between participant/family factors (43%) and health-care
provider factors (47%). Only four participants (all AT) contributed data on adherence to LBT prescriptions;
all had good, achievable prescriptions, with a median weekly compliance of > 70%.
The mean 6MWD at 6 months was 347.63 m [standard deviation (SD) 81.88 m] in the AT arm (n = 8); only
one participant contributed 6MWD data in the control arm (255 m). The mean NSAA score at 6 months
was 21.0 (SD 15.6) in the control arm (n = 2) and 21.4 (SD 8.5) in the AT arm (n = 8), a difference of
–0.38 [95% confidence interval (CI) –17.95 to 17.2]. The change score was –5.5 (SD 7.8) in the control
arm and –2.8 (SD 4.1) in the AT arm, a difference of –2.8 (95% CI –11.3 to 5.8).
Interviews with families revealed a context in which parents were attempting to ‘keep it as normal as
possible’ while having ‘to fight . . . to put everything in place’ for their children. In four families (five boys),
there were other boys with DMD aside from those in the study. Parents, teaching assistants or, less
frequently, community physiotherapists delivered LBT. Some parents reported back pain and a lack of
confidence in delivery. Outside the study, most parents had been able to access at least one block of
4- to 6-weekly half-hour AT sessions since their sons had developed mobility problems. Some would be able
to apply for another block in 6 months’ time. They valued exercise in warm water, reporting that their sons
were unable to function for long in regular pools and that they felt that the break between ‘blocks’ was
unhelpful. Patient and public involvement members made the point that long-term aquatic exercise is the
last form of exercise that people with DMD maintain. Responding to the study AT, most parents valued
perceived gains in function or social/water confidence, as well as the closer working relationship with the
therapy team. Fatigue was a problem for two boys attending morning sessions. One of them, who was the
oldest in the study and the boy experiencing the most rapid decline in function, also missed school as a
result of his fatigue. This child was the only one who had both optimised therapy and good attendance,
but reported dissatisfaction with the AT and with pain, although the pain resolved the same day. Attending
AT at specialist centres involved long journeys, sometimes 3-hour round trips through rush hour traffic,
for parents who mostly lived 15 miles away. All would have liked to have accessed AT at more local
community pools.
Physiotherapists at two trusts questioned the value of the AT because of the opportunity cost to the trust.
The message delivered in AT training was that AT prescriptions should be focused on the needs and
capability of the individual, but many therapists thought that they had been asked to deliver stretches that
could be delivered on dry land or a range of exercises regardless of relevance. As a result, some were
dissatisfied with the intervention. Participating physiotherapists believed that, in future, AT should be
delivered in community rather than tertiary settings. Host organisations did not normalise the ongoing
delivery of the intervention. Most of the physiotherapists were pleased with the new skills that they had
acquired and felt that they would advocate the use of more frequent and intensive AT in other, more
patient-convenient, settings, where resources permitted.
Physiotherapists and parents valued AT and believed that it should be delivered in community settings. The
independent rater considered AT optimised for three out of eight boys, with other boys given programmes
that were too extensive and insufficiently focused.
Estimated direct NHS costs of AT provision at a tertiary centre ranged from £1970 to £2734 over 6 months,
based on attendance; societal costs ranged from £2541 to £3775. The estimated direct NHS costs of LBT
were £80–320, depending on the frequency with which the physiotherapist saw the boys; societal costs
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ranged from £732 to £1094. This could compare unfavourably with other specialist paediatric services, but
delivery in the community could reduce the costs substantially.
Conclusions
Neither a full-scale RCT, designed on frequentist lines and recruiting in the UK alone nor a twice-weekly
open-ended AT course delivered at tertiary centres is likely to be feasible. Many of the barriers that we
encountered in the delivery of AT may not be encountered to the same extent if the intervention was
delivered more locally to the service user and in community settings. Further intervention development
research is needed to identify how community-based pools can be accessed and how DMD families can
link with each other as well as community physiotherapists who can tailor AT programmes guided by
highly specialised physiotherapists from tertiary centres. Bayesian RCTs may be able to reduce sample sizes
such that UK-based recruitment is feasible over 2–3 years. Future studies should use the routinely collected
NSAA score as a primary outcome.
Trial registration
This trial is registered as ISRCTN41002956.
Funding
Funding for this study was provided by the Health Technology Assessment programme of the National
Institute for Health Research.
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Chapter 1 Introduction
Duchenne muscular dystrophy
Epidemiology
Duchenne muscular dystrophy (DMD) is a genetic disease mainly affecting boys. It affects between 1 in
3600 and 1 in 6000 live male births;1–3 the prevalence is 5 in 100,000.4
Aetiology
Duchenne muscular dystrophy is caused by deletions, duplication or point mutations in a gene on the
X chromosome.5 The gene codes for a protein, dystrophin, that links the cell’s cytoskeleton to a
transmembrane complex. Absence of this protein causes disease in muscle cells and brain neurons. The
precise mechanism is still uncertain.
Pathology
In muscle, pathological studies show a ‘dystrophic’ picture in which there are dying muscle cells and
regenerating muscle cells, together with inflammatory cells and excess amounts of fat and connective
tissue.6,7 Clinically, this manifests as weakness, first of the larger skeletal muscles around the shoulders and
hips, and later of all skeletal muscles in the limbs and trunk. With increasing age, this causes a progressive
loss of functional abilities that affect mobility (going up stairs, walking, standing, sitting and transferring
between objects such as a chair or bed), activities of daily living (dressing, bathing and eating) and
eventually breathing. As the disease progresses, muscles and tendons become shorter. These ‘contractures’
then prevent the joints they operate from moving through their full range, because the muscle can no
longer stretch as completely as it should. The calf and long finger muscles are often involved by the age of
5 years, causing an inability to bend the foot fully up towards the shin (dorsiflexion) or straighten the
fingers back. If untreated, contractures become more severe with time. Later, weakness of the trunk
muscles causes scoliosis or curvature of the spine. The heart muscle is increasingly affected with age,
eventually leading to impaired function and cardiac failure. The smooth muscle of the bowel deteriorates,
affecting bowel function. The lack of dystrophin subtypes in the brain increases the risk of non-progressive
cognitive dysfunction, which is associated with communication difficulties.8
Prognosis
Untreated, half of boys will lose independent ambulation by the age of 9 years, and all will do so by the
age of 12 years. Scoliosis and impaired heart function start in early adolescence, whereas breathing
difficulty develops later in adolescence. In the 1960s, survival beyond mid-adolescence was unusual. With
better therapies, survival increased to late adolescence in the 1970s to the 1990s. In the past two decades,
the introduction of more effective respiratory support and heart treatment has increased survival into the
early 30s, or longer. The more widespread use of corticosteroids from a young age has slowed disease
progression; in those taking daily steroids, the average age at loss of ambulation has increased to
14 years.9
Significance in terms of ill health
Health-related quality of life for boys with DMD and their carers is lower than for the general population.10,11
Although physical and psychosocial domains of health-related quality of life are comparatively low in boys
with DMD, psychosocial quality of life is sometimes higher in adolescents than in school-age children,
indicating the development of coping strategies.12–14 The psychosocial well-being of parents is greatly
impacted, particularly around the time of a boy’s transition to wheelchair use.15,16 Parents, especially mothers,
report high levels of anxiety, depression and guilt.17,18 Early diagnosis and the resilience of the family unit,
expressed as their commitment and control, were associated with improved psychological adjustment by the
parent, resilience on the part of the boy and response from siblings.18–22 Parents, and mothers in particular,
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report care activities, such as including help for bathing and toileting, as time-intensive and contributing to
social isolation.23
Health-care costs are associated with access to specialist paediatricians/physicians in neurology, respiratory,
cardiac and endocrine fields, orthopaedic surgeons, psychologists, physiotherapists and occupational
therapists. Boys will sometimes have care co-ordinators or advisors, dietitians or nutritionists, or speech/
language/swallowing therapists. Young men older than most of those in our study are likely to make
increased use of emergency and respite care. Outside the health services, older boys may access home
help, personal assistants and transportation services. From around 8 years of age, the median age of boys
entering our study, families will typically make investments in and reconstructions of the home, for
instance making adaptations for wheelchair accessibility.24 Adaptations may also be required to educational
facilities. A systematic review of the cost of illness4 noted only three studies that reported cost-impact data,
all of which were > 20 years old.25–27 However, a questionnaire study24 involving people with DMD in
Germany, Italy, the UK and the USA provided per-patient annual costs of DMD in 2012 in international
dollars. The questionnaire elicited information about hospital admissions, visits to health-care professionals,
tests, assessments, medications, non-medical community services, aids, devices, alterations to the home and
informal care. Mean per-patient annual direct cost was $23,920–54,270, which is between 7 and 16 times
higher than the mean per-capita health expenditure. The total societal costs were $80,120–120,910 per
patient per annum, increasing sharply with disease progression. Mean household costs were estimated
at $58,440–71,900.24
Current service provision
Pharmacological management and multidisciplinary care excluding physiotherapy
At diagnosis, a boy and his family will typically be seen by a paediatrician at their local hospital, often
a district general hospital. They will then be referred to a specialist muscle clinic, usually involving a
paediatric neurologist, in their regional teaching hospital.28 Regular review and ongoing medical care is
provided by these services. The boy and his family will also be seen by the regional genetics service.
As part of this service provision they will also be referred to the local paediatric physiotherapy team for
assessment and management (see Physiotherapy). If needed, they may be referred for occupational
therapy advice as well. Educational services will also be involved. Some children and their families may also
benefit from psychological support.
From the age of 3–4 years, most boys will start treatment with corticosteroids, which requires 6-monthly
monitoring visits. If complications develop, extra visits and referrals may be needed. One frequent early
complication is excess weight gain, which would lead to referral to dietetic services. Approximately
one-third of the current population of ambulant boys is eligible for trials of newer treatments designed
to increase the amount of the missing dystrophin protein in muscle cells, leading to a milder disease course.
If successful, these treatments are likely to become generally available, and additional products are likely to
be designed to expand the number of boys who could benefit.
Physiotherapy
Although physiotherapy has been a mainstay of treatment since the 1960s, there is relatively little evidence
for its efficacy. There have been no generally accepted guidelines on what type or dose of physiotherapy
intervention should be provided.29,30 Many recommendations are based on animal studies in which
contraction-induced muscle injury was observed in dystrophinopathy.31 A Muscular Dystrophy Campaign
workshop29 agreed that the main aims of physiotherapy in neuromuscular disease should be to:
1. maintain or improve muscle strength by exercise
2. maximise functional ability through the use of exercise and the use of orthoses
3. minimise the development of contractures by stretching and splinting.
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The prevention of joint contractures is a multidisciplinary effort, involving specialist hubs and community
spokes.32 Regional consultant neurologists and specialist neuromuscular physiotherapists review disease
progress and treatment regimens at clinic visits, typically twice a year, and offer management suggestions
to community physiotherapists.28 While a boy is still able to walk, a community paediatric physiotherapist
will monitor him for hip and ankle contractures until he becomes wheelchair dependent.33 The community
physiotherapist is responsible for tailoring a programme of stretches and exercises to the boy’s individual
needs and tolerance levels,28 and for training parents, carers, school staff or, occasionally, other health and
social care staff to deliver the stretches.33
Management should consist of a variety of treatment options aimed at maintaining the length and
extensibility of affected muscle groups.34 Although evidence to support interventions aimed at improving the
range of movement is lacking, there are generally recognised principles that should be carried out to delay
or, where possible, prevent the development of contractures.35 These include the prescription of a regular
targeted stretching regime and the use of specific orthotics (e.g. resting or night splints are generally
recommended). Stretches are typically prescribed to be performed at home, in school or occasionally in
community clinics, on a minimum of 4–6 days per week.28 They are intended to maintain dorsiflexion and
hip flexion range, among other targets, with a view to postponing the onset of contractures and prolonging
the length of time the child can walk independently.33 There are no clear guidelines to specific exercise
prescription, but regular submaximal exercise is recommended to maintain existing muscle strength and
avoid secondary disuse atrophy,36,37 along with general advice on regular activity such as walking, cycling
and swimming. Although there is still the need for further research, there is general agreement that exercise
that contains a substantial eccentric component (such as trampolining, stair descending) should be avoided
because of the risk of exacerbating muscle damage.38
Physiotherapy plays its part in the holistic, multidisciplinary management of children with DMD, providing
specialist assessment, physiotherapy prescription and ongoing monitoring and evaluation of a complex and
progressive condition.28 Liaison with other specialist services, such as orthotics, wheelchair services, social
and housing services, and schools to ensure the provision of appropriate equipment and support in a
timely manner to maximise function and independence wherever possible is key. Hyde et al.39 recommend
the use of night splints. Resting or night splints, generally ankle–foot orthoses, are provided for use in
combination with a regular stretching regime to optimise the length of the tendo-Achilles complex and
maintain ankle dorsiflexion at night.28,33,39 Children who are losing the ability to walk may be provided with
knee–ankle–foot orthoses and may have surgical intervention to release tendons with a view to maintaining
joint motion and independent ambulation.28,33 Postponing wheelchair use may also defer the more or less
inevitable associated onset of spinal scoliosis.33
Aquatic therapy
Introduction
Exercise that is safe and controlled but still sufficiently intense to maintain physical function is a challenge for
children with altered muscle tone, balance or motor control problems and severe contractures.40 Warm water
allows children with DMD to perform targeted stretches, exercises and function-based and play activities that
are progressively lost to them on dry land.33 An aquatic therapy (AT) pool may be the only setting in which
these children can learn new postures or skills and maintain fitness without damaging their joints.
Although definitions sometimes overlap, common usage distinguishes hydrotherapy and ‘aquatic therapy’
and, especially, ‘aquatic exercise’, from ‘balneotherapy’, which denotes seated immersion or spa therapy
without exercise.41–43 The Aquatic Therapy Association of Chartered Physiotherapists (ATACP) defined
aquatic physiotherapy as:
A physiotherapy programme utilising the properties of water, designed by a suitably qualified
Physiotherapist. The programme should be specific for an individual to maximise function which can
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be physical, physiological, or psychosocial. Treatments should be carried out by appropriately trained
personnel, ideally in a purpose built, and suitably heated pool.
ATACP43
They permit the use of the term ‘aquatic therapy’ for water-based programmes, designed by a suitably
qualified physiotherapist, but carried out by non-specialist physiotherapists, or by carers and teaching
assistants without specialist knowledge of anatomy and physiology.
Theoretical basis
In addition to the theories underpinning land-based therapy (LBT) (see Physiotherapy), the theoretical bases
for AT are our understanding of the physical properties of water and a learning theory that accounts for
developmental aquatic readiness, a model of systematic desensitisation44 and the biomechanical principles
of the floating human body,45 as encapsulated in the Halliwick Concept.46
The physical properties of water that are relevant to physiotherapy are density and specific gravity,
hydrostatic pressure, buoyancy, viscosity and thermodynamics.47 For DMD, a musculoskeletal condition,
immersion brings the following benefits. First, warm water may increase cardiac output away from the
splanchnic beds to the skin and musculature.48–50 Blood flow to the muscles may be enhanced at rest51 and
during exercise.52 Second, body weight is offloaded with immersion, with the desired amount of loading
variable by depth.53 In musculoskeletal conditions, then, it is hypothesised that the hydrostatic effects and
the warmth of the water, compared with cooler water in community swimming pools, make muscles more
supple. The buoyancy and antigravity effects relieve pressure on joints, leading to a reduction in pain and
an increase in joint mobility compared with strengthening and stretching exercises performed on dry
land.47 The metacentric or rotational effects, caused by altering the amount of the body that is immersed
or the shape of the body in water so that the body is displaced requiring postural adjustments, are used to
develop balance, core/proximal stability (stomach, shoulder and hip muscles) and to simulate function
(transitions between positions – sit to stand, rolling over, going up steps, lying to sitting).
Systems such as Halliwick, which teach people with disabilities to return to a safe breathing position in
water,46 thereby producing confidence and safety, are essential for an AT/physiotherapy programme.54
They combine two elements: first, the ‘Ten Point Program’, which covers aspects of mental adjustment
(including water confidence and breath control), balance control and movement; and, second, a protocol
for ‘Water Specific Therapy’, involving assessment and objective setting, based on which the therapist
chooses appropriate exercise patterns and treatment techniques.46
Intervention methods and materials
Aquatic therapy pools typically operate at temperatures of 32–36 °C, higher than the 28 °C of conventional
swimming pools, with a greater level of disinfectant and more frequent microbial sampling.55 Pool size
varies, with a recommended minimum space of 2.5 m × 2.25 m per patient and a typical depth of 1–1.2 m,
often on a gradient. The provision of changing rooms with adequate space and wide entrances is optimal,
along with hoists, both in the changing rooms and to get in and out of the pool. An ATACP foundation
programme for chartered physiotherapists is necessary for safe and effective treatment.56 Subjective,
Objective, Assessment and Plan (SOAP) record keeping is recommended.33
Evidence for effectiveness
In an overview,42 three systematic reviews evaluating aquatic exercise against controls in adults with
musculoskeletal conditions showed small post-intervention improvements in function [n = 648, standardised
mean difference 0.26, 95% confidence interval (CI) 0.11 to 0.42], quality of life (n = 599, standardised
mean difference 0.32, 95% CI 0.03 to 0.61) and mental health (n = 642, standardised mean difference
0.16, 95% CI 0.01 to 0.32).57–59 They also found a 3% absolute reduction and a 6.6% relative reduction in
pain, measured on a visual analogue scale (n = 638, standardised mean difference 0.19, 95% CI 0.04 to
0.35). The meta-analyses identified no differences for walking ability or stiffness.
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Although annotated bibliographies on the use of AT in disabled children exist,60,61 we are aware of only
one relevant systematic review of aquatic interventions for children with neuromotor or neuromuscular
impairments.62 It included one randomised controlled trial (RCT) and 10 observational studies. Only three
studies, all with low levels of evidence, investigated neuromuscular disorders. Seven articles indicated
improvements in physical function and activity level, and two out of four articles investigated levels of
participation-indicated improvements. The review concluded that there was a lack of quality evidence on
the effects of AT in this population.
Current aquatic therapy provision in the UK
Although many health professionals believe that AT can improve mobility, strength, flexibility and
cardiopulmonary fitness,63 and although AT is a routine part of care in other countries, access is uneven
and restricted in the UK.64 At the end of 2015, the charity Muscular Dystrophy UK (MDUK) identified 179
AT pools in the UK that people with muscle-wasting conditions could potentially use, but highlight that:
l many hydrotherapy pools are based in schools and are only open during school hours and terms
l privately-owned hydrotherapy pools can be expensive to access – often more than £75 for a
half-hour session
l people have to travel long distances to get to a pool, and this is not sustainable
l hydrotherapy pools do not always have hoists, or accessible changing facilities.
Reproduced with permission from MDUK, Hydrotherapy in the UK: The Urgent Need for
Increased Access64
Muscular Dystrophy UK asserts that NHS-funded AT ‘is often restricted to patients whose improvements
can be demonstrably measured’;64 as such, functional improvements are difficult to demonstrate in
degenerative conditions and funding is often absent or limited. In MDUK’s report, a young person with
DMD is quoted as saying:
We have an ongoing need for hydrotherapy, which is not fulfilled by just being given a block of
sessions for six weeks. This does not allow us to continue to maintain our condition because once our
block of six sessions is over we struggle to be able to access hydrotherapy treatment anywhere else.
Reproduced with permission from MDUK, Hydrotherapy in the UK: The Urgent Need for
Increased Access64
The aspiration to access AT throughout the year, rather than in 4- to 6-week blocks, is confirmed by our
patient and public involvement (PPI) author, James Parkin, who notes ‘If you have AT regularly, it improves
self-esteem; self-esteem improves how you deal with self-management’. A long hiatus between sessions
can decrease water confidence and result in a loss of skills. Our qualitative research (see Chapter 5,
Environmental factors and Operational work) confirms that, where publicly funded AT is available, it often
comes in blocks of 4 or 6 weeks, ≥ 6 months apart, and is not necessarily routine but may be contingent
on a successful application. MDUK end their report by arguing that access to AT helps people with
muscle-wasting conditions ‘to manage their condition and improve their quality of life by reducing pain
and increasing mobility’.64 They make an appeal to equity, proposing that access should not depend on
where a person lives or their disposable income.64
Rationale and objectives
Rationale
The National Institute for Health Research (NIHR) published a commissioning brief (commissioning brief
HTA 12/144) requesting a ‘feasibility study’ to evaluate the addition of ‘manualised hydrotherapy’ to
‘optimised land-based exercise’ for children and young people with DMD who still have some mobility.
There are several ways in which we might have interpreted and responded to this brief so, at this point,
it is worth taking the reader through the choices we made and why we made them. First, confusion about
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the definition of feasibility studies, which has since been widely acknowledged,65,66 meant that a decision
had to made on the primary objective of this study. The request for a control group, and the focus on the
ability to recruit and randomise, led us to interpret the brief as requiring an external pilot RCT, sometimes
defined as ‘a version of the main study run in miniature to determine whether the components of the
main study can all work together’.66 In other words, we interpreted the brief primarily as a study to
understand the feasibility of a research protocol for a full-scale RCT, rather than of the feasibility of
delivering manualised AT per se. As the reader will see, an understanding of both issues is likely to be
important for future clinical decision-making and the commissioning of further research.
Primary objective
A future full-scale trial would test the hypothesis that AT in addition to LBT is more effective than LBT
alone for the maintenance of functional, participation or quality-of-life outcomes. The primary objective
of this external pilot RCT was to determine the feasibility of a full-scale trial, defined in terms of
participant recruitment.
Secondary objectives
Secondary objectives were the identification of:
1. the best primary outcome for a full-scale trial
2. the consent rate among eligible boys with DMD who were approached about the study
3. why boys with DMD refuse consent
4. the proportion of boys who provide valid outcome data 6 months after entering the trial
5. reasons for attrition from the trial
6. the views of participants and their families on the acceptability of the research procedures and the
AT intervention
7. the robustness of the intended data collection tools
8. the willingness of participating centres to provide an AT service and to recruit participants
9. the ability of participating physiotherapists to deliver the AT intervention faithfully in accordance with
a manualised protocol
10. therapist views on the feasibility of the AT intervention and the acceptability of the research protocol.
INTRODUCTION
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Chapter 2 Methods
The final protocol for this study can be found on the NIHR website.67
Developing the intervention and associated theory
Overview
None of the team’s specialist physiotherapists knew of intervention manuals tailored to the needs of boys
with DMD, as per the NIHR brief. As they would be interventions ‘with several interacting components’,
we followed the steps recommended by the Medical Research Council Framework in developing them in
parallel with the grant application process.68 The first step, identification of the evidence base, has been
discussed: there is no standard approach to LBT or AT for boys with DMD based on evidence for
improvement in function, participation and emotional well-being. Either may help children with DMD
maintain physical function but certain types of exercise are thought to be dangerous (see Chapter 1,
Physiotherapy and Evidence for effectiveness). The second step, identifying/developing intervention theory,
is addressed in The development of treatment manuals and theory. The third and final step is modelling
the process and outcomes of implementation, culminating in the development of a programme theory
(see Modelling process: developing programme theory). As researchers do not always have the same vision
of what theory is supposed to be or do,69 to clarify, then:
1. The function of a pilot RCT is not to test physiological treatment theory, but to determine whether a
future full-scale RCT would be capable of doing so.70,71
2. Initial testing of the programme theory, using linear logic modelling, is one subject of this report.
3. We also access theory to consider why patterns of observations may have occurred. We use general
theories and conceptual frameworks, concerning disability and participation, the burden and
implementation of services and the character of AT service delivery traditions, to better understand how
the social context mediates programme delivery.
The development of treatment manuals and theory
Key stakeholders attended an all-day meeting on 27 March 2013, 4 hours of which were set aside to
inform the design of the study intervention (Table 1).
Specialist physiotherapists proposed a set of exercises appropriate to manage the development of DMD in
the target population group (see Figure 1 and Interventions). They also agreed that there should be free play
at the end of the session, that disease progression should be monitored throughout the study with exercise
prescription adapted accordingly and that, in the context of this study, it was worth experimenting with a
twice-weekly programme that continued for as long as possible. Members of the team felt that, with no
reliable ‘dose–response’ data available for the use of AT in people with DMD, maximising the dose would
improve the chances of detecting a treatment effect, if one existed, in any future, full-scale trial. After the
meeting, Heather Epps modified an AT manual created for the management of junior idiopathic arthritis,73
Marion Main adapted an existing LBT manual for the management of DMD,34 and the physiotherapists
agreed that the manual was suitable for testing. The intervention protocols are described in Interventions.
At successive meetings we developed a treatment theory that hypothesises links between ingredients
(observable measurable actions, chemicals, devices or forms of energy), mechanisms of action (processes
through which the ingredients bring about change) and targets (measurable aspects of the individual’s
functioning that is predicted to be directly changed).74,75 Figure 1 shows the treatment theory, with
ingredients 1 and 2 applying to LBT and all three ingredients applying to the AT intervention. Stretches
(ingredient) provide mechanical traction for,76 and relax,37 muscles (mechanisms), which tend to tighten
with the progression of DMD, thereby maintaining muscle length and soft tissue structure, while deferring
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the development of contractures (target).37 Muscle training and general aerobic, submaximal exercises
(ingredients) create biochemical adaptations that increase muscle mass by means of muscle fibre
hypertrophy37 and maintained stroke volume77 (mechanisms) to prevent disuse atrophy and maintain or
improve skills such as sit to stand, getting up from the floor and stair climbing (targets). Warm water
(ingredient) creates haemodynamic changes78 and offers properties such as buoyancy and turbulence
(mechanisms)47 that are not available in land-based physiotherapy, thereby reducing mechanical stress
during muscle strengthening and allowing activation of muscles in ways not possible on land (target).
The mental adjustment and disengagement stages of the Halliwick Concept46 (ingredients) may use
mechanisms (e.g. reciprocal inhibition,79 systematic desensitisation80 and extinction81) that psychologists
associate with exposure with graded support to achieve water confidence and participation (targets).
Modelling process: developing programme theory
A treatment theory is essentially physiological and, in this project, limited in scope to the prescribed
exercises performed in the pool. Around these exercises is a ‘programme’, that is, a ‘set of planned activities
directed toward bringing about specified change(s)’82 in boys with DMD through prescribed exercises. A
programme theory recognises that, around the AT exercises, there is a complex series of contracts, actions,
interactions and emergent relationships between people and organisational units. For many researchers, the
purpose of evaluating a programme is to develop or test a theory about how it works, rather than merely
evaluating whether it works.83 If the programme is successful, then the evaluation can identify essential
elements for replication; if the programme is unsuccessful, then it can identify whether or not this was
through failures of implementation, translation to unsuitable contexts or treatment theory.84 A programme
theory, then, is broader than a treatment theory; it focuses on assumptions about background behavioural,
social and economic mechanisms that operate if the treatment is to be delivered as scheduled.85 Programme
theory was developed iteratively: (1) deductively, through a review of the literature, (2) by articulating
mental models, through discussions at stakeholder meetings, and (3) inductively through interviews with
participants and professionals.86
TABLE 1 Those contributing to the intervention development process
Name by category of expertise Affiliation
DMD family
Victoria Whitworth Parent of service user
AT
Heather Epps Epps Consultancy, Dorking
Physiotherapists specialising in DMD
Michelle Eagle Newcastle University
Marion Main Great Ormond Street Hospital, London
Lindsey Pallant Leeds Teaching Hospitals
Elaine Scott University of Sheffield
Allison Shillington Alder Hey Children’s Hospital, Liverpool
Neurology
Peter Baxter Sheffield Children’s Hospital
Valeria Ricotta University College London (also the North Star Project)a
Trials Unit
Daniel Hind University of Sheffield
a The North Star Project is substantially funded by MDUK and aims to optimise the care of young patients with DMD by
achieving a consensus on best clinical management.72
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TARGET
Measurable aspects of the participant’s
functioning that are predicted to be
DIRECTLY changed by the
treatment and are
functionally relevant
Structural tissue properties
(b710, b715, b730, b735)
Skilled performances
(b760, b770, d410, d415, d420, d450,
d455)
• Improved walking, sit to stand,
   getting up from floor, stair
   climbing, etc.
Structural tissue properties
(b710, b715, b740, b760, d410)
Cognitive and affective
representations
(d920)
Organ function (b740)
For improved exercise tolerance,
stamina and fitness
Structural tissue properties
(b730, b740)
Organ functions (b440)
Lung function
Skilled performances (b440)
Breath control
• Maintaining
   • muscle length
   • connective tissue length
   • soft tissue around joint
• Thereby: contracture prevention
• Maintaining strength and size of
   muscle to delay secondary (disuse)
   atrophy
• Maintained energy expenditure
• Maintained oxygen cost during 
   exercise
• Maintained oxygen uptake in muscle
• Maintained VO2
• Activation of muscle in
   positions not possible on land
   (antigravity). Facilitation of
   movement (buoyancy)
• Reduction of mechanical stress
   through joints and soft tissue
   structures while undertaking
   muscle strengthening activities
• Water confidence
• Participation with motivation
MECHANISM
Processes by which the
essential ingredients
induce change in the
object of treatment
Relaxation of the muscle
(Vignos37)
Mechanical traction and
viscoelastic deformation
(Klingler et al.76)
Biochemical adaptations,
which increase muscle mass
by means of muscle fibre
hypertrophy
(Vignos37)
Maintained stroke volume
(Neufer77)
Physiological changes
during immersion in
warm water
(Weston et al.78)
Buoyancy, turbulance,
meta-centric (rotational)
effect and elimination of
gravity, hydrostatic pressure
(Becker47)
Reciprocal inhibition
(Wolpe79), systematic
desensitisation (Watts80)
and extinction
(Waters et al.81)
INGREDIENTS
Observable, measurable actions,
devices or forms of energy that are
selected or delivered by the clinician
1. Stretches (LBT and AT)
2. Muscle training/strengthening
(LBT and AT)
General aerobic, submaximal
exercise
3. Aquatic therapy
(AT only)
• Active stretching
• Active-assisted stretching
• Passive stretching
• Prolonged elongation using
   positioning, etc.
• Targeted muscle training dependent
   on individual clinical presentation
• Specific submaximum (gentle)
   functional strengthening/activity
   in the community
• Pool water
• Temperature of 34–36 °C
• Simulated and real functional
   activities not possible on land
• Breath control exercises
• Making exercises fun
• Desensitisation and exposure
   to water
FIGURE 1 Treatment theory for AT programme. VO2, oxygen consumption.
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We searched the literature to inform an initial thematic framework about how children with neurological
or musculoskeletal problems, their parents and physiotherapists respond to physical therapy programmes.
We used Medical Subject Headings, such as ‘musculoskeletal diseases’, ‘nervous system diseases’, ‘children’,
‘adolescents’ and ‘physical therapy modalities’, as well as free-text terms such as ‘qualitative’ and ‘themes’ in
a MEDLINE search to find papers. We found four relevant qualitative research studies on the acceptability of
physiotherapy in children with neuromuscular conditions, consisting mainly of inductive thematic analyses.87–89
One study90 drew on two social science theories. The themes of social model theory, distinguishing
impairment from disability and eliminating discrimination and removing barriers to access91,92 have been
incorporated into the International Classification of Functioning, Disability and Health – Children and Youth
version (ICF-CY)93 (see Modelling process: developing programme theory), which is recommended for
understanding context in evaluative studies.94 The theory of psychosocial development95 was used to
understand how changes brought on by adolescence affect adherence to therapy and adaptation to illness.
Our population was younger and more compliant than that in that study. As neither theory seemed suited
to this population, we constructed an initial framework by which to understand responses to the interventions
from themes observed in the four studies. Table 2 shows the key themes of the a priori framework.
We later employed a number of conceptual frameworks and models to ‘make sense of or shed light on’69
the empirical data we gathered, to better understand the implementation and acceptability of the AT
programme and to consider how processes could be improved.
The ICF-CY is a conceptual framework used to define disability, which has widespread appeal and acceptance
among physiotherapists, one target audience of this work.93 It describes functioning in terms of body
structures and function, desired activity or activity limitations, and participation restrictions (the inclusion of
the young person in social situations). The ICF-CY Environmental factors component views disability as the
outcome of interactions of these factors with other contextual factors, both environmental and personal.
The way in which participation is understood has developed rapidly since this work was commissioned.96–99
The conceptual framework developed through an integrative review by Kanagasabai et al.100 suggests
contextual conditions under which participation is reduced or maintained (Figure 2). Another review, by
Kang et al.,101 proposes that participation is optimised with physical, social and self-engagement. Social
engagement refers to interpersonal interactions during activities, feelings of being included or belonging.
TABLE 2 Key themes of the a priori framework
Theme
Christy
et al., 201089
Capjon and
Bjørk, 201087
Wiart
et al., 201088
Redmond and
Parrish, 200890
(a) Improvement in physical function ✓ ✓ ✓ ✗
(b) Improvement in confidence and independence ✓ ✗ ✓ ✗
(c) Increased participation ✓ ✓ ✗ ✗
(d) Achievement of goals ✓ ✗ ✓ ✗
(e) Fatigue during the programme ✓ ✓ ✗ ✗
(f) Pain during the programme ✗ ✓ ✗ ✗
(g) The duration and spacing of therapy sessions ✗ ✗ ✓ ✗
(h) The quality of the relationship with the therapist
and communication between therapist and families
✗ ✓ ✗ ✓
(i) Stress associated with the programme and
balancing therapy with the demands of everyday life
✓ ✗ ✓ ✗
(j) Responsiveness of schools to children’s therapy
schedule
✗ ✓ ✗ ✗
METHODS
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Self-engagement refers to feelings of enjoyment, self-determination and how a person thinks about themselves,
especially in the setting and achievement of goals.
A range of child-, family- and environment-related attributes affect participation. Personal factors covered
later in Figure 23 relate to how children adapt to keep engaging with peers or to cope with rejection.102,103
Age, gender and preferences for particular activities or experiences also play a part in the extent of
participation.104–106 Family socioeconomic status,104 functioning,105 mental well-being,107 orientation towards
physical activity105,106 and other factors108 also contribute. A physical environment, societal attitudes and
supportive services can provide physical assistance, guidance and broader opportunities for activity.109–112
Often, the strategies that we develop to manage chronic disease created additional burdens of work for
patients, leading to poor adherence and clinical outcomes, as well as wasted resources.113,114 Minimally
disruptive medicine should identify this burden, encourage improved co-ordination of care and design, or
prioritise care from the patient perspective.115 Burden of treatment theory provides a way of understanding
the relationship between health-care users, their social networks and the health services they use, with a
view to redesigning those services to make them minimally disruptive.113,116 As burden of treatment theory
has been developed around the adult service user, it is useful to consider it in tandem with a conceptual
model of parental work of care for children with special health-care needs (Figure 3 and Table 3).117
Burden of treatment theory helps us to understand the response of patients and carers to complex
interventions. To understand the perspectives of physiotherapists delivering AT, we draw on normalisation
process theory (NPT), a general theory of how complex interventions become routinely embedded in health
services.119,120 NPT categorises the different kinds of work that people do when they implement a new
practice as sense-making, relational, operational and appraisal. Problems in any of the categories can result
in implementation failure.
Finally, we draw on themes identified by a systems analysis of problems encountered in aquatic programmes
for disabled children (Figure 4).121 The author describes a split between recreational and therapeutic
approaches that existed in both practice and the literature of the early 1980s.121,122 She identified problems
in this division of philosophy, principles, staff composition, roles and training (Figure 5), and described an
integrated approach to aquatic intervention for disabled children. Retrospectively, we find this theory useful
to interpret the responses of some participating physiotherapists to manualised AT.
Based on the above literature and through team discussions, we developed the programme theory, which
could be briefly described as follows:
Boys, parents, specialist physiotherapists will be willing and able to conduct twice-weekly AT and
tertiary centres will allocate resources for this (inputs and activities). This will be manageable within the
existing roles, interactions and relationships that characterise the management of DMD (context).
Delivery of the programme per protocol (immediate outcomes) will bring about physiological benefits
described in the treatment theory (intermediate outcomes).
We developed a logic model to illustrate how chains of events over time were to bring about the desired
outcomes, in accordance with the programme theory (Figure 6).123,124 Contextual factors that can influence
and be influenced by implementation are included.
Most elements of the logic model are self-explanatory, but some are worth unpacking. First, there are a
number of definitions of ‘case management’ containing functions that also appear in definitions of
‘programme management’.125,126 Although we acknowledge this overlap, we use the term to mean a
micro-level episode of health-care management in a health-care setting in which one is accountable for
service user outcomes. To simplify, by ‘case management’, we mean everything that a physiotherapist does
with a boy with DMD and their notes, from identifying a boy as suitable for AT to discharging them from the
service. By ‘programme maintenance’, we mean everything that the physiotherapist, his or her colleagues
and organisation do to sustain (continue and institutionalise) an AT service beyond case management.127–130
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The programme theory and the logic model form the starting point for a process evaluation, which
investigates what is delivered and how, mechanisms of impact (broadly defined) and how context affects
implementation and outcomes.131 In the standard format of a process evaluation, there is an imperative to
evaluate implementation fidelity,131–134 which is typically interpreted as the consistency with which intervention
components are delivered.135 However, insofar as front-line physiotherapy often involves making sense of
rapidly changing and ambiguous phenomena to revise treatment plans, it is not the kind of work that
benefits from standardisation.136 A body of theoretical literature suggests that the standardisation of function,
that is, being faithful to the intervention theory, is more important than standardising the form of an
intervention.137–139 In this study, standardisation would not meet the physical and psychological needs or
capabilities of individual children. For these reasons, we evaluate treatment optimisation to the child’s needs
and capabilities, adjudicated by an independent physiotherapist, rather than fidelity to intervention
components. We define optimisation as good adherence to a good-quality prescription (see Optimisation
of prescription).
TABLE 3 Work of care constraints/resources for parents117
Category Selected codes relevant to study population
Child
Disease Severity, symptoms and child’s quality of life
Episodic quality of illness and uncertainty
Medical care Type of technology or equipment
Frequency of treatments
Behaviour Cognitive and emotional function/expression
Functional ability/activity limitations
Location Home, hospital or elsewhere
Parent
Gender roles How the roles of mothers and fathers differ
Mental health Emotions, quality of life and stress
Personality Hardiness, self-esteem and coping style
Knowledge Medical and parenting skills and experience
Education level
Social support Availability of friends and family
Family
Family structure Family cohesion, including marital dynamics
Single parents
Siblings
Finances Employment, income and expenses
Society
Geographic locale Different regions, countries. Immobility
Attitudes and norms Disability and disease in childhood
Parental responsibility and gender norms
Health services Availability of care facilities and providers
Awareness of available services
Political system Government policies and funding
METHODS
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Recreational staff training
and composition
Recreational methods
Documentation
Setting: recreational,
community, educational
Medical-therapeutic staff
training and composition
Hydrotherapy and other
therapeutic methods
Setting: medical-therapeutic
Integrated approach
to aquatics
Documentation: reticent
medically anecdotal
Documentation: sparse,
research sparse
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Teaching, learning
training
Aquatic
programming
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Medical-therapeutic
Intervention
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FIGURE 4 Dulcy’s systems analysis of problems in aquatic programmes for disabled children. Copyright 1983 from
Aquatic programs for disabled children by Faye H. Dulcy.121 Reproduced by permission of Taylor & Francis, LLC
(www.tandfonline.com). Tx, treatment.
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The pilot trial
Trial design
This was a parallel-group, open-label, randomised external pilot trial with a 1 : 1 allocation ratio (Figure 7).
Consolidated Standards of Reporting Trials guidelines are observed.140 Important changes to the methods
after trial commencement are reported in Appendix 1.
Participants
Inclusion criteria
1. Genetically confirmed DMD: a muscle biopsy report from a registered NHS pathology laboratory showing
dystrophin deficiency compatible with DMD and/or a report from a registered NHS molecular genetics
laboratory showing the DMD gene to have a pathogenic deletion, duplication or point mutation.
2. Aged 7–16 years: children aged < 7 years were excluded because natural history studies have shown
that there is a continuing improvement in the 6-minute walk distance (6MWD) up until that age and,
therefore, any improvement might be spontaneous rather than a result of the intervention.141
Therapeutic
Lack of ‘fun’ activities,
development of
recreational skills
Input Unidisciplinary
Unidisciplinary professional
training
Decreased
communication
Decreased use
Decreased
efficiency
Safety problems
Output
Lack of changes
in practice
Unidisciplinary
attitudes
Lack of
training
Recreational
Lack of, or deficient
knowledge about,
safety, diagnosis,
functional ability
Aquatic programmes
FIGURE 5 Dulcy’s vicious cycle of problems in aquatic programmes. Copyright 1983 from Aquatic programs for disabled
children by Faye H. Dulcy.121 Reproduced by permission of Taylor & Francis, LLC (www.tandfonline.com).
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1.   INTERVENTION ARM:
Manualised hydrotherapy 2 days per week
(up to 52 × 30-minute sessions over 6 months)
PLUS
Optimised LBT (as defined by study group, 
delivered by local services and
recorded by research nurses) 4 days per week.
To be started WITHIN 4 WEEKS of
randomisation
2.   CONTROL ARM
Optimised LBT
(as defined by study group,
delivered by local services and recorded
by research nurses) 6 days per week
To start recording data WITHIN
2 weeks of randomisation
Adverse events collected after each
hydrotherapy session:
Pain (visual analogue scale)
Children’s OMNI Scale of perceived
exertion
26 WEEKS from Visit 2.  VISIT 3 (routine clinical visit): (1) NSAA,
(2) 6MWD, (3) FVC, (4) CHU-9D, (5) ACTIVLIM, (6) CarerQoL and 
(7) health and social care resource use questionnaire
Potentially eligible patient identified from clinic list by participating physiotherapist.
Contraindications to AT excluded. Research nurse or physiotherapist sends material
introducing study, information sheet and cover letter to patient
carers. Carers invited to discuss study over the telephone
Telephone call: study discussed. Interested patients invited in for clinic visit for
enrolment, consent and baselines
RANDOMISATION. To be completed within 1 week of last visit
MINUS 4 WEEKS: CONSENT and SCREEN (VISIT 1): (1) informed consent 
(2) NSAA and (3) FVC. Visit to be conducted at site
0 WEEKS: ELIGIBILITY and BASELINE VISIT (VISIT 2) (routine clinical visit): (1) eligibility
assessment NSAA. Those with 20% variation over 4 weeks can enter study.
Other baselines: (1) 6MWD, (2) FVC, (3) CHU-9D, (4) ACTIVLIM, 
(5) CarerQoL and (6) health and social care resource use questionnaire.
Visit conducted at sites (for eligibility assessment) but questionnaires may
be completed at home and posted/e-mailed back to site
FIGURE 7 Pilot RCT summary. 6MWD, Six-Minute Walk Distance; ACTIVLIM, Activity Limitations Measure;
CarerQol, Care-related Quality of Life; CHU-9D, Child Health Utility 9D Index; FVC, forced vital capacity;
NSAA, North Star Ambulance Assessment.
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3. Established on glucocorticoid corticosteroids [patient has been treated with prednisolone or deflazacort
(Calcort®, Sanofi-Aventis) for at least 6 months with no major change in drug, dosage or frequency for
at least 3 months before the initial assessment]. Such changes were defined as follows:
i. Frequency covered a change from daily dose to alternate day or another non-daily regimen
(or vice versa).
ii. A dose increase in line with weight was acceptable. Any other change was an exclusion criterion.
iii. A change in prescription from prednisolone to deflazacort (or vice versa) was an exclusion criterion.
4. A North Star Ambulatory Assessment (NSAA) score of ≥ 8 to 34. Those with more than a 20% variation
between baseline screens 4 weeks apart (at pre-screen and initial assessment) were excluded.
5. Able to complete a 10-m walk test with no walking aids or assistance.
Exclusion criteria
1. Involvement in another RCT.
2. More than a 20% variation between screening and baseline NSAA scores.
3. Unable to commit to the programme of twice-weekly AT for 6 months.
4. Any absolute contraindications or precautions to AT43 listed in Table 4 at the point of determining eligibility.
Settings and locations where the data were collected
Staff at six specialist neuromuscular clinics identified a sufficient pool of eligible patients. Each expected to
be able to recruit 10 patients in the 6-month accrual window, during which all patients would have one
routine clinic visit. Site staff received training in protocol procedures by the trials unit; many of the research
procedures, especially matters of documentation, were already routine in clinical practice.
TABLE 4 Absolute contraindications and precautions to AT
Absolute contraindications Precautions
Severe cardiac failure Fear of water
Resting angina Behaviour problems that prevent participation in physiotherapy or AT
Shortness of breath at rest Arterial hypotension/hypertension
Renal failure Chemical sensitivity
Proven allergy to chlorine or bromine Indwelling catheter/PEG tube
Uncontrolled epilepsy Tracheostomy
Uncontrolled faecal incontinence Poor skin integrity/open wounds
Febrile conditions: acute systemic illness or
pyrexia (until resolved)
Unstable angina, cardiac arrhythmias or additional cardiac considerations
Acute vomiting/diarrhoea (until resolved) Dizziness/vertigo
Wound infection (until resolved) Diabetes mellitus
Weight in excess of available pool
evacuation equipment
Thyroid problems
Widespread MRSA (until resolved)
HIV/AIDS
Haemophilia
AIDS, acquired immunodeficiency syndrome; HIV, human immunodeficiency virus; MRSA, meticillin-resistant Staphylococcus
aureus; PEG, percutaneous endoscopic gastrostomy.
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Screening and consent
Recruitment was undertaken by good clinical practice-trained site staff who screened health records to
identify study candidates. Candidates with absolute contraindications were excluded at this stage. A cover
letter and information sheet were sent to the carers of study candidates. Carers were invited to discuss the
trial by telephone. For those interested, an appointment was booked at the site at which candidates and
carers were invited to ask further questions. We acquired full written consent and assent from carers and
participants, respectively.
Assessment of eligibility
Confirmation of eligibility (including repeat NSAA) took place 4 weeks later.
Interventions
Research arm: aquatic therapy programme
Materials
A manual providing a ‘menu’ of aquatic exercises is available as a web-only appendix.142
Procedures
Exercises, using the properties of water (buoyancy, turbulence, etc.), included:
1. Stretches – active assisted and/or passive regime that targets key muscle groups in ambulatory boys
(e.g. hip flexors, hip abductors; iliotibial band; hamstrings; knee extensors, ankle plantar flexors;
supination, pronation; wrist and finger flexors; neck flexors). Some movements used the properties of
‘drag’, for example for a passive trunk side flexion stretch.
2. Muscle training/strengthening – hip extension, abduction; knee extension; ankle dorsiflexion; shoulder
abduction, horizontal extension, flexion; elbow extension; wrist extension.
3. General aerobic – walking backwards and sideways, bobbing, swimming, punching, ball activities.
Submaximal exercise in the water.
4. Simulated or real functional activities (e.g. sit to standing, running, jumping, hopping, using the
unencumbered, three-dimensional properties of water). For example, going from a seated to a standing
position in water, when there is no actual seat, uses the metacentric effect and the properties of water
to develop core strength and balance, and to learn or maintain the task, which is becoming more
difficult out of water. A previous protocol was adapted for this aspect, with the exception that children
would not be asked to lie fully prone, but only three-quarters prone (face not quite submerged).34
5. Breath control exercises and games.
6. Swimming and other ‘fun’ activities.
Provider
The intervention was delivered by suitably qualified physiotherapists who worked in tertiary paediatric
neuromuscular centres and had experience in the management of DMD. Most, but not all, physiotherapists
had previously attended foundation training courses and had experience of delivering aquatic exercise, but
not necessarily using the properties of water. Those delivering the intervention from four trusts attended a
specialist day course, delivered by Heather Epps, an accredited trainer, in which they were trained in the
principles and practice of AT; a training video was also provided. Physiotherapists at a further trust did not
attend face-to-face training but did receive the video.
Location and mode of delivery
Aquatic therapy was delivered face to face in a NHS AT pool, heated to a temperature of 34–36 °C.
Although group sessions were anticipated, participating trusts could schedule only individual sessions with
one exception, in which brothers were randomised to AT.
METHODS
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Schedule
Aquatic therapy was to be delivered twice a week for a maximum of 30 minutes per session in the water
(to avoid fatigue) for a period of 6 months. The research physiotherapists at the site were responsible for
booking participants into sessions for those randomised to the AT arm and for supervising their treatment
regime throughout the study. The research protocol specified that study interventions should commence
within 4 weeks of randomisation.
Tailoring
It was intended that the treating physiotherapist should choose options appropriate to each child’s level of
ability and particular presenting clinical problems. The prescription should be focused and achievable; it
was not expected that most/all exercise categories in the manual would be represented in a prescription or
that prescribed LBT exercises would be replicated in the water (training session minutes, Birmingham,
19 November 2014). To avoid excessive fatigue, participants were asked not to undertake their LBT on
days that they received AT.
Modifications
No modifications were made to the manual during the project.
Optimisation
We define optimisation as good adherence to a good-quality prescription (see Optimisation of prescription).
Details of the AT prescribed for and delivered to the participant were entered on to the patient’s care
plan/AT log. An independent physiotherapist who was not a co-applicant was commissioned to assess if AT
and LBT had been optimised to the need and capacity of the participant (see Optimisation of prescription).
We asked physiotherapists to complete a form detailing why sessions did not take place, with the following
options: did not attend, unable to attend (cancelled), pool closed, no pool time available, staff unavailable
or other.
Control arm: land-based therapy
Materials
A manual was developed, based on best existing practice, again providing a ‘menu’ of exercises from
which the treating physiotherapist could choose options appropriate to the child’s level of ability and
particular presenting clinical problems. Physiotherapy intervention/prescription depended on the clinical
need and capability of the individual patient (see Chapter 1, Physiotherapy).
Procedures
Depending on the needs and capability of the individual participant, a regular stretching regime
(4–6 days/week) would target key muscle groups in ambulatory boys (triceps surae complex, hamstrings,
hip flexors, iliotibial tract, long finger flexors). To avoid disuse atrophy, while being aware of the potentially
detrimental effects of overexercising, particularly with regard to activities that promote eccentric activity,
a directed programme of exercises dependent on the individual’s need was prescribed. General advice on
regular activity was also recommended (e.g. walking, cycling and swimming).
Provider and locations
Although it is normal for community physiotherapists to prescribe therapy for children with DMD,28,33 for
the purposes of this trial (see Chapter 3, Problems with the delivery of land-based therapy), LBT exercises
were prescribed by the research physiotherapist at participating tertiary centres. They informed the
community physiotherapist of the exercises prescribed, and asked them to feed back if the prescription
changed. Exercises were delivered, in varying proportions, by parents at home, by support workers in
school and, less commonly, by local community physiotherapists. Parents and support workers were
trained in the delivery of exercises by the prescribing physiotherapist, as is routine practice.
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Schedule
Typically 4–6 days per week.
Tailoring
The number of sessions, schedule, duration and intensity were based on the child’s level of ability and
particular presenting clinical problems.
Modifications
As in usual practice, community therapists could modify prescriptions depending on the rate of functional
change. They were asked to notify the study team when they did so.
Optimisation
Parents were asked to complete the LBT log every week, indicating the number of days on which they had
completed each exercise; they were provided with self-addressed envelopes and asked to return completed
forms. Research physiotherapists sent out a maximum of three letters reminding participants to return
overdue LBT logs over the course of the period of trial involvement. An external assessor evaluated if
therapy had been optimised for each participant.
Outcomes
Outcomes are summarised in Table 5.
Primary outcome
Recruitment rate.
Other feasibility outcomes
1. Decision on the primary end point for the main trial.
2. Number and characteristics of patients who were identified as potentially eligible, approached for the
study, at each study visit, randomised, withdrawn and lost to follow-up, discontinued from the AT
intervention (with reasons), and included and excluded from analysis (with reasons). We also report the
recruitment rate (defined as the proportion of patients approached that consent into the study).
3. Reasons for refused consent.
4. Participant attrition rate (the proportion of the consented and randomised participants who withdrew or
were lost to follow up).
5. Reasons for attrition.
6. Number of missing values/incomplete cases. For questionnaires we report the item response rate at
each time point.
7. Feasibility of recruiting participating centres and estimation of costs, given as a narrative assessment.
8. Therapist views on intervention/research protocol acceptability/perceived contamination of control arm.
Clinical outcomes
The following outcomes, assumed to be those of any future full-scale trial, were assessed during routine
clinical visits at baseline and 6 months (* indicates routine assessment):
l 6MWD disease-related limitations on ambulation143
l NSAA measures of functional exercise capacity144,145*
l forced vital capacity (FVC)146*
l Child Health Utility 9D Index (CHU-9D) health-state utility147
l Activity Limitations Measure (ACTIVLIM) measure of independence and activity148
l Care-related Quality of Life (CarerQoL) measure of carer burden149
l health and social care resource use questionnaire for economic evaluation.
METHODS
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The following safety outcomes were assessed at the AT session for those in the intervention arm only after
each AT session:
1. pain (visual analogue scale)
2. Children’s OMNI Scale of Perceived Exertion.150
Changes to trial outcomes after the trial commenced
Changes to outcome assessments, made during the study, are detailed in Appendix 1.
Sample size
The sample size was based on a recommended minimum of 30 participants (15 per group) for feasibility
objectives involving parameter estimation.151 Assuming a dropout rate at 6 months of 20%, we set a
target of randomising at least 40 participants (20 per group).
Feasibility criterion
This pilot aimed to recruit 40 children in 6 months and to deliver AT to 20 of them. If this objective success
criterion was met, then a full-scale study would be deemed feasible.
Generation of the random allocation sequence
The randomisation schedule was computer generated prior to the study by the clinical trials research unit
(CTRU) in accordance with standard operating procedures. It was stratified by centre with randomly
permuted blinded block sizes to ensure that enough patients were allocated evenly.
Allocation concealment
The allocation schedule was concealed through the use of the centralised web-based randomisation
service.
Implementation
After eligibility and written consent were confirmed, patient details were entered into the randomisation
system by good clinical practice- and protocol-trained site staff (physiotherapists), and the treatment
allocation was returned.
Blinding
Although the physiotherapists, physicians and participants were not blinded, the data analysts remained
blind to treatment allocation until after the statistical analysis plan was finalised, the database was locked
and the data review was completed. Initially, blinded data were delivered to the statistician by the data
manager to define analysis sets and to test statistical programs. Any queries were communicated to the
study and data manager prior to database lock. The database was locked after agreement between the
statistician, data manager and study manager. No changes were made once the data had been locked.
Database freeze and lock were conducted in accordance with CTRU standard operating procedures.
Statistical methods
Analysis population
The intention-to-treat population included all patients for whom consent was obtained and who were
randomised to treatment. This was the primary analysis set, and end points are summarised for the
intention-to-treat population unless stated otherwise.
Baseline characteristics
For continuous variables (e.g. age), either mean and standard deviation (SD) or median and interquartile
range (IQR) have been presented, along with minimum and maximum variables. The number of
observations used has been presented alongside the summaries. For categorical variables (e.g. ethnicity),
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the number and percentage of participants in each of the categories and the total number of observations
are presented.
Feasibility outcomes
Subject-specific AT adherence is reported as the number of AT sessions attended within 6 months and the per
cent compliance (out of the 52 anticipated sessions) with mean (SD), median (IQR) and minimum–maximum
values for the number of sessions attended. We also report the number and percentage of participants
who attended all AT sessions and tabulate reasons for missed sessions. LBT adherence is reported as the
number of days for which a participant was prescribed exercise and compliance is reported as the
percentage performance (over the total number of days for which exercise adherence was recoded).
Clinical outcomes
Descriptive statistics are presented for the clinical outcomes; significance testing has not been undertaken.
NSAA measures (final measure and change from baseline) are presented as mean differences between
groups and their associated 95% CIs. Clinical outcomes have been presented for the intention-to-treat set
with available 6-month outcome data, by group and overall. Spaghetti plots of participant trajectories have
been provided for various outcomes, stratified by treatment group, to provide a visual display of the
change over time.
Missing spurious and unused data
The extent of missing data has been reported as it was one of the fidelity outcomes of the study. No
sensitivity analyses involving imputation for missing data was performed. Any spurious data were queried
and checked for consistency with data management before data lock. Patient and carer questionnaires
were scored only if all relevant items that make up a domain were complete.
Ethical aspects
The study received a favourable opinion from the National Research Ethics Committee, East of England –
Cambridge South, on 4 July 2014 (reference 14/EE/0204).
Patient and public involvement
James Parkin, a young man with DMD, and Victoria Whitworth, his mother and former carer, were
involved in the design of the intervention, the study, the qualitative research analysis and the drafting of
the report. They reviewed, made changes to and approved the final lay summary.
The intervention optimisation substudy
Introduction
Physiotherapists are legally obliged to record treatments given in a patient’s record at each intervention
session. Participating physiotherapists collected standardised information on the type of exercises, number
of repetitions and the time spent on each exercise, in a log based on the AT manual. Parents did the same
for LBT. These data were entered onto a web-based data capture system and validated through on-site
source data verification. An independent physiotherapist (JS), who was not a co-applicant, acted as an
independent reviewer. She assessed whether or not prescribed treatment was ‘optimal’ given the treatment
need and capacity of the boy concerned. We tabulated and charted summary data completeness. Missed/
cancelled sessions were attributed to provider, patient or unknown factors. In attendance calculations we
assumed that when the reasons for a missed session were unknown, then they were due to provider
factors; the sum of sessions attended and sessions missed for family reasons were used as the denominator
for attendance statistics.
Optimisation of prescription
The assessor made an assessment of whether AT or LBT prescriptions were optimised based on treatment
logs and baseline data (NSAA, ACTIVLIM, medical/social history and schooling). The NSAA score was
METHODS
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assessed as above or below average depending on the participant’s age and steroid regime.9 The AT
attendance was assessed as good if > 70% of available sessions were attended. The quality of the AT/LBT
prescription was classified as ‘good’ if it was individualised to patient’s needs and focused on priorities, as
‘varied’ if the prescription was inconsistent, less focused or too extensive, or as ‘poor’ if it was unfocused
and had too much content. In addition, prescriptions were classified as achievable if the exercises were
appropriate and could be completed in a half-hour session. The LBT was also classified as realistic if it was
clinically appropriate and achievable for the child’s level of ability, contractures and functional score
(NSAA). This accepts that prescriptions may need to change with time, loss of function and loss of range
of movement.
Adherence to the prescription
As a result of the shortfall in recruitment, sampling was unnecessary and all completed records were
evaluated. Full LBT adherence would be demonstrated by completed logs, demonstrating that all
prescribed exercises were performed, for each of the seven 4-week periods throughout the 26-week study.
Full AT adherence would also be demonstrated by completed logs.
The number of exercises prescribed for AT and LBT is sometimes provided as a range when prescriptions
changed during the trial period. Weekly (LBT) or by session (AT) percentage compliance with the
prescription was described using mean, median and range values. Prescription compliance of > 50%
was assessed as good for both AT and LBT. For both the AT and LBT data, Jennie Sheehan assessed
whether or not priority stretches were prescribed according to baseline joint range, NSAA score and
knowledge of natural history of DMD. In addition, Jennie Sheehan assessed if any changes in the LBT
prescription appeared to affect compliance.
Assessment of overall treatment optimisation
To summarise, the independent reviewer was asked to assess the following:
(a) Was the quality of the prescription ‘good’, ‘varied’ or ‘poor’?
(b) Was adherence with the prescription ‘good’ or ‘poor’?
If the answer to both (a) and (b) was good, then we considered treatment to be optimised. We considered
attendance as a separate variable, but note that it is possible for treatment to be optimised but for there
still to be poor receipt of the treatment (see Figure 6). Physiotherapists were given the chance to respond
to detailed feedback from the independent rater. Only two took up the opportunity.
The qualitative research
The Consolidated criteria for Reporting Qualitative studies are observed. The topic guides used in the
qualitative research are available in Appendices 2 and 3.
Interviewer characteristics
All interviews were conducted by Daniel Hind, a male graduate anthropologist, with 10 years’ experience
of qualitative research, employed as a senior research fellow at the University of Sheffield.
Relationship with participants
No relationship was established with interviewees prior to commencement of the qualitative substudy.
Participants were informed of the purpose of the research and the professional identity of the interviewer
via the information sheet, and reminded, immediately before the interview, that he was an employee of
the university, not of their care provider.The interviewer is a health services researcher with no motivational
interest in either the population or the success of either intervention.
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Theoretical and thematic framework
Rationale
Our rationale for using qualitative research alongside the pilot RCT is that it can tell stakeholders how to
optimise interventions and research protocols, or why trials are likely to be infeasible.152–154 Qualitative
methods also enable research teams to capture how an intervention is implemented and experienced,
thereby enabling better understanding of causal pathways.131
Worldview155/epistemology156
Our rationale is pragmatic;157 it is concerned less with building, testing or advancing social science
theory131,158 than with the ‘conceivable practical consequences’159 of different lines of action and with
establishing a basis for ‘organising future observations and experiences’.160 In other words, we hope to
guide those who might want to develop, evaluate, commission or use AT services in the future by
describing the experiences of those involved in our study. To do so, we do not rely on a single ‘favourite
theory’,161 but aim to be ‘informed theoretical agnostics’,162 exploring how different theories of change
might work at different levels and in different contexts.
Research design155/methodology156/approach163
Holistic single-case design with the unit of analysis at the intervention programme and research protocol level.164
Theory
We used the four papers to inform our participant interview schedule.87–90 To understand the conditions
necessary to support the introduction and embedding of protocolised AT as a routine element of care, and
to support a future evaluation, the health professional interview schedule was based around NPT.120,165–167
Prompts related to the Theoretical Domains Framework168 were later added, but insufficient time was
available for this additional coding work.
Participant selection
Convenience samples of children/parents and interventionists were taken. The consent of children and
their parents was sought by the site principal investigators at the same time as RCT consent, but was not a
precondition of the trial entry. Interventionists were informed at site initiation and approached for consent
by a member of the research team directly. We interviewed all of the seven families whose boys (n = 8)
received AT. In one case, the child was unavailable on the day and only the parent was interviewed. We
interviewed seven physiotherapists who had delivered the intervention at five NHS trusts and a consultant
paediatric neurologist at a sixth trust where the only participant had been randomised to the control arm
(total health professional interviews, n = 8). None of the families approached declined an interview; one
physiotherapist declined an interview, without giving a reason. Once recruited, no-one dropped out. All
interviewed physiotherapists (n = 7) had experience of delivering AT prior to this project. Using the NHS
Agenda for Change paygrade system,169 two physiotherapists we interviewed were band 6 (the most
junior), three were band 7 and two were band 8. To put this in context, all those interviewed would have
specialised in a particular condition (whereas it is typical that grade 5 physiotherapists rotate around
specialties). Band 8 is usually an indicator that the individual is a physiotherapy service manager.
Setting
Semistructured interviews took place between 22 September 2015 and 14 January 2016 for participants
and between 17 September 2015 and 29 January 2016 for physiotherapists. Parents chose the setting for
data collection: most parent and child dyads were interviewed in their own home, in person; one dyad was
interviewed by SkypeTM (Microsoft Corporation, Redmond, WA, USA); and one parent was interviewed by
telephone after the failure of a Skype call. In general, interviews were conducted in quiet and private
settings to reduce distractions; one interview was somewhat disrupted by the unavoidable presence of a
younger child, otherwise, parents aside, no non-participants were present at interviews. All health
professionals were interviewed by telephone around the time of site closure.
METHODS
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Data collection
In addition to the a priori themes identified in Table 2, semistructured interview guides for participants
contained questions about the acceptability of intervention and research protocols. Interview guides were
piloted with interventionist and patient/carer members of the study management group. The interview
guide for health professionals adapted questions suggested by the NPT developers166 and was not piloted.
No repeat interviews were undertaken. All interviews were recorded on an encrypted digital recorder and
fully transcribed, with transcriptions anonymised. Field notes were taken after interviews as required.
Participant/parent interviews lasted a median of 32 minutes (range 20–42 minutes), with durations typically
related to the responsiveness of the child; the researcher’s sensitivity and judgement were used to
determine the length of the interview.170 Physiotherapist interviews took a median of 52 minutes (range
44–81 minutes). Formal assessment of whether or not saturation has occurred or of stopping criteria for
qualitative data collection was not employed.171 Although fewer than planned (because of the trial’s
recruitment shortfall), some researchers would consider 16 interviews with families and professionals
adequate for thematic172 (if not other sorts173,174 of) saturation. There was, for the most part, great
consistency in messages from both groups. Transcripts were not returned to participants for correction.
Data analysis
We used the National Centre for Social Research ‘Framework’ approach to analysis, with its five ‘key
stages’: (1) familiarisation, (2) identifying a thematic framework, (3) indexing, (4) charting and (5) mapping/
interpretation.175 ‘Framework’ analysis allows sufficient flexibility for analysts to pre-specify themes of
anticipated importance as coding categories and to combine them with others that are identified during
inductive analysis, allowing the reformulation of ideas during the progress of the analytical process.176
Transcripts were imported into NVivo version 11 (QSR International, Warrington, UK). Daniel Hind, James Parkin
and Victoria Whitworth read and re-read transcripts (familiarisation), considering them in light of the
initial thematic framework (see Table 2), NPT and the logic model (Figure 8; see also Figure 6), with notes
being taken on new categories inductively derived from the data. We did not develop subthemes because
of the number of different theoretical approaches that we were interested in accommodating. Daniel Hind,
James Parkin and Victoria Whitworth independently coded a sample of the transcripts (indexing), before
conferring with each other with regard to the coded transcripts for items relating to the thematic
framework (see Table 2). Daniel Hind also coded within the NPT166 and against items in the logic model.
Further literature reviews were conducted to understand emergent themes (see Modelling process:
developing programme theory). New frameworks were added to NVivo, where necessary transcripts were
recoded and categories refined or merged. We summarised coded data using NVivo matrices, linked to
the relevant quotations (charting). Completed charts (available on request) were compared within and
between participants.
We noted if a participant held strong views on a subject and if there was considerable agreement or
disagreement between participants. Emerging ideas were mapped out on paper to aid interpretation
(mapping). In addition to the involvement of patient representatives, protection against the researcher’s
own views and prejudices were minimised by involving a specialist physiotherapist (ES) in three discursive
debriefing sessions in which we reviewed coding and discussed interpretations. We actively sought
discrepant and divergent views to combat confirmatory bias and to avoid overly simplistic interpretations of
phenomena.177 Participants were not asked to provide feedback on the findings.
Reporting
Before the main results, we provide an exploration of context, which critical interpretivists define as more
than the physical environment,178,179 factors, variables and causal relationships,180 but as something
sociorelational, which incorporates settings, ‘roles, interactions and relationships’;178 ‘people’s social
connectedness, their social locations, or their affinity with the intervention itself’;179 and conflicts,
‘perspectives, relationships, and trust’.180 As proposed elsewhere,181 to add greater insight,182 participant
quotations are sometimes supplemented with accounts from PPI representatives. We provide quotations
for major and some minor themes.
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The cost analysis substudy
As a result of the shortfall in participant recruitment, we had insufficient numbers to meet our original
objectives of identifying key resource use items for a larger study and conducting a value-of-information
analysis. We took the decision not to examine individual resource use items, as it would be difficult to
establish whether a potential key resource item was just that or whether it was observed by chance in a
small sample. In order to estimate the cost of AT intervention, we have supplemented information from
the quantitative study with information from the qualitative interviews to estimate the costs of AT to the
NHS as well as the costs borne by participants and their carers in participating in AT.
Logic model-based coding
(systematically for families and professionals)
  L01 Willingness of parents to travel
  L02 Availability of hydrotherapy pool
  L03 Engaged NHS Trust
  L04 Pool hire and staff costs
  L05 Motivated physiotherapists
  L06 1-day training course
  L07 Manual
  L08 Hydrotherapy sessions
  L09 Case management
  L10 Programme maintenance
  L11 Eligible boys offered hydrotherapy (’reach’)
  L12 Twice-weekly sessions delivered for 26 weeks
  L13 Attendance at all sessions (’dose received’)
  L14 Hydrotherapy optimised for individual boy
         (‘optimisation’ rather than ‘fidelity’)
  L15 Gross motor function
  L16 Exercise tolerance
  L17 Respiratory capacity
  L18 Activities of daily living
Codes from related studies
(systematically for families; ad hoc for
professionals)
  A. Improvement in physical function
  B. Improvement in confidence
  C. Increased social participation
  D. Achievement of goals
  E. Fatigue during the programme
  F. Pain during the programme
  G. The duration and spacing of therapy sessions
  H. The quality of relationship and communication
       between therapists and families
  I. Stress associated with the programme and
     balancing therapy with demands of everyday life
  J. Responsiveness of schools to children’s therapy
      schedule
NPT
(systematically for professionals, separately for normalisation of intervention and trial; ad hoc use for
acceptability of trial procedures for families)
    01. Coherence or sense-making
        NPT01 Differentiation: they distinguish the intervention/research from current ways of working
        NPT02 Communal specification: they collectively agree about the purpose of the intervention/research
        NPT03 Individual specification: they individually understand what the intervention/research requires of them
        NPT04 Internalisation: they construct potential value of the intervention/research for their work
    02. Cognitive participation or relational work
        NPT05 Initiation: key individuals drive the intervention/research forward
        NPT06 Enrolment: they agree that the intervention/research should be part of their work
        NPT07 Legitimation: they buy into the intervention/research
        NPT08 Activation: they continue to support the intervention/research
    03. Collective action or operational work
        NPT09 Relational integration: they maintain their trust in each other’s work and expertise
        NPT10 Interactional workability: they perform the tasks required by the intervention/research
        NPT11 Contextual integration: the intervention/research is adequately supported by its host organisation
        NPT12 Skill-set workability: the work of the intervention/research is allocated appropriately
    04. Reflexive monitoring or appraisal work
        NPT13 Systematisation: they access information about the effects of the intervention/research
        NPT14 Communal appraisal: they collectively assess the intervention/research as worthwhile
        NPT15 Individual appraisal: they individually assess the intervention/research as worthwhile
        NPT16 Reconfiguration: they modify their work in response to their appraisal of the intervention/research
FIGURE 8 Coding framework.
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Triangulation protocol
Rationale
The rationale for using different methods and informants in this study, and a formal framework to compare
their findings, was to address different aspects of the overall research question, making the study more
comprehensive, increasing confidence in findings and providing a platform for feedback by professionals
and patient representatives.183
Design
Quantitative and qualitative methods described above were used concurrently, with no priority granted to
either, to assess the feasibility of a research protocol and an intervention. We used a modified version of the
protocol proposed by Farmer et al.184 to compare quantitative and qualitative findings (methodological
triangulation of data sets), with the following stages: sorting, convergence coding, convergence assessment,
completeness assessment and feedback (researcher comparison was not undertaken because of resource
constraints).
We reviewed the various data sets to identify key components of the intervention logic model (see Figure 6) to
compare for presence and examples (‘sorting’). A convergence coding matrix summarised similarities and
differences between data sets for each of the 17 logic model components in the Resources (n= 6), Activities
(n= 3), Immediate outcomes (n= 4) and Intermediate outcomes (n= 4) categories. We compared the
prominence of logic model components in the data sets, selecting examples to support or explain how each
component had contributed to the success or failure of the intervention (‘convergence coding’). We applied
the following convergence coding scheme: ‘agreement’ – full agreement between data sets in terms of the
interpretation, partial agreement (some disagreement within or between either data sets), silence (only one set
of results covers a logic mode component) and dissonance (disagreement between data sets). We quantified
the level of agreement between the data sets (‘convergence assessment’) and highlighted differences in the
contribution to the research question (‘completeness comparison’). We shared the triangulated results with
team members and other selected stakeholders at a face-to-face meeting on 13 April 2016 for ‘feedback’,
allowing points of disagreement to be discussed and changes in interpretation to be incorporated if supported
by the data.
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Chapter 3 Results of the pilot trial
Implementation of the intervention and trial
Implementation summary
Overall, 17 sites were approached to participate in the study: six sites opened and 11 were unable to do so.
Of the six sites involved in the grant application, four opened between October 2014 and December 2014,
one was unable to proceed because of difficulties securing treatment costs and another because of pool
access. Ten sites approached between December 2014 and May 2015 either declined or were unable to
gain the relevant approvals in time. Reasons for non-involvement included treatment costs, a lack of eligible
participants within travelling range, lack of AT pool availability, organisational change (e.g. moving
premises) and therapists being on maternity leave. In April 2015, two additional sites were initiated. The
duration between site initiation and the first participant consent was 30–40 days for two sites, 50–60 days
for another two sites, 90 days for one site and 169 days for another site.
NHS treatment costs as a cause of centre attrition
Considerable problems were encountered in accessing treatment costs for the research. Where the cost of
an experimental treatment is greater than the cost of usual care, in the UK this cost falls on health-care
commissioners rather than grant-awarding bodies.185 Although at the time at which the trial was run most
NHS commissioning was devolved, local commissioners recognised that the commissioning of services for
rare disease groups was the responsibility of NHS England, an executive non-departmental public body of
the Department of Health, established in 2013. However, NHS England responded that they did not have a
process in place to support the alignment of commissioning priorities and research needs and refused to
meet the treatment costs. After negotiating for several months with local commissioners, one of the original
sites withdrew from participation in the study because they could not meet the treatment costs for the trial
locally [minutes, Trial Management Group (TMG), 19 January 2015]. Neither local commissioners nor the
participating trusts effectively met the treatment costs at other trusts, with physiotherapy teams absorbing
the costs within their units or, more usually, participating physiotherapists delivering the intervention and
trial procedures in their own time (see Chapter 5, Therapist views of the service, Operational work and
Chapter 5, Comments on the trial procedures, Operational work). This was possible only because of the low
levels of recruitment and the goodwill of research enthusiasts in research-active trusts.
Specialist centres and distance from the target population
The use of highly specialist physiotherapists from tertiary centres to deliver the AT intervention proved
problematic. The eligible patients who were approached for participation in a RCT, which could see them
come into the centre twice per week, would have to travel for long distances. Eligible participants at Leeds
lived as far afield as Hull and York; Great Ormond Street Hospital, London, drew its patients from as far as
Watford and Guildford. At other centres, the majority of study candidates lived > 20 miles away. Unlike in
a previous paediatric AT trial, in which usual care involved a 2-week inpatient stay in a specialist centre,
at the beginning of which children could be randomised, the contemporary DMD treatment pathway
was wholly based on outpatient visits. The team at Great Ormond Street Hospital planned to deliver the
intervention not on their own premises, but at AT suites in east and north-west London, which were closer
to, and more accessible for, the target population (minutes, TMG, 7 July 2014). However, on investigation,
the costs proved prohibitive (minutes, TMG, 3 November 2014). The inability to reimburse travels costs for
travel to intervention sessions caused some consternation (minutes, TMG, 7 July 2014).
The idea of subcontracting delivery of AT to therapists at satellite centres, nearer to participants’ homes
was discussed (minutes, TMG, 7 July 2014, 19 January 2015). However, given that the population is
small and geographically dispersed, we have had to contract with almost as many community trusts as
participants would, not to mention agree treatment costs (see previous paragraph) for interventionist
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training and the delivery of the intervention. The team’s perception was that less research-active
community trusts were less likely to tolerate implementation of the study and intervention without access
to treatment costs. All trusts had intended to run AT as a group intervention with two or more children in
the pool, something that was prevented by under-recruitment. All the trusts were limited to providing
AT sessions in office hours because of staffing requirements for safety and evacuation procedures and
lone-working policies (minutes, TMG, 3 November 2014).
Participant recruitment and the prohibition on co-enrolment
The general prohibition on co-enrolment of patients,186 especially those deemed to be vulnerable,
considerably reduced the pool of candidates available to the study. For instance, at Great Ormond Street
Hospital, the children with the best cardiac function tended to be already enrolled in the DMD Heart
Protection Study (ISRCTN50395346), meaning that the potential sample could have poor external validity.
In addition, there were concerns that many parents were anticipating the opening of well-advertised drug
studies (NCT02383511, NCT02369731, NCT01957059, NCT01826474) and would withhold their children
from the AT trial, or enrol and then drop out, in the hope of access to a disease-modifying drug therapy
(minutes, TMG, 7 July 2014). Although the NIHR urged us to co-enrol patients who had already consented
to drug trials (Emma Catlin, NIHR, 2013, personal communication), the research ethics committee refused
our request to do so (Leslie Gelling, NRES Committee East of England-Cambridge South 2014, personal
communication).
Problems with the delivery of land-based therapy
The commissioning brief required that LBT be ‘optimised’. Normally, community physiotherapists see families
between once every 6 weeks and once every 6 months to give an exercise prescription (the minority of patients
that are at special schools have therapists who come into school to deliver exercises two or three times per
week). Specialist physiotherapists on the team felt that the delivery of LBT would be variable between
participants in between seeing community physiotherapists. In routine practice, specialist physiotherapists can
recommend problems to work on and specific techniques to community physiotherapists, but varying degrees
of co-operation between specialist and community physiotherapists were reported. The reorganisation of
services in 2013, when this research was commissioned, following the Health and Social Care Act 2012,187
resulted in complexity and a lack of uniformity of services previously hosted by primary care trusts, including
community physiotherapy.188 As we anticipated difficulties finding out with whom to engage and approach, in
order to gain the appropriate NHS Research and Development permissions to implement the study, we asked
physiotherapists at participating specialist centres to prescribe LBT for the duration of the trial (minutes, TMG,
15 September 2015). We then relied on parents to capture the weekly delivery of LBT on a log.
Problems with data collection
The ability to deliver the 6MWD, which requires a 30-m corridor,189 was a source of great anxiety in the
set-up period. Some hospital sites, where the NSAA would normally have been conducted, did not have
passageways of this length (minutes, TMG, 7 July 2014, 15 September 2014, 3 November 2014). It was
also posited that, in trusts that were not research active, training would have to be given regarding the
administration of the 6MWD (minutes, TMG, 15 September 2014). Although the costs of data capture and
entry were adequately funded, this money did not translate into extra resource for the units in terms of a
data entry clerk at any of the sites. Instead, relatively expensive physiotherapists ended up entering data,
with the CTRU personnel team making on-site visits to help out as the trial advanced (minutes, TMG,
3 November 2014).
Recruitment and participant flow
The first site was initiated on 24 October 2014 (Figure 9). All sites were instructed to cease consenting new
patients when recruitment closed on 30 June 2015, so that those consenting could be randomised by
31 July 2015 because of the need to take two NSAA scores 1 month apart (see Chapter 2, Participants). The
first patient was consented on 23 December 2014 and randomised on 10 February 2015. The last patient
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was consented on 24 June 2015 and randomised on 17 July 2015. The trial ended as planned when the
window for 6-month follow-up closed on 28 January 2016. In 40 centre-months we consented and
randomised 12 participants (0.3 per centre-month), of whom 10 have 6-month follow-up data for
the NSAA and between five and nine have 6-month follow-up data for other outcomes. The six sites
screened 348 boys for eligibility, of whom only 17 were interested and eligible (Figure 10). Thirteen were
formally screened and consented (32.5% of the recruitment target, n = 40), and 12 were randomised (30%
of the recruitment target, n = 40). Eight participants were randomised to AT plus LBT and four to LBT alone.
Patients identified
(n = 348)
Patients contacted
[n = 66 (18.96%)]
Patients interested
[n = 17 (4.89%)]
Patients screened
[n = 13 (3.74%)]
Patients consented
[n = 13 (3.74%)]
Patients randomised
[n = 12 (3.45%)]
Patients discontinued
[n = 3 (0.86%)]
Allocated to control
[n = 4 (1.15%)]
6 months’ follow-up
[n = 1 (0.29%)]
Allocated to intervention
[n = 8 (2.3%)]
6 months’ follow-up
[n = 8 (2.3%)]
Patients not contacted
[n = 282 (81.03%)]
Patients not interested or not
eligible:
[n = 49 (14.06%)]
Patients not assessed for
eligibilty
[n = 4 (1.15%)]
Patients not randomised
[n = 1 (0.29%)]
Reason:
• Could not be contacted
Reasons:
• Identified as not eligible, n = 280
• No contact number, n = 1
• Geographically too far away, n = 1
Reasons:
• Not interested, n = 41
• Participant not eligible, n = 8
Reasons:
• Pool distance and time
  commitment
• Patient changed mind
• Too great a commitment
• Failed to attend assessment visit
FIGURE 10 Participant flow diagram.
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Protocol non-compliances
Table 6 shows protocol non-compliances. In general, these were to do with the timing of assessments not
being within acceptable ‘windows’. Issues with consent included getting verbal but not written assent at
the same time as consent and using superseded versions of consent/assent forms.
Losses and exclusions after randomisation
Table 7 shows the pilot trial completion rate by site. One of the 13 boys for whom the study team received
parental consent withdrew from the study before randomisation; his family could not be contacted to
confirm the reason, which was, according to a physiotherapist, to enter a drug industry trial. Two participants
formally withdrew from the study before completing, both from the control arm: one gave the reason as
‘burden of attending the trial procedure for child’ (R06/001), the other was ‘accepted onto another trial’
(R01/001). One participant was lost to follow-up in the control arm (R07/002). No patients were excluded by
the study team.
Baseline data
Demographic and social and schooling information for randomised participants is displayed in Tables 8 and 9,
respectively.
TABLE 6 Protocol non-compliances summary
Site Event date Category Class
Date reported to
sponsor
Corrective
action
Preventative
action
R02 16 March 2015 Consent Minor 01 July 2015 NA NA
R07 24 July 2015 MW Minor 28 July 2015 Other NA
R05 28 January 2015 MW Minor Not reported Other NA
R05 24 February 2015 MW Minor Not reported Other NA
R01 22 January 2015 Other Major 02 April 2015 Other Staff training
R01 28 April 2015 MW Minor 28 October 2015 NA NA
R06 7 September 2015 MW Minor 28 October 2015 NA NA
R01 23 July 2015 Consent Major 28 July 2015 Other NA
R04 10 August 2015 Other Major 18 August 2015 Other NA
R05 11 September 2015 MW Minor 11 September 2015 NA NA
R01 9 October 2015 MW Minor 13 October 2015 NA NA
R02 9 October 015 MW Minor 13 October 2015 NA NA
R01 28 April 2015 MW Minor 28 October 2015 NA NA
R05 14 October 2015 Other Major 28 October 2015 Other Other
R02 12 October 2015 Other Major 28 October 2015 Other Other
R05 3 November 2015 MW Minor 17 November 2015 NA NA
R04 6 July 2015 MW Minor 30 November 2015 NA NA
R01 13 November 2015 MW Minor 11 December 2015 NA NA
R04 28 January 2016 MW Minor 29 January 2016 NA NA
MW, missed windows; NA, no action.
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TABLE 7 External pilot trial completion summary
Site Date initiated Consented Randomised
6-month visit
(completed)
Withdrew
consent
Lost to
follow-up
Other
withdrawn
R01 24 October 2014 5 5 4 1 0 0
R02 27 November 2014 2 2 2 0 0 0
R04 11 December 2014 1 1 1 0 0 0
R05 19 November 2014 2 1 1 0 0 1
R06 28 April 2015 1 1 0 1 0 0
R07 29 April 2015 2 2 1 0 1 0
TABLE 8 Demographics
Characteristic Control Intervention Total
Age
n 4 8 12
Mean (SD) 9.8 (2.5) 8.0 (0.9) 8.6 (1.7)
Median (IQR) 9.5 (8.0–11.5) 8.0 (7.5–8.0) 8.0 (7.5–9.5)
Min., max. 7, 13 7, 10 7, 13
Ethnicity, n (%)
English/Welsh/Scottish/Northern Irish/British 3 (75.0) 2 (25.0) 5 (41.7)
Any other white background 1 (25.0) 2 (25.0) 3 (25.0)
Indian 0 1 (12.5) 1 (8.3)
Any other Asian background 0 2 (25.0) 2 (16.7)
Any other mixed/multiple ethnic background 0 1 (12.5) 1 (8.3)
Other (specify)
Korean 0 1 1
Filipino 0 1 1
Polish 1 2 3
Weight (kg)
n 2 5 7
Mean (SD) 25.550 (2.616) 26.480 (4.572) 26.214 (3.910)
Median (IQR) 25.550
(23.700–27.400)
26.500
(23.800–26.600)
26.500
(23.700–27.400)
Min., max. 23.70, 27.40 21.70, 33.80 21.70, 33.80
Height (cm)
n 2 5 7
Mean (SD) 117.000 (0.849) 119.960 (6.280) 119.114 (5.339)
Median (IQR) 117.000
(116.400–117.600)
121.000
(114.600–121.200)
117.600
(114.600–121.200)
Min., max. 116.40, 117.60 113.70, 129.30 113.70, 129.30
Max., maximum; min., minimum.
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Feasibility outcomes
Owing to reporting guidelines, several protocol-specified feasibility outcomes sit more comfortably
elsewhere in the report. For information on eligible patients approached for the study, see Recruitment
and participant flow. For reasons for refused consent and participant attrition rate, see Losses and
exclusions after randomisation. Reasons for attrition from the research protocol are detailed in Losses and
exclusions after randomisation. Participant and parent views on the feasibility and acceptability of the
intervention can be found in Chapter 5, Context understood through the International Classification of
Functioning, Disability and Health – Child and Youth version and burden of treatment theory and Patient
and parent views of the aquatic therapy intervention; those of the therapists can be found in Chapter 5,
Therapist views of the service analysed within normalisation process theory. Participant, parent and
therapist views on the acceptability and feasibility of the research protocol can be found in Chapter 5,
Comments on the trial procedures. We did not consult, as originally stated in the protocol, therapists on
the risk of control arm contamination after understanding how technical, and therefore impossible to
replicate without training, the intervention was. The feasibility of recruiting participating centres is
addressed in Implementation of the intervention and trial and the estimation of costs is addressed in
Chapter 6. Finally, intervention optimisation (in place of intervention fidelity) is addressed in Chapter 4.
Decision on the primary end point and sample size for a full-scale trial
Although the 6MWD is the most popular primary outcome in drug trials for ambulant children with DMD,
the study raised concerns about its feasibility (see Problems with data collection). Such concerns would be
magnified if, as seems likely, any future study involved community trusts, which are more likely to lack the
necessary 30-m corridors for the shuttle walk or staff already trained in assessment. For this reason, the
NSAA, which is routinely collected for all boys with DMD in the UK, seems like the most feasible outcome
for any future full-scale trial. Not only could data collection costs be minimised through its use, but, given
TABLE 9 Social and schooling information
Characteristic Control, n (%) Intervention, n (%) Total, n (%)
Housing adaptions
n/a at present 1 (25.0) 0 1 (8.3)
Pending 1 (25.0) 3 (37.5) 4 (33.3)
In process 0 2 (25.0) 2 (16.7)
Completed 2 (50.0) 2 (25.0) 4 (33.3)
Educational statement of needs
No 0 4 (50.0) 4 (33.3)
Yes 4 (100.0) 4 (50.0) 8 (66.7)
Substantial learning difficulties
No 4 (100.0) 7 (87.5) 11 (91.7)
Do not know 0 1 (12.5) 1 (8.3)
Level of educational support needed
Mainstream: no dedicated 0 5 (62.5) 5 (41.7)
Mainstream: > 50% support 2 (50.0) 1 (12.5) 3 (25.0)
Mainstream: < 50% support 2 (50.0) 1 (12.5) 3 (25.0)
Special school 0 1 (12.5) 1 (8.3)
n/a, not applicable.
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the small number of DMD patients available, it is essential that we minimise any loss of information –
especially in the control arm – as a result of patient attrition.
Table 10 lists the maximum sample sizes and expected sample sizes on termination required by three-stage
ρ-family error spending tests of H0. We fix the power to detect a minimum important difference of 9 points
at 0.8, and take the response SD to be 15 points, which looks sensible given the results of Mayhew et al.190
We consider designs for a range of values for the type I error rate; given the small sample sizes available,
we may be willing to conduct a trial at higher than conventional significance levels, acknowledging the
increased risk of a false-positive conclusion when interpreting the trial results.
To interpret the numbers listed in Table 10, please note that once a patient enters the trial, there will be
a 6-month delay before their primary response to treatment can be measured. As a result of this delay,
when the trial is conducted, at each interim analysis there will be patients in the pipeline who have not yet
been followed up for their 6-month response. Conservatively, this external pilot indicates that a future trial
might recruit up to 16 boys per year, which implies that approximately eight boys would be in the pipeline
at an interim analysis. The standard group sequential designs summarised in Table 10 make stopping
decisions using only those data available at an interim analysis. However, the expected sample sizes listed
are the expected numbers of patients recruited on termination, incorporating those who are in the pipeline
when a stopping decision is made.
From Table 10 we see that the maximum sample sizes needed to conduct a definitive trial with a
conventional type I error rate of α = 0.025 are likely to be prohibitive in the context of a national UK trial,
which could recruit up to 16 boys with DMD per year. At this rate of recruitment, it would take > 6 years
to reach the maximum sample size in the absence of early stopping. If we relax the type I error constraint
to test at the 10% significance level, we would expect to take around 2.5 years to come to a conclusion
and, in the absence of early stopping, just under 4 years to recruit the maximum sample size.
Table 11 summarises the findings of a simulation study, listing the percentage of trials satisfying the
proposed success criterion for various sample sizes when prior distributions are as previously defined. The
frequentist type I error rate at θ = 0 is approximately 10%, which is much higher than the conventional
2.5% significance level permitted for one-sided tests of superiority. Under the assumptions of the
simulation study, we estimate that a future Bayesian trial would have frequentist power of ≥ 0.7 to detect
a clinically relevant treatment effect if ≥ 40 patients could be recruited and followed up for their primary
response at 6 months.
TABLE 10 Frequentist sample size calculation
Significance level Fixed sample sizea Maximum sample sizea
Expected sample size on termination
θ= 0 θ= δ/2 θ= δ θ= 3δ/2
ρ= 1
α = 0.025 87.2 104.7 58.5 74.1 73.2 57.9
α = 0.05 68.7 82.9 50.5 60.2 58.3 47.8
α = 0.1 50.1 60.7 41.0 45.6 43.7 37.5
ρ= 2
α = 0.025 87.2 93.3 62.1 75.9 74.4 60.3
α = 0.05 68.7 73.5 53.0 61.2 59.3 49.8
α = 0.1 50.1 53.5 42.2 46.0 44.3 38.9
a Exact sample size calculations are presented. The trial would be implemented rounding the sample size up to the nearest
even number but this would have little impact on the expected sample sizes.
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Results are based on 10,000 simulations. N is the total sample size divided equally between interventions.
Data are simulated according to the model θ^ ∼ N(θ, 4σ2/N) and s2 ∼ (σ2/N) χN− 22 setting σ = 15 and δ = 9.
Delivery and receipt of the aquatic therapy and land-based
therapy interventions
If eight participants allocated to AT attended all 52 AT sessions, there would be 416 session reports. In
fact, several participants did not have their first AT session until some time after randomisation (Table 12).
The median time between randomisation and commencement of AT was 47 days (range 7–211 days); the
mean was 63 days. As a result, not all 416 sessions were possible, especially for those randomised late in
the project because the 6-month assessment is anchored to the randomisation date. Of the 349 scheduled
sessions for which we have data, 203 (58.2%) expected sessions took place and 146 (41.8%) did not.
Reasons for aggregate non-attendance are reported in Table 13 (for individual non-attendance, see Chapter 4,
Attendance). Where reasons for session cancellation were discernible (10% of sessions were unaccounted
for), there was an even split between participant/family factors (43%) and health-care provider factors (47%).
Of the 12 participants who were randomised, only five returned any LBT data, and for one of those there
was only 1 week’s worth of data (Table 14). The other four participants returned more or less full sets of
data. The median duration between randomisation and the first date on a LBT parent-completed data
collection form was 25 days (range 11–52 days); the mean was 28 days. The LBT adherence data
completion summary is shown in Table 15.
Number of missing values/incomplete cases
Data completeness is described in Tables 16 and 17.
TABLE 11 Sample size calculation for Bayesian design
θ
Percentage of trials declaring E as superior to
n= 20 n= 30 n= 40 n= 60
θ = 0 9.99 10.41 10.51 9.99
θ = δ/2 26.79 33.04 37.63 39.32
θ = δ 51.61 64.47 73.15 74.87
θ = 3δ/2 75.23 88.08 93.98 93.46
TABLE 12 Time to first AT session and number of sessions by participant
Participant
Days between randomisation
and intervention
Number of sessions done
(by AT log entered) (n/N)
Number of sessions done
(by attendance log) (n/N)
1 80 29/52 29/52
2 80 29/52 29/52
3 48 29/52 30/52
4 21 23/52 23/52
5 7 18/52 18/52
6 46 28/52 28/52
7 211 16/52 16/52
8 11 30/52 30/52
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TABLE 13 Aquatic therapy session attendance by centre
Process outcome
Centre number
TotalR001 R002 R004 R005 R007
Hydrosession counts
n (number of participants) 3 2 1 1 1 8
Mean (SD) 29.3 (0.6) 20.5 (3.5) 28.0 16.0 30.0 25.4 (5.7)
Median (IQR) 29.0
(29.0–30.0)
20.5
(18.0–23.0)
28.0
(28.0–28.0)
16.0
(16.0–16.0)
30.0
(30.0–30.0)
28.5
(20.5–29.5)
Min., max. 29, 30 18, 23 28, 28 16, 16 30, 30 16, 30
Did the session occur?, n (%)
No 47 (30.1) 63 (60.6) 10 (19.2) 12 (23.1) 14 (26.9) 146 (35.1)
Yes 88 (56.4) 41 (39.4) 28 (53.8) 16 (30.8) 30 (57.7) 203 (48.8)
Missing 21 (13.5) 0 14 (26.9) 24 (46.2) 8 (15.4) 67 (16.1)
Reason for non-attendance, n (%)
DNA 2 (1.3) 6 (5.8) 0 1 (1.9) 4 (7.7) 13 (3.1)
UTA 12 (7.7) 27 (26.0) 5 (9.6) 3 (5.8) 3 (5.8) 50 (12.0)
Pool closed 3 (1.9) 27 (26.0) 1 (1.9) 0 5 (9.6) 36 (8.7)
Staff unavailable 24 (15.4) 0 4 (7.7) 6 (11.5) 1 (1.9) 35 (8.4)
Other 3 (1.9) 2 (1.9) 0 2 (3.8) 1 (1.9) 8 (1.9)
Bank holiday 3 1 0 0 0 4
Dental work 0 1 0 0 0 1
Forgot swimming trunks 0 0 0 2 0 2
Patient unwell 0 0 0 0 1 1
DNA, did not attend; max., maximum; min., minimum; UTA, unable to attend.
TABLE 14 Time to first recorded LBT session and number of sessions by participant
Participant Group Days between randomisation and LBT Number of weeks for which data returned
1 AT 41 27/26a
2 AT 25 24/26
3 AT 12 24/26
4 LBT 52 1/26
5 AT 11 20/26
a Extra week completed by participant with no explanation.
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TABLE 16 Data completeness for outcome assessments
Instrument Follow-up time point
Control
(N= 4), n (%)
Intervention
(N= 8), n (%)
Overall
(N= 12), n (%)
NSAA score Consent 4 (100) 8 (100) 12 (100)
Baseline 4 (100) 8 (100) 12 (100)
6 months 2 (100) 8 (100) 10 (100)
FVC absolute Consent 4 (100) 7 (88) 11 (92)
Baseline 2 (50) 5 (63) 7 (58)
6 months 0 (0) 5 (63) 5 (56)
FVC % predicted for height Consent 2 (50) 4 (50) 6 (50)
Baseline 2 (50) 5 (63) 7 (58)
6 months 0 (0) 5 (63) 5 (56)
6MWD Consent 0 (0) 0 (0) 0 (0)
Baseline 4 (100) 8 (100) 12 (100)
6 months 1 (100) 8 (100) 9 (100)
CHU-9D utility value Consent 0 (0) 0 (0) 0 (0)
Baseline 3 (75) 8 (100) 11 (92)
6 months 1 (100) 8 (100) 9 (100)
CarerQoL score Consent 0 (0) 0 (0) 0 (0)
Baseline 3 (75) 7 (88) 10 (83)
6 months 1 (100) 7 (88) 8 (89)
CarerQoL happy VAS Consent 0 (0) 0 (0) 0 (0)
Baseline 3 (75) 8 (100) 11 (92)
6 months 1 (100) 8 (100) 9 (100)
ACTIVLIM patient score Consent 0 (0) 0 (0) 0 (0)
Baseline 3 (75) 8 (100) 11 (92)
6 months 1 (100) 8 (100) 9 (100)
ACTIVLIM patient measure Consent 0 (0) 0 (0) 0 (0)
Baseline 3 (75) 8 (100) 11 (92)
6 months 1 (100) 8 (100) 9 (100)
VAS, visual analogue scale.
TABLE 15 Land-based therapy adherence data completion summary
Process outcome Control Intervention Total
Land-based session count
n (number of participants) 1 4 5
Number of weekly forms submitted
Mean (SD) 1.0 23.8 (2.9) 19.2 (10.5)
Median (IQR) 1.0 (1.0–1.0) 24.0 (22.0–25.5) 24.0 (20.0–24.0)
Min., max. 1, 1 20, 27 1, 27
Max., maximum; min., minimum.
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Clinical outcomes and estimation
In the statistics that follow, a difference in means starting with a zero reflects a direction of effect that
would favour AT, were the trial adequately powered; those starting with a ‘1’ would favour the control
arm. Owing to control arm attrition, comparative statistics are presented for the NSAA only. NSAA
measures of functional exercise capacity are shown in Figure 11, in which we include the observed average
annual decline in function on the NSAA scale for UK boys diagnosed with DMD aged > 7 years, calculated
as 3.7 units per year.72 Therefore, over the study period of 6 months, the expected decline for the boys in
our sample is estimated to be 1.85 units. On average, the 12 study participants who were randomised
had a NSAA value of 24.75 and would be expected to have an estimated value at 6 months of 22.9 units.
The mean score at 6 months was 21.0 (SD 15.6) in the control arm (n = 2) and 21.4 (SD 8.5) in the AT arm
(n = 8), a difference of –0.38 (95% CI –17.95 to 17.2). The mean change score was –5.5 (SD 7.8) in the
control arm and –2.8 (SD 4.1) in the AT arm, a difference of –2.8 (95% CI –11.3 to 5.8). The clinical
outcomes are displayed in Table 18 and the change in 6MWD over 6 months is shown in Figure 12.
TABLE 17 Questionnaire completion
Scoring Follow-up time point
Control Intervention Overall
Min.–max. Median Min.–max. Median Min.–max. Median
NSAA score Consent 100–100 100 100–100 100 100–100 100
Baseline 100–100 100 100–100 100 100–100 100
6 months 100–100 100 100–100 100 100–100 100
CHU-9D Baseline 100–100 100 100–100 100 100–100 100
6 months 100–100 100 100–100 100 100–100 100
ACTIVLIM Baseline 81.82–100 100 63.64–100 95.45 63.64–100 100
6 months 81.82–81.82 81.82 72.73–100 81.82 72.73–100 81.82
CarerQoL Baseline 100–100 100 85.71–100 100 85.71–100 100
6 months 100–100 100 71.43–100 100 71.43–100 100
Max., maximum; min., minimum.
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Figures 13 and 14 show the FVC absolute and FVC percentage predicted for height, respectively.
Figures 15 and 16 display the CHU-9D and CarerQol scores over 6 months, respectively.
Adverse events
A total of 15 adverse events were reported to the trial team (Table 19). The only event related to
the intervention was delayed muscle soreness, which was expected. Of the rest, 10 were falls related,
two were related to influenza immunisation and the remainder were related to chest infection and sleep
hypoventilation. There were no serious adverse events. In addition, two parents reported back pain, which
they attributed to home delivery of LBT exercise (see Chapter 5, Fatigue and pain). Post-AT pain, as
measured on the Wong–Baker pain inventory, and fatigue, as measured on the Children’s OMNI Scale of
perceived exertion, are addressed in Table 20.
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Sample size calculations for candidate future trials
We calculated a sample size calculation for a full-scale trial comparing optimised LBT versus LBT plus AT for
boys with DMD. Based on feasibility data, we assumed that the primary end point would be the NSAA score
at 6 months from randomisation (see Problems with data collection and Decision on the primary end point
and sample size for a full-scale trial). The linearised version of this score was used with transformed scores
lying between 0 and 100.190 This is preferred to ensure that a unit change in score implies the same change
in function across the breadth of the scale. We restricted our attention to frequentist and Bayesian designs
for randomised designs. It may be difficult to learn about the effectiveness of AT from observational studies,
as patients will receive varying background therapies of glucocorticoid steroids, which may influence disease
progression. The designs were proposed under the simplifying assumption that linearised NSAA scores are
approximately normally distributed. When performing sample size calculations, we take a minimum
important treatment effect to be a 9-point change on the transformed NSAA scale.
TABLE 19 Adverse events experienced by children in the trial
Randomisation
group Category Details Ongoing Serious?
Intervention
discontinued
Intervention Other Participant falls 2–3 times a week Yes No No
Control Other Fell and sprained ankle resulting in visit
to A&E. Had radiography, no fracture
No No No
Control Other Participant falls four times a week Yes No No
Intervention Other Participant falls 15–20 times a week Yes No No
Intervention Other Participant falls once a week Yes No No
Intervention Pain Fell off slide, reported back pain, spinal
radiography clear, self-resolved
No No No
Intervention Other Participant falls occasionally: two falls in
past 6 months
Yes No No
Intervention Acute infection Chest infection No No No
Intervention Other Symptoms of sleep hypoventilation –
headaches and tiredness
Yes No No
Intervention Other Falls Yes No No
Intervention Other Influenza immunisation No No No
Intervention Other Falls daily Yes No No
Intervention Other Influenza immunisation nasal spray
given. Information shared as part of
expected adverse events questions at
visit 3
No No No
Intervention Other Regular falls 2–3 times a week Yes No No
Intervention Other Delayed-onset muscle soreness – as part
of expected adverse events questions for
visit 3
Yes No No
A&E, accident and emergency.
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Frequentist group sequential trial
In the following, we refer to optimised LBT and LBT plus AT as interventions C and E, respectively. We
assume that transformed NSAA scores at 6 months would be analysed by fitting a general linear model
adjusting for baseline NSAA score and other relevant baseline covariates. Therefore, the 6-month response
of the ith patient would be modelled as:
Yi = µC + θ XEi + η XBi + εi, (1)
where XEi is an indicator variable that takes the value 1 if patient i is randomised to the intervention, and 0
otherwise; XBi is the NSAA score at baseline; and εi is an independent random-error term with εi ∼ N(0, σ2).
We interpret θ as the adjusted difference between expected transformed NSAA scores at 6 months on E
versus C; positive values indicate that E is superior to C.
Our first proposal is to conduct a future trial according to a group sequential test of H0: θ ≤ 0 against
H1: θ > 0 with type I error rate α at θ = 0 and type II error rate β at θ = δ. We take δ = 9 as the minimum
important difference we wish to detect. We shall consider group sequential designs, which permit early
stopping either for futility (i.e. to abandon a lost cause) or for success (i.e. to declare E superior to C). By
testing the H0 group sequentially, we reduce the expected number of patients needed to conduct the trial,
which is particularly desirable in this context when sample sizes are small. We consider one-sided, rather
than two-sided, tests of null hypotheses as AT would be adopted in practice only if it can be shown to be
superior to standard care.
We propose group sequential tests of H0 following error spending designs, so called because stopping
rules are derived such that certain probabilities of making a type I or type II error are ‘spent’ at each
interim analysis. The advantage of this type of design is that it can accommodate unpredictable group
sizes, which are likely to occur if recruitment rates are unpredictable and Data Monitoring and Ethics
Committee meetings are scheduled at fixed calendar times. We consider designs spending error
probabilities according to the ρ-family of functions:
f(t) = α minf1, tρg and g(t) = β minf1, tρg, (2)
where t, 0 ≤ t ≤ 1, represents the fraction of the test’s maximum information level that has been accrued.
Here, f and g stipulate the cumulative type I and type II error probabilities to be spent by the time
information fraction t has been accrued. The error-spending parameter, ρ, governs how rapidly error
probabilities are spent as a function of the statistical information available for θ: smaller values of ρ imply
more aggressive stopping rules with greater opportunity for very early stopping.
Bayesian design
We could shift the aim of a future trial from reaching definitive conclusions on the relative merits of
interventions E and C to increasing our understanding of these merits. A future trial would then proceed
by recruiting as many patients as possible over a reasonable time frame; based on the HydroDMD pilot
study, we believe that 32 patients could be recruited over 2 years. The accumulated data would then be
analysed using Bayesian methods to quantify our current thinking about treatment benefits.
Before the future trial begins, the Bayesian approach would start with a thorough evaluation of what is
already known about probable patient responses on interventions E and C. For simplicity, we shall take
µE and µC to represent the average change from baseline to 6 months in the linearised NSAA score on
interventions E and C, respectively. Furthermore, let σ2 denote the common variance of the change from
baseline scores. We propose that our prior understanding of the relative merits of interventions E and C
could be summarised by placing the following independent prior distributions on θ = µE – µC and σ:
θ∼N(5:375, 213:222) and σ∼ U(0,100Þ: (3)
RESULTS OF THE PILOT TRIAL
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The prior for θ summarises the findings of the HydroDMD pilot study: the mean is equal to the observed
sample mean difference while we set the prior SD equal to twice the estimated standard error of the
sample mean. This inflation is made in order to downweight the contribution of the pilot information to
a future efficacy trial and reflects our uncertainty about the estimated standard error. An independent
and vague prior is used for σ to reflect our uncertainty about the response variance. We could seek to
incorporate into the stated prior distributions data from other relevant historical controlled trials; however,
the natural history of DMD is known to have changed markedly in recent years with the introduction of
glucocorticoid therapy and the standardisation of usual care (Ricotti et al.72). Therefore, it is unlikely that
the average responses seen in historical trials would be commensurate with those seen in contemporary
studies.
The next step would be to conduct the Bayesian trial, recruiting as many patients as possible across a
network of UK centres. Patients would be randomised in a 1 : 1 ratio between interventions E and C.
On termination of the trial, once all recruited patients have been followed up for their 6-month outcome,
the new trial data would be summarised by the pair of sufficient statistics for θ and σ, that is, the maximum
likelihood estimate of θ and the sample variance. A Bayesian analysis would then be performed, using Bayes’
theorem to update the priors to derive posterior distributions incorporating the trial data. A provisional
decision to introduce intervention E would be made if the posterior probability that θ > 0 exceeds 0.9.
Figures 17 and 18 show the OMNI after the session and change for each intervention participant,
respectively.
Figures 19 and 20 show the Wong–Baker visual analogue scale after the session and change for each
intervention participant, respectively.
1 9 17 25 33 41 49 57 65 73 81 89 97 105113121129137145153161169177
Session days
0
2
4
6
8
10
O
M
N
I a
ft
er
 s
co
re R01/002
R01/004
R01/005
R02/001
R02/002
R04/001
R05/001
R07/001
Randomisation
FIGURE 17 OMNI score after the session.
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FIGURE 19 Wong–Baker visual analogue scale after the session.
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FIGURE 20 Wong–Baker change.
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Chapter 4 Intervention optimisation study results
Introduction: characterisation of participant functional ability
Good-quality data on the optimisation of AT and LBT were available for only eight and four participants,
respectively (Table 21); all were from the research arm, and control arm participants contributed no useful
data. The mother of AT arm participants R01/002 and R01/004 and control arm participant R01/003
indicated that no LBT was delivered at home, but that some was delivered at school (see also Chapter 5,
Environmental factors). The total number of AT sessions with data available ranged from 16 to 30 sessions
per participant. The total number of LBT sessions with data available ranged from 20 to 27 sessions. The
median total number of stretches, with data as a percentage of the total number of stretches prescribed,
varied from 66.67% to 100% for participants (minimum 30.77%, maximum 100%). The mean total
number of stretches with data as a percentage of the total number of stretches prescribed varied from
72.16% to 97.92% for participants.
Aquatic therapy
Attendance
Aquatic therapy attendance (Table 22 and Figures 21 and 22) overall was assessed as good for six of the
eight participants. The actual number of sessions attended by participants varied between 16 and 30
sessions overall, and the actual number of sessions not attended ranged between 10 and 34 sessions
overall. Patient and pool factors for non-attendance were equal for three participants, pool factors were
higher for three participants and patient factors were higher for two participants. Two participants had
overall attendance of < 40%, one had overall attendance of between 40% and 50% and five participants
had attendance levels of between 50% and 60%.
TABLE 21 Aquatic therapy and LBT data completion summary
Participant Total number of AT sessions with data Total number of weeks with LBT data
R01/002 29 0
R01/004 29 0
R01/005 29 27
R02/001 23 24
R02/002 18 24
R04/001 28 0
R05/001 16 0
R07/001 30 20
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TABLE 22 Aquatic therapy attendance summary by participant
Randomisation
number
Actual
sessions
attended
Actual
sessions not
attended
Patient
factors
Pool
factors Unknown
Available
sessionsa
Per cent attendance
based on available
pool
R01/002 29 16 5 10 1 34 85
R01/004 29 16 4 10 2 33 88
R01/005 30 15 5 10 0 35 86
R02/001 23 29 14 14 1 37 62
R02/002 18 34 20 14 0 38 47
R04/001 28 10 5 5 0 33 85
R05/001 16 12 6 6 0 22 73
R07/001 30 14 8 6 0 38 79
a Assumes sessions with unknown reasons are because of pool factors. Owing to starting late, some participants could not
have completed 52 sessions by the time of study closure.
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FIGURE 21 Number of AT sessions completed.
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The aquatic therapy prescription
The NSAA score was assessed by the independent rater as above expected for age for three participants and
below expected for five participants. Between the consent and baseline assessments (a gap of 1 month),
five participants improved, one maintained function and two declined on the NSAA. Seven of the participants
had contractures and all participants had a reduced range of movement (Table 23). Note the rapid decline
in NSAA score for participants R04/001 and, in particular, R07/001, during the 6-month trial period.
The prescription overall was assessed as good for three participants, variable by session for two and poor
for three participants. The independent assessor assessed the AT prescriptions as realistic and achievable
for four of the eight participants. The prescription was assessed as unachievable for four participants at
two centres. The independent assessor stated that the number of exercises prescribed per session ranged
from 4 to 27 exercises across all participants who contributed data. In relation to overall prescription
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FIGURE 22 Timing of AT sessions.
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compliance, three participants were assessed as poor and five as having good levels of compliance. Overall
prescription compliance was between 20% and 30% for one participant, 30% and 40% for two participants,
70% and 80% for two participants, and 80% and 90% for three participants. The prescription compliance
per session ranged from 9% to 100% across participants. One physiotherapist, who was deemed to have
optimised treatment based on the data given to the independent rater, commented that her participant
(participant R07/001) encountered significant fatigue and dissatisfaction (see Chapter 5, Fatigue and pain
and Appraisal work). She explained that, although the prescription remained the same, the actual number
of exercise repetitions was adjusted depending on the participant’s fatigue, which the independent assessor
agreed was appropriate.
Five of the eight participants had additional non-prescribed exercises completed during sessions with no
explanation provided. The independent rater considered exercises not to be appropriately prioritised in
three cases: with R01/002, she would have prioritised hips in addition to ankles; with R01/004 she would
have prioritised more hip and trunk exercises, and fewer wrist exercises; with R07/001 she would have
prioritised iliotibial band exercises in addition to ankles. The independent rater felt that too much emphasis
was placed on wrist exercise in a number of prescriptions (R01/002, R01/005, R01/004 and R05/001).
Although wrist stretching was appropriate, it did not require the properties of water and, with limited
time, other exercises that do benefit from the properties of water (particularly lower limb exercises) could
have been prioritised. The independent rater remarked that wrist exercises were placed first on the manual
menu of exercises and that this may have led to overprescription.
Land-based therapy
The LBT prescription was assessed as appropriately focused and achievable at baseline for all four of the
AT participants who returned the LBT pro forma, and compliance was initially good (Table 24). However,
after intervention by the community physiotherapist, midway through the course, the number of exercises
increased and compliance decreased (R01/005, R02/001 and R02/002). Across the course, the number of
exercises prescribed ranged from 5 to 13 per day. Participant prescription compliance was generally good
and compliance with priority stretches did not fall below 85% for this participant (R02/001).
Attendance at AT was variable, with provider and patient factors playing an equal part in non-attendance
(see Chapter 3, Delivery and receipt of the aquatic therapy and land-based therapy interventions and
Chapter 5, Balancing the demands of the programme with work, school and family life). AT prescriptions
were well optimised (focused and realistic) for three boys. For others, there was insufficient focus on the
prescription, with too many/less important exercises for those that did not require the properties of water
included. This resulted in insufficient clarity about the need to develop, at the outset, a prescription that
was achievable and focused on the needs of the boy. There had been a difference in understanding
whether or not it was intended that exercises from most categories of the AT manual should be
implemented or if the prescription should be more focused (see Chapter 5, Sense-making). More or less
complete data were available for LBT in only four boys. In general, compliance was good and the
prescriptions were appropriately optimised.
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Chapter 5 Qualitative research results
Context understood through the International Classification of
Functioning, Disability and Health – Children and Youth version
and burden of treatment theory
Figure 23 shows the ICF-CY as it applies to DMD; ICF-CY codes are provided in the text for reference.
Impairment and activity limitation
The children in our study were already starting to have problems walking (d450) and moving around
as a result of increasing muscle weakness and secondary joint contractures (b710). Many had already
transitioned into a phase involving adaptive equipment to improve mobility and quality of life. Some were
using canes, walkers or power wheelchairs for parts of the day to maintain independence of mobility. One
interview took place as an occupational therapist was inspecting the participant’s house for modifications.
To assist with care, one child’s bedroom had recently been moved to the ground floor. Modified vans and
ramps were often in evidence as aids to assist with care. Several children were falling frequently (d455),
and some were using motorised wheelchairs for portions of the day.
Yeah, playing in the street, he walk, and when he walking, he fell down very easily . . . now he can’t
walk maybe more than hundred metre, something like that.
Parent R05/001
Participation restriction
Predictably,100,191 some parents reported that their boys were increasingly frustrated at the loss of function
(see Perceived improvement in confidence, independence or participation) and consequent withdrawal
from sport, play (d880) and their peer group (d7500).
Personal factors
Typically for the age group, most participants were on steroid therapy with the anticipation of prolonging
ambulation,9,192 sometimes with attendant weight gain and behavioural issues (b152, d310).193 We are
not aware that any of our participants had substantial learning difficulties (b117, b164), which are
sometimes associated with DMD.193 With life expectancy now much longer as a result of improved disease
management,194 the prospect of further education and profession was likely to be an important goal for
many families. However, at an average age of 9 years, a child’s awareness of possible futures is
somewhat limited.
We are now having a population that lives to go on to university and, in that case, academia is very
important . . . the ones that are cognitively good, you know, that’s really important.
Physiotherapist S07/001
I have a 14-year-old son and obviously [his brother and participant] is 8 . . . now. [Participant] knows
he’s got poorly muscles, he knows he’s got something called DMD; he knows that he’ll need a
wheelchair more and more. But, for him, it’s the day by day. I think, as a parent, you keep it as normal
as possible for as long as possible . . . we’ve also got to think about the 14-year-old who can go on
Google [Google Inc., Mountain View, CA, USA] and see all the worst case and the future . . . we’re
pumping [participant] full of steroids every day so, emotionally, that changes him, gives him high and
lows . . . When he’s tired he becomes quite emotional he can laugh uncontrollably at the slightest
thing or cry uncontrollably at the slightest thing.
Parent R02/001
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Environmental factors
Immediate and extended family (e310, e315) and their attitudes (e450)93
Burden of treatment theory: workload113
Although we did interview one father who was the principal carer for his children, it was relatively clear
that, in most families, mothers shouldered the burden of care, regardless of the fact that many of them
did work, or had until recently worked, full-time (see Balancing the demands of the programme with
work, school and family life). In at least two families, working patterns involved both parents working long
days to guarantee mutually exclusive non-working time where one of them could be available for care. In
five interviews (six participating boys), there were multiple DMD boys in the household, with one family
having four DMD boys and an unaffected girl (participants R01/002, R01/003 and R01/004).
The difficulty faced by the parents of disabled children in accessing appropriate services within striking
distance of their home and resorting to private provision is well charted.64,195–197 It is also well established
that services are often fragmented, that intra-agency service planning is poor and that professionals, as
well as families, are confused about provision.195,197,198 The obstacles to accessing services (see Figure 3)
were in evidence, as in other studies, and parents had to ‘fight for everything’,199 and relationships with
providers are described as ‘repeatedly asymmetrical, non-collaborative, and negative’:199–202
I’ve had to fight . . . to put everything in place . . . they used to have statements; they got rid of
statements and replaced it so, but to get someone to assist [participant] to come in especially for
school for him has been a nightmare. It’s been an absolute nightmare and you know it’s been quite
upsetting that they’re failing him . . . the government not providing the right level of care, but I’m
on it.
Parent R07/001
Burden of treatment theory: capacity113
The ability of parents to do this work, which ensures care for their boys, is constrained and enabled by a
variety of factors (see Table 3).117,203 Their own health, morale, beliefs, parenting skills, personality and
potential to absorb adversity (resilience) all have a role in how parents cope.113,196,203 By way of illustration,
two parents, each with two DMD boys, responded differently to the expectations that they would deliver
LBT exercises, which are causing each of them back pain:
I’m always concerned I’m not quite doing it right . . . but yeah it’s part of the norm. We sit down, he
watches Simpsons, I do his physio[therapy] . . . roughly about 15 to 20 minutes per night . . . perhaps,
you know, he’ll have a Friday or Saturday night off . . . I’ve pulled my back many times with
[participant] . . . to be honest with you it’s part of the reason I think he does so well . . . if anything I’m
probably lighter on him than the actual physiotherapists.
Parent R02/001
It’s me who’s got the aches and pains yeah, because when I do his stretches I also have to exert some
effort you see . . . this one time that I hardly get up because of the pain . . . I even went to see my GP
[general practitioner] . . . that’s why I can’t really do [the LBT exercises] every day, it’s . . . stressful
for me.
Parent R02/002
The often endemic stress experienced by mothers of disabled children (see Chapter 1, Significance in terms
of ill health) is frequently related to inadequate, unco-ordinated and hard-to-access services.195,197,200 As
social networks have often shrunk,196 close family becomes the main support.204–206 Grandparents, who
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often enable parents to undertake paid employment by providing informal daytime care,207–209 were
mentioned in only one interview:
My little un, he goes to me [sic] mum’s [while the participant goes to hydrotherapy] . . . we all have tea
at me mum’s so we don’t get home till about 7.
Parent R01/005
Other parents described the struggle to manage without such informal support. For at least two families,
for whom English was a second language, the extended family was living outside the UK. Economic capital
can buffer stress, but having a disabled child is typically linked with a loss of earnings and a range of
additional household costs (see Chapter 1, Significance in terms of ill health and Chapter 6); employment
can be a stressor as well as a coping resource.196
Twenty-first century DMD parents are, by reputation, proactive and knowledgeable about their sons’
condition and associated treatment.192 Cultural capital (education) often results in improved access to
information and problem-solving skills.196 As in other studies,200 there was no sense that parents who were
more highly educated could more easily access professional support for disabled children, but some
demonstrated skill in exploiting alternative opportunities:
I have had contact with hydro[therapy] since [participant] was a little boy. That’s purely my just nosing
around . . . and finding out so, there is one [a pool] not far from the general hospital and it’s a special
needs school, so weekends and some weekdays they have availability so we go. It’s £16 – it’s
expensive . . .
Parent R07/001
There was little or evidence in the way of ‘bridging social capital’210 the creation of ‘weak ties’211 between
people with a common purpose. An example of such social capital is provided by PPI coauthor, Victoria
Whitworth. Victoria Whitworth’s family used to block-book an AT pool for successive Sunday afternoons,
sharing the cost and use with other families, whom she had met via MDUK and whose boys also had
DMD. The boys would develop friendships and spend time together in an environment in which they were
not restricted, having fun and doing AT exercises. Some parents who we interviewed had contemplated
this kind of arrangement, but did not yet see how it could be done:
I’m probably being very utopian but I’m sure other parents would volunteer to enable their son to
have the treatment . . . do a 2-hour session and four children get treatment.
Parent R02/001
Health services, systems and policies (e580)
In theory, community physiotherapists are seeing boys with DMD and prescribing exercises for them at
regular intervals of at least twice per year, but it was not clear that this was happening in all cases:
Interviewer: So do you see a local physiotherapist?
Mother: Err yes, yeah we do err, we only see them when we need, when we need erm, when he’s,
when he’s got a problem.
Interviewer: So you wouldn’t see that physiotherapist regularly?
Mother: Oh no, oh no, no.
Interviewer: But that physiotherapist has given [participant’s name] some exercises and . . . ?
Mother: Err no, no exercise at all.
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Interviewer: So you’re not doing any exercise . . . ?
Mother: No we seldom see the physio[therapist].
Parent R02/002
As related previously (see Chapter 1, Current aquatic therapy provision in the UK), access to AT was
unpredictable and, at best, involved the episodic provision of blocks of sessions:
Community physiotherapists hire a pool [at a local hospital] . . . they do like eight sessions and then
you have to wait for maybe 6 months and then another eight sessions.
Parent R04/001
Health professionals and their attitudes (e450)93
Aquatic therapy is often considered to be a very expensive form of treatment; even those who dispute this
advocate a careful, problem-based selection of clients, so that it is seen as ‘extra’ rather than core to a
treatment programme:33
The issue with hydrotherapy with muscular dystrophy is that patients all want it but for no particular
reason other than they think it will be nice to exercise in warm water . . . I think there is a real place for
hydrotherapy in certain periods within them and I think the period is when they’re actually going off
their feet to supplement them maybe going into KAFOs [knee–ankle–foot orthoses] to support a
particular objective . . . As long as they’re swimming . . . and there’s appropriate access in and out of a
pool, I personally don’t see that there is more benefit of doing a specific hydro[therapy] programme
than swimming and doing some things at home . . . So I think you need to have a clear goal . . . You’ve
gotta think, what is the point of hydrotherapy over and above land. And at the end of the day, [LBT]
can be done by teaching assistants, can be done by parents; hydrotherapy you have to go somewhere
or pay extra money [yeah]. So I think you have to really work out what you’re getting over and above
swimming, which we encourage . . . (and as I say there are certain pools that you can also go to that
are warmer pools) . . . You just have to rationalise what, what an extra intervention is giving you.
Physiotherapist S07/001
Patient and parent views of the aquatic therapy intervention
Perceived improvement or decline in physical function
In five cases, parents or boys perceived some improvement (R01/005, R01/004, R01/002, R02/001, R07/001),
although in one case the child and physiotherapist disagreed. In two cases (R02/001 and R01/005) this was
based on specific observations:
I actually think his range on his heels improved.
Parent R02/001
Mother: The next morning [after the AT], his legs were like really, really good. They weren’t stiff and
they didn’t feel heavy . . . it keeps him flexible and it stops the cramps. On the assessment that [the
physiotherapist] did at the hospital [at the 6-month assessment] he actually had to step up . . . without
holding onto anything. He didn’t do it the first time . . . then he did. We were all amazed. He did
absolutely fantastic.
Interviewer [to child]: Have you been able to do that before?
Mother: Not as high as what it were, no.
Interviewer: So it’s actually improved over the last 6 months you think?
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Mother: Oh definitely . . .
Child: And I couldn’t jump either. I couldn’t jump and now I can.
Parent and child R01/005
In some cases, the perceived benefits were less specific, but still valued:
They’re seeing a difference to what it was before and we think it’s helping . . . They’re more active,
more active in the water that’s for sure.
Parent R01/002 and R01/004
It makes his muscles relax and then when I bring him home to massage him after the hydro[therapy]
session you know he’s much more looser and I can tell the difference . . . I think he benefited from it
. . . I mean the calf muscle is definitely something that was tight always before anyway and it’s much
looser now. And I find that I can stretch him a bit further . . . I can see the difference.
Parent R07/001
In another case, a parent felt that function had remained the same, but also commented on the beneficial
morning-after effect, also observed in child R01/005 previously mentioned:
His mobility, his strength, everything stayed where it was, even if it has not improved much, but it’s
not going down . . . he was more relaxed, had a nice sleep at night when he does the [AT] exercises
and the next day the body is more refreshed actually . . . it was nice way to start the day.
Parent R04/001
One parent perceived that his son’s condition had deteriorated despite the AT:
Unfortunately, I couldn’t find any, any kind of good positive result from hydrotherapy . . . I expected
you know hydrotherapy would have more, er . . . stopped progressing in his symptom . . . but recently
I found that [participant] quite often fell quite easily when he was playing or when he’s walking.
Parent R05/001
Perceived improvement in confidence, independence or participation
Some parents discussed fewer physiological benefits when asked about benefits, volunteering that they
perceived improvements in confidence and participation. Sometimes, as with child R01/005, this related to
a sense of achievement linked to a goal of maintaining or improving function:
The step up, me and [the physiotherapist], we were gobsmacked . . . You were happy weren’t you?
You were buzzing.
Parent and child R01/005
For others, the outcomes might be less tangible, but the psychosocial response was nonetheless appreciable.
He really did come out of himself and be excitable in the pool and actually chat to the physiotherapists
. . . rather than being the reserved [child’s name] he often is in public . . . he’s incredibly competitive,
and [the physiotherapists] were able to fetch that out of him . . . a lot of the time when [child’s name]
does physical activity he’s, he’s the slow one, he’s behind the standard, he’s the one being specially
accommodated for. Whereas, this being one on one, it was just at his own ability to be able to push
that. He goes swimming at school now, no matter how hard he tries, he’s not going to keep up with
the other children so it becomes a negative. So to be able to do this physical, fun thing without any
kind of peer pressure or benchmark it may be why [he] enjoyed it so much.
Parent R02/001
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Patient representative and coauthor, James Parkin, confirms the importance of swimming and, therefore,
water confidence as DMD progresses in terms of cardiovascular exercise, self-esteem and enjoyment:
‘When every other sport or exercise is taken away from you with Duchenne, that’s what you’re left with’.
As something you can do as a family, it can be incredibly important. In that sense, AT can be about more
than just stretching muscles for the assessment of function in 6 months’ time, it is about longer-term
outcomes (see Chapter 2, Methods Modelling process: developing programme theory and Figure 4 on the
views of Faye Dulcy,121,122 and physiotherapist S01/001 on water confidence in Appraisal work below).
Here, another parent describes the importance of a perceived improvement in water confidence at a time
when the child is beginning to be marginalised in participation terms:
In school he’s not involved in any sports because, if he was hit by other kids then he’ll just fall . . . I
could see what [the physiotherapists] are doing and that, from day one until the last session, he knows
how to swim. So yeah it’s really amazing what it [the AT] did.
Parent R02/002
Fatigue and pain
Fatigue was not generally a concern for either parents or children. In general, descriptors for how children
felt after the session ranged from ‘not tired at all’ (R02/002) to ‘a bit tired’ (R05/001), with some indicating
that it depended on the pressures of the school day when AT sessions immediately followed school
(R001/002 and R001/004). One parent maintained that the child’s energy levels had decreased since the
AT programme stopped:
After he stopped [the 6-month AT programme] he feel more tired.
Parent R04/001
In one case, the child, mother and physiotherapist expressed concerns about pain and, particularly, fatigue
arising from sessions delivered before the school day, with school missed as a result of fatigue:
Patient: Well I get really exhausted I feel like I wanna go to bed, but obviously I can’t go to bed
because I have to go to school . . . when I get in class my legs are in a little bit of pain but then, when
it’s the afternoon my legs feel better.
Mother: Between the trip from the hospital to school it’s about half hour in the car so [participant]
then sits in the car and has a good rest . . . some of those days [the school] would call and say ‘he is
extra tired, could you come and pick him up?’.
Child and parent R07/001
We had huge issues with fatigue . . . it was too much with the burden for the patients . . . and I also
think the community teams had a bit of a panic about it, and were wanting to do different exercises
and we ended up cutting them back because they were too tired. I also think that we didn’t get
involved in what they were doing at school, we kept them doing the same things at school but
obviously with each new school term the physio[therapist] goes in and changes things and then I think
by the time they did [LBT exercises] at school, then parents felt they need to do [LBT exercises] as well
. . . the fatigue was way too much, our patient that did do the hydro[therapy] was constantly fatigued:
we ended up stopping all the land exercises except the stretches; we’ve ended up cancelling a lot of
the hydro[therapy]; the fatigue was a real issue.
Physiotherapist S07/001
No other child receiving AT complained of pain. Two parents volunteered information about back injuries
brought on by the delivery of LBT exercises to their children in the home (see Environmental factors).
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Quality of the therapist–family relationship and communication
Parents and children were almost universally effusive about their physiotherapists. Only in two interviews
did parents distinguish between physiotherapists who had delivered AT to their sons, and then only to
highlight the difference in their skill at making physiotherapy fun, which they perceived as crucial to
maintain their children’s engagement (see Chapter 2, Modelling process: developing programme theory
and Figure 4):
It’s a testament to the team there for understanding his learning style . . . and adapting to it.
They build rapport . . . they all got to know him as an individual and were able to kinda trigger
conversations about the things he likes doing, like splashing me at the side of the pool or whatever
that might be . . . you’d hope to get a good physio[therapist] to be concerned about his journey . . .
rather than just being about physical [function].
Parent R02/001
We thought they were amazing, because they had the skills to deal with children. So they treated
[participant] as how he should be treated at his age and made it fun in the pool.
Parent R07/001
This conscious effort to engage children in what could be fairly unpalatable exercises was summed up by
one physiotherapist as follows:
[Children] don’t really see it as exercising; they see it as a fun thing to do . . . It’s the therapist’s skill,
isn’t it, in making the exercises into a game so they don’t even really realise what they’re doing.
Physiotherapist S02/001
Balancing the demands of the programme with work, school and family life
There was general agreement on the burden of a twice-weekly programme. Universally, this related to
travel time to the AT sessions, often through rush hour traffic to make slots at the beginning and end of
the day. Even those with strong relational networks, for example, extended family who could help with
sibling child care, said that ‘it takes a lot of organisation’ and felt that ‘it would be better if it was a bit
closer to home’ (parent R01/005). Two mothers had given up full-time work during the last year for
reasons related to the burden of care for their sons; one stated unequivocally that this had happened
before involvement with the trial, in the other case, the mother had moved to casual work as a response
to being allocated twice-weekly AT. Some parents had employers who were fairly inflexible about working
arrangements or whose self-employment made for an uncomfortable choice:
New business, not having a wage and having to turn down work due to attend is, is something I’m
more than willing to do and I’ll do every single time but obviously a challenge . . . It was probably
only 15 miles each way, but via the school and then rush hour traffic. Bear in mind my session was
at 4 o’clock so sometimes it was an hour and a half on the way back, not a challenge unless you’ve
got a 5-month-old screaming baby in the back.
Parent R02/001
Mother (via translator): There was no other option, no other choice but to attend. It was really
important for the boys . . . we’ve got five children . . .
Father (via translator): Sometimes there were child [care] problems and I finish my work at 8 p.m.
Family R01/002 and R01/004
No parent highlighted that the programme had created any problems with school. For some children,
this was because the session was after the working day. Even those who had attended 4 p.m. sessions
remarked that it had not been a problem to miss the last 30 minutes to 1 hour of the day. Only one
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parent mentioned concern that the programme might compromise his son’s education, a concern that had
been allayed by the school:
[School] were happy, because they said like most of the work is done by 1 o’clock, with respect to the
main studies. After 2 o’clock is more like activities, fun things, so it’s OK. And they normally give him
homework before 1.
Parent R04/001
The two boys whose therapy took place before school found this particularly difficult and, although the
parents reported that the schools were co-operative, the therapists were concerned (see Fatigue and pain
and Appraisal work):
He did miss a fair few sessions . . . he’s now said that he can’t do the Wednesday [morning] because
it’s just too early for him because that’s all we could offer him was an early appointment . . . Basically
it’s not as convenient a time that we were offering him.
Physiotherapist S05/001
Summary
Notwithstanding the burden of treatment and the fact that some boys experienced functional decline
while receiving AT, there was a widespread enthusiasm for continuing to access AT, more locally, once per
week, for reasons of participation and the hope of maintenance of function:
A lot of them did sort of say, ‘Oh, what’s next? Is there any way we can continue?’ or ‘Will the service
be continuing?’. The feedback that I’ve had is that they’re dying [for] it to be continued or to, to
access more if there’s the opportunity.
Physiotherapist S01/001
Therapist views of the service analysed within normalisation
process theory
Sense-making
Unsurprisingly, physiotherapists distinguished the AT intervention from standard LBT (differentiation).
Many specified that the properties of water, particularly buoyancy, which were unavailable on dry land,
were highly relevant and helpful to people with muscle conditions who wished to exercise. There was a
shared sense of the aims of physical therapy (communal specification), but differing understandings about
the desired objectives (deliverables) (individual specification), for which the research team must take
some responsibility:
We were confused . . . we didn’t realise we were supposed to go through the exercises and decide at
the beginning which ones we were going to do and then each week tick them off. So we . . . didn’t
quite get it right at the beginning. So I don’t know whether that was explained quite clearly enough.
Physiotherapist S05/002
The collective understanding within some centres was as specified in the training, that the manual formed
a ‘menu’ of exercises that could be selected to address specific, emerging problems. However, some
centres, which had sent physiotherapists on face-to-face training, characterised the manual as prescriptive
and prescribed exercises from most categories in the manual, regardless of relevance. This was not the
intended message of the training, which asked for focus and realism (see Chapter 2, Interventions). At
other centres, physiotherapists who did optimise treatment delivery (see Chapter 4, The aquatic therapy
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prescription) nonetheless perceived the manual as prescriptive and questioned whether certain types of
exercises or intensive AT in general were necessary:
I know the purpose of physio[therapy] for this type of condition, but . . . I’m not convinced that
stretching in the pool is a better way of stretching than stretching out of the pool.
Physiotherapist S05/002
I think just putting somebody in hydrotherapy all the time just as an extra form of therapy I don’t think
is a purpose . . . I think you can make hydrotherapy have a purpose in specific.
Physiotherapist S07/001
All but one participating physiotherapist constructed some sort of potential value of the AT intervention for
their work (internalisation). Part of this value included ensuring that stretches were actually being conducted:
People used to go for physiotherapy, but that doesn’t happen now: stretches are done by parents or
carers . . . the benefit of hydro[therapy] is that . . . you can tell it’s happening because you’re in
the pool.
Physiotherapist S02/001
Relational work
Several centres were unable to set up the service because of problems accessing treatment costs (see
Chapter 3, NHS treatment costs as a cause of centre attrition). At all centres that eventually participated
in the study, key individuals drove the intervention forward (initiation). In each case, the site principal
investigator was charged with setting up systems and procedures, as well as engaging with others to make
the intervention happen. Once a senior physiotherapist got agreement from a service manager, then there
was no problem getting others’ implementation as part of their work (enrolment), at least at the scale
required by and for the duration of the study:
I have to go to a manager to say ‘Right, this is what we want to do, this is how long it’s going to take,
this is how many staff I’m going to need’ . . . and the staff then have to agree to take it on.
Physiotherapist S02/001
Although the majority of physiotherapists thought that increased access to AT was beneficial for boys with
DMD, none believed that it was right for them, as specialist physiotherapists in tertiary centres, to be involved
in its delivery (a problem of ‘legitimation’). They also questioned if it was a sound use of scarce resources,
with some explicitly addressing the issue of opportunity cost, that is, the benefits other populations could
have received by diverting resources to them:
My role is mainly assessment and communication with the community services, who communicate
with the physiotherapist who provides the treatment, so [delivery of AT] is in addition to what I would
normally do.
Physiotherapist S05/001.
You’re having to look at it and say, ‘where am I going to pull staff from?’. If you’ve got the resources,
then it’s quite straightforward to set it up. What’s difficult is if everybody’s saying, ‘well hang on a
minute, where are we going to find people to do it?’, because they’d be pulling them from
other work.
Physiotherapist S02/001
Thinking of costs, you’ve got to think, ‘what is the point of hydrotherapy over and above land[-based
therapy]?’.
Physiotherapist S07/001
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The physiotherapists continued to support the intervention (activation), but stressed that this could be
done only for the duration of the study and because of the scale required by the low participant study
consent rate:
So we are willing to invest the time but the problem is . . . we said originally we said we could
probably take five hydro[therapy] people [participants who were allocated to do AT] and we only
ended up having one, which was jolly lucky because actually in reality I don’t think we could have
fitted five in . . . we haven’t got the staffing numbers, we haven’t got the pool availability, you know,
it just doesn’t work.
Physiotherapist S07/001
It’s not really very sustainable to be able to offer two sessions a week for 6 months to a family, that’s
certainly over and above what would be sustainable to be able to offer on a regular basis.
Physiotherapist S01/001
Operational work
Most physiotherapists described a process of translating or adapting instructions from the AT manual in
order to get participants to perform a particular procedure in the pool (interactional workability):
Yeah it seemed like the right thing to be doing but we also applied our own assessment and clinical
reasoning. We spent quite a bit of time looking at our patients and what their needs were, and
modifying it a little bit to address their problems.
Physiotherapist S02/002
As more than one physiotherapist was involved at each trust, this knowledge work was a communal
process and helped to maintain confidence in the intervention and in each other (relational integration):
At the beginning when we first started doing it we had to really think, sit down and write down what
our treatment plans for our two children in the pool, looking at the manual and then saying, ‘Right so
we want to do that exercise, how are we going to get it done? How are we going to do it? How are
we going to deliver it?’. I’ve got our treatment plan that we came up with . . . we used the manual to
do it, but we needed to streamline it to make it more user friendly for the sessions.
Physiotherapist S02/001
Other staff were involved in the delivery of AT, and their availability was among the factors that
affected delivery:
The staffing’s got to be there to run it safely . . . you need some experienced physio[therapist]s but
you also need some of the junior staff . . . who are very capable of delivering the service, but there’s
training and supervision issues. And then you need your pool-side assistant who is usually a physio
assistant or a technical instructor . . . then we also had to have three other people in the department
in case of pool rescue . . . Then you need all your maintenance people who keep the pool up and
running . . . I mean we had our pool closed for a lot of sessions because we had some building work
that had to be done.
Physiotherapist S02/001
Although the work of delivering AT was not always considered appropriate to the role, physiotherapists
were consistently confident that they had the expertise to enact it (skill set workability). This was not just
based on their technical knowledge of physiotherapy technique (intervention) but also because, as
physiotherapists who were highly specialised in musculoskeletal conditions, they understand how to apply
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it given the complicated changing needs of the condition (which would not apply to community
physiotherapists):
The complexity of deciding on the treatment plan, knowing the boys well enough to know how to do
their treatment plan and then how to deliver it just wasn’t something that could just be handed out.
Physiotherapist S02/001
Critically, there was no participating NHS trust in which the delivery of the intervention was adequately
supported by a host organisation (absence of ‘contextual integration’). Although all physiotherapists
reported that their NHS trusts were enthusiastic about participating in the research study, this did not
extend to backfilling their posts so that they could deliver the study intervention after NHS England
declined to pay excess treatment costs (see Chapter 3, NHS treatment costs as a cause of centre attrition):
We’ve done this over and above what we normally do . . . we’ve ended up having to do this on our
non-working days . . . By the time we’re doing it all on extra hours and fitting it around our child care
and home life and everything else . . . it’s a non-viable service.
Physiotherapist S07/001
No participating physiotherapist believed that a twice-weekly, ongoing AT service delivered from a tertiary
centre was viable (programme maintenance), with some indicating that their organisation’s commitment to
AT more generally was wavering in a period of fiscal constraint:
It’s not really very sustainable to be able to offer two sessions a week for 6 months to a family . . . But
you know, more blocks of hydro[therapy] to try and show them activities so they can go away and do
[them], is a good idea.
Physiotherapist S01/001
I know that they would love to shut the pool . . . because of the financial drain.
Physiotherapist S05/001
Even those physiotherapists who believed that AT was a useful intervention for boys with DMD thought
that it should be delivered elsewhere in the health-care system:
I just see the patients when they come to clinic, do the assessments and provide advice. So I don’t
provide any treatment, I don’t go to the schools, I don’t go to the homes, whereas the community
physio[therapist]s do that and set up their treatment programmes . . . where there is a pool, they will
have a designated physio or physio team, that provide the hydrotherapy.
Physiotherapist S05/001
Appraisal work
All highly specialised physiotherapists who see boys with DMD enter their physical function data on to the
North Star database every 6 months and so are keenly aware of changing rates of disease progression.
However, with the disease progression being so unpredictable and treatment effects being confounded by
concomitant therapies, especially steroids, physiotherapists were sceptical that they could attribute
objective clinical outcomes to AT:
Most of the boys that had the therapy maintained their function which, for those boys, is a goal . . .
maintenance is part of the battle. But, then again, it’s hard to know whether they would have
maintained [that level of physical function] over that 6-month period without the hydro[therapy] . . . so
it is quite difficult to say explicitly that they’ve been able to maintain [physical function] because of
that input.
Physiotherapist S01/001
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However, there are other effects of AT that physiotherapists were able to access (systematisation), both
positive, such as perceived small physical gains, water confidence and ‘carryover’ (‘the extent to which
treatment gains are maintained and used functionally between treatment sessions’212), and negative,
in particular fatigue:
[The family] perhaps don’t always see a lot of the small gains that you might be able to get in the water
in terms of a bit of extra range or a bit of activation in muscles that they might not necessarily have used
in that way on land . . . the one boy in particular he had never really been in water before, he’d never
done activity in water, he was quite water cautious and was quite fearful of coming in the pool, and by
the end of the intervention he was very water confident and was able to independently float and swim in
the water . . . I think it’s definitely helped to encourage families to carry that over into what they’re doing
at home in terms of like recreation err and sort of sport and extracurricular activities.
Physiotherapist S01/001
All he’s done is get progressively worse and had more and more issues at school with fatigue, and I
think we’ve affected his quality of life very negatively.
Physiotherapist S07/001
The majority of participating physiotherapists contributed to the triangulation exercise detailed in Chapter 7,
Convergence assessment (communal appraisal). Although most of them assessed the AT intervention to be
worthwhile in principle (with some dissent), they were united in their agreement that it was too costly as
currently implemented and that AT interventions should be delivered in community settings. Those who
believed that the intervention was worthwhile thought that the manual represented a good starting point
for treatment but that it should be used as a menu of options from which exercises could be selected and
adapted to the individual patient and available materials (reconfiguration; see Sense-making). This flexible
implementation of complex interventions to local circumstances is often held to be inevitable, desirable and
an indicator of sustainability.137,213 It is also, to some extent, a normal, if arduous, part of physiotherapy case
management, manifested through SOAP note keeping (see Chapter 1, Intervention methods and materials):33
You do need to think about planning the treatment programme and then you need to reassess it and
modify it and try different things . . . and you need time to do that and then time obviously to reflect
and evaluate on it afterwards. So it’s not just about being in the pool, it’s the time before and after
the sessions and time to document it all. Because it all has to be documented, even though we were
filling in the forms for the [RCT]; we had to write patient notes and a patient treatment plan each time
as well . . . It is, again, quite resource heavy.
Physiotherapist S01/001
Some participating physiotherapists did individually assess the AT programme’s effects on themselves and
their work contexts in terms other than those already discussed (individual appraisal). These reflections
were generally positive:
I definitely benefited from additional training to help skill me up more, into delivering a more pure sort
of hydrotherapy-based activity [where you use the properties of the water] as opposed to what you
would describe as exercises or activity in water.
Physiotherapist S01/001
To actually be able to see one child over that length of time is extremely unusual in tertiary referral
and I think it’s been a positive experience for me in terms of, not only [because] I enjoyed it, but also
that I really feel that this is something that I would advocate even more than I was already doing.
I mean I’ve often said ‘this child needs hydro[therapy]’ but I think I would be even more dogmatic
now and say ‘look it really is a good intervention’.
Physiotherapist S04/001
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Summary of therapist views within normalisation process theory
Normalisation process theory is a framework for understanding how new complex interventions are
implemented and embedded in health service contexts.119,120 When we used NPT to analyse the views of
seven specialist physiotherapists who delivered the AT programme in their tertiary centres, we found that
the roll-out of the intervention had not been successful. Although the intervention made sense to all, not
everybody thought it to be of value and there were different perceptions about how flexible their use of
the AT manual should be, with those who took the most flexible approach being most satisfied with the
intervention. Although participating physiotherapists implemented the intervention energetically, they
believed that community settings, not tertiary settings, were the right place for the intervention, and their
organisations permitted its delivery, with sometimes indifferent support, only for the duration of the trial
(programme maintenance). Case management was arduous and is unlikely to be feasible at scale.
Nevertheless, most of the physiotherapists were pleased with the new skills that they had acquired and felt
that they would advocate the use of frequent and intensive AT in other, more patient-convenient, settings
where resources permitted. Figure 24 shows a summary of physiotherapist views within NPT.
Comments on the trial procedures
Sense-making
Stakeholders (physiotherapists and patients) distinguished the evaluation from other, mainly
pharmaceutical, research (differentiation). Physiotherapists understood correctly and collectively agreed on
the feasibility purpose of the research (communal specification); some thought that many patients saw the
study as a way of getting AT for 6 months. This view was borne out by interviewed parents who professed
a lack of equipoise in favour of AT and worried that participation would exclude their son from a drug
trial, a declared reason for non-participation by parents who declined involvement and by some in the trial:
That was one of the worries that by partaking in this would it stop him being eligible for another trial
because, as great as this is, as a parent, you’re always online seeing what NICE [National Institute for
Health and Care Excellence] are going to approve.
Parent R02/001
Sense-making
Physiotherapists:
• distinguish hydrotherapy
   from LBT
• agree on its aims,
   objectives and expected
   benefits
• had different
   interpretations of what
   it required of them
• mostly saw the potential
   value of more frequent
   and intensive 
   hydrotherapy
Participation
Physiotherapists:
• drove the 
   implementation forward
• got support from
   colleagues
• did not believe that 
   it was their role to 
   deliver it
• could not continue to
   support it beyond the
   trial
Action
Physiotherapists:
• translated manual into
   exercises
• maintained confidence
   in each other
• had sufficient skills to
   deliver it
• found that delivery 
   could not be supported 
   by their host 
   organisations
Monitoring
Physiotherapists:
• accessed information
   about hydrotherapy’s
   effects
• collectively dismissed
   the worth of twice-weeky
   hydrotherapy in acute 
   trusts
• individually, were mostly 
   positive about the 
   programme’s effects on 
   them and their workplace
• believed that the manual
   offered a good starting 
   point for flexible and 
   reflexive practice
FIGURE 24 Summary of physiotherapist views within NPT.
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Physiotherapists understood what the research required of them (individual specification) and constructed
potential value for the research (internalisation). Specific value was expressed in terms of the study being
a necessary precursor to a definitive evaluation and the general value of being involved in research.
Physiotherapists believed that parental guilt (see Chapter 1, Significance in terms of ill health) or a sense
that they had to do everything they could for their sons drove participation, and this was confirmed by
interviews with parents.
Relational work
Site investigators drove the research forward (initiation) and physiotherapists agreed that the research
should be part of their work (enrolment). They confirmed that participant enrolment was difficult because
of competition with more attractive industry trials, and challenged the reasoning behind the Research
Ethics Committee’s prohibition on co-enrolment (see Chapter 3, Participant recruitment and the prohibition
on co-enrolment). Participant enrolment was particularly challenging at one site where access to AT was
good. Two physiotherapists questioned the restrictiveness of the eligibility criteria, proposing that younger
and more disabled children should be eligible. Physiotherapists bought into the research (legitimisation),
but some questioned whether or not long follow-up (several years) might be needed to disaggregate the
treatment effects of physical therapy from those of other interventions. They continued to support the
research (activation) despite finding research procedures burdensome. They valued support from one
individual in the trials unit, felt that they worked well as site teams and continued to support the trial
(relational integration). However, they felt that participants’ continued engagement was contingent on
their allocation to AT, something borne out in quantitative findings and parent interviews. Allocation to
the control had been difficult for those with friends or brothers in the research arm.
Operational work
Physiotherapists performed the tasks required by the research (interactional workability), although, as
elsewhere,214 clinicians selected out eligible patients thought to be capricious. They reported that families
were struggling to complete LBT documentation or were dropping out because of it. Physiotherapists
found documentation version control, data capture and data query resolution overly burdensome, but
appreciated the rationale for them (relational integration). In particular, one interviewee found the AT logs
confusing and restrictive compared with SOAP note taking, and this may account for certain data quality
issues. Although some complained of insufficient administrative support, physiotherapists said that the
research was adequately supported by host organisations (contextual integration). However, they said that
backfilling hours was difficult with the resources available, and, other than at two organisations where
dedicated research professionals were used for data collection and entry, physiotherapists conducted
research procedures on top of their clinical workload (see Operational work):
Just the fact that we only got the one patient [randomised to AT in the pilot RCT] made it feasible for
us. But if we’d have got a bigger uptake then we probably would have struggled.
Physiotherapist S05/002
The physiotherapists felt that, although research tasks were not always part of their normal job role, they
were nonetheless appropriate for them (skillset workability). Most were resistant to involving generic
research nurses, believing that they would not understand the clinical environment.
Appraisal work
Physiotherapists have access information about the trial and intervention feasibility (systematisation)
and dissemination to participant families is planned. Communal and individual appraisal was positive.
Physiotherapists made proposals on how the study design and procedures could be modified in response to
their appraisal (reconfiguration): streamlining of documentation, smartphone/tablet access to the study
database for easier data collection and extending routine clinical sessions by 1 hour to allow for completion
of research-specific patient assessments. One physiotherapist wanted more mechanistic outcome assessments
about fatigue, joint range and muscle power. More than one requested a longer, observational, design. The
importance of measuring fatigue and pain pre and post session was stressed.
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Although signed assent forms were available for all participants, interviewed children often could not
remember being approached about entry into the study. Those who could remember the approach
described feeling ‘good’, ‘excited’ or ‘nervous’. Parents were pleased to be approached about entry to the
study, although expressed anxiety about forgoing the opportunity to be in future drug trials. Only one
child recalled the randomisation process and reported not liking it. Only two parents (both in the AT arm)
described a positive response to the randomisation process. Three families reported the number of items
on the questionnaire battery as being too many. Only two families made more specific remarks, in each
case in relation to well-documented problems with responding to vague questions on health-related
quality-of-life instruments.215
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Chapter 6 Cost analysis
Cost of aquatic therapy
The cost of AT to the NHS was estimated by taking the NHS 2013 tariff cost of AT of £110 for a first session
and £74 for subsequent sessions inflated to current prices using the Hospital and Community Health Services
Index.216 We also examined some of the individual components of AT including staff time and maintenance
costs. Qualitative interviews and discussions at our TMG showed that a minimum of five staff members
were needed on site to run a 30-minute AT session: one physiotherapist at NHS band 5, 6 or 7; one
physiotherapist assistant (NHS band 3); and three other staff (band 2 or 3). We took the midsalary point on
NHS Agenda for Change169 and assumed that staff needed to be available for 1 hour to deliver a half-hour
session. We were unable to obtain maintenance costs directly from the centres participating in our study;
however, a NHS report from trusts showed annual costs of £12,000 per year.217
Land-based therapy was prescribed by the specialist physiotherapist during this study. Outside this study, in
usual care, it would be prescribed by a community-based physiotherapist. The frequency between visits to
a community physiotherapist varied between once every 6 weeks and once every 6 months. The unit cost
of a physiotherapist was taken from the Personal Social Services Research Unit.216 The exercises prescribed
were then carried out by carers and teaching assistants.
Costs borne by patients
Although not a NHS cost, there is an opportunity cost to participants and their carers and family to attend
an AT session; this includes time off work or usual activities for the carer, time out of school for the
participant, child care costs for other children, journey time getting to the session and parking.
The intervention also included LBT two to four times a week, which may be delivered by a
community-based physiotherapist, parent or teaching assistant. For NHS costs it was assumed that the
community physiotherapist saw the participant once per month and that sessions were delivered by
parents or teaching assistants at all other times. It was assumed that the amount of contact time the
community physiotherapist had with participants was the same in both groups. However, we allowed for
the fact that parents in the usual care group would have to spend more time delivering LBT, as they would
have to provide, on average, three more LBT sessions than required for the AT group.
Using information from the qualitative interviews and from discussions with our PPI representatives on the
TMG, we made the following assumptions about time:
l time off work or usual activities to take participant to an appointment – 3 hours
l time to look after other siblings during the session, assuming that each carer had at least one other
child who would need child care arrangements – 3 hours
l time out of school for participant – 30 minutes
l travel to appointment by car – 30-mile round trip
l car parking costs.
Productivity loss was taken to assume any time taken away from usual activities by the carer regardless of
whether this was time away from paid or unpaid activities. In the main analysis we excluded the time the
child was taken out of school but this was then included in an alternative scenario. Costs per hour were
taken from the Office for National Statistics Annual Survey for Hours and Earnings for 2015218 and were
£528 per week or £14.08 per hour. Based on the qualitative interviews it was assumed that all participants
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travelled to the AT sessions by car; average running costs were obtained from the Automobile Association
(Basingstoke, UK) website and assumed to be, for a petrol car costing £18,000–25,000 when new and
covering 20,000 miles per year (median cost and travel distance), 42.52p per mile.219 Car parking costs
were assumed to cover 1–2 hours of parking at a NHS car parking fee of £2.50.
Land-based therapy was delivered 4–6 times per week in the usual care group and 2–4 times a week in
the intervention group. This tended to be shared between teachers and parents. We assumed that parents
would help with LBT two or three times a week in the usual care arm and once or twice a week in the
intervention arm, for approximately 30 minutes per session. Costs per hour were taken from the Annual
Survey for Hours and Earnings for 2015.218
For both NHS cost and costs borne by patients, perspectives costs are estimated per patient per session
and for a 6-month block of treatment. Discounting was not applied as costs are presented over the
6-month time period of the study. All costs are presented in 2015 prices.
Attendance
Alternative costs for a course of AT were estimated after allowing for non-attendance. If the AT pool had
been available for all sessions over the 6-month period, then participants would have had the opportunity
to attend 52 sessions. In reality, participants were offered anywhere between 28 and 52 sessions (349 over
eight participants). This resulted in an attendance rate of 58% over the 349 sessions that were offered, or
49% if all 416 sessions had been available. In 50 of the 349 sessions, participants were unable to attend
and were assumed to cancel the session in advance; assuming that the pool was put to other use over this
time would give attendances of 68% over 299 sessions or 55% over 366 sessions.
Results
Using NHS tariff costs, AT cost £113.88 for a first session and £76.61 for subsequent sessions. Over a
6-month course of AT this would result in a cost of £4021 over 52 sessions. Allowing for alternative
attendance rates, costs of AT would range between £1970 (49% attendance rate) and £2734 (68%
attendance rate) (Table 25).
Over a 6-month course of AT, staff costs would be £3504.28 and range between £1717 (49% attendance
rate) and £2383 (68% attendance rate). Assuming annual maintenance costs of £12,424 for an AT pool
used by a range of services and offered for 39 weeks per year during core hours would work out at £8.49
per hour.
Land-based therapy provided in its usual setting would cost the NHS between £80 and £320 over a
6-month period, assuming that physiotherapists saw boys once every 6 weeks to once every 6 months.
The remainder of the costs of LBT would be borne by the carers and the education system (teaching assistants).
TABLE 25 Summary of staff costs for AT session
Staff Midpoint salary (£) Cost per hour (£)
One band 5/6/7 physiotherapist 29,043 19.85
One band 3 physiotherapy assistant 17,972 12.29
Three band 2/3 staff 17,179 (×3) 35.25
Total NHS staff costs 67.39
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Costs borne by participants and their carers for aquatic therapy
Table 26 shows costs borne by participants and their carers per AT session to be £99.74 or £106.78 if
including time lost by a child from being taking out of school early. These costs would rise if child care
for other children was undertaken by professionals (e.g. after-school clubs or childminders rather
than volunteers).
If participants attended all 52 sessions, the costs borne by them and their carers would be £5186 (£5552
if including time out of school). Costs would range between £2541 (49% attendance rate) and £3526
(68% attendance rate) if participants’ time out of school is unaccounted for or £2720 (49% attendance
rate) and £3775 (68% attendance rate) if participants’ time out of school is accounted for.
Land-based therapy costs to parents in the usual care group ranged from £732.16 to £1098.24 for two
or three sessions over the course of 6 months and from £366.08 to £732.16 for one or two sessions
over 6 months in the intervention group; a difference in costs of £366.08. Overall, the costs borne by
participants and their families for AT plus LBT could be as much as £6000 assuming attendance of all
sessions, in comparison with £1098 for LBT alone.
TABLE 26 Summary of activities and costs borne by participants and carers attending AT sessions
Activity Effort Cost (£)
Carer time off work or usual activities 3 hours 42.24
Child care costs assuming time borne voluntarily by other carers 3 hours 42.24
Travel costs by car 30-mile round trip 12.76
Parking 1–2 hours 2.50
Total per session 99.74
Including time out of school 0.5 hours 7.04
Total per session 106.78
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Chapter 7 Triangulation exercise
Convergence assessment
The convergence between quantitative and qualitative findings is presented in Table 27. There was agreement
on six components, silence on eight (all expected areas amenable only to qualitative assessment) and
dissonance on two. The areas of dissonance concerned attendance and optimisation. In each case, simple
reading of the quantitative data might lead to an overly simplistic attribution of cause. In the case of session
attendance, most of the quantitative data pointed to illness or simple non-appearance of the family; the
qualitative data revealed that the convenience of available time slots had a strong role in non-attendance for
some families (see Chapter 5, Balancing the demands of the programme with work, school and family life).
Similarly, the quantitative study identified an apparent failure to optimise the intervention on the part of
several physiotherapists (see Table 23); the qualitative data revealed this to be part of a misunderstanding,
with therapists wrongly assuming that the study required them to apply the manual prescriptively or
extensively (see Chapter 5, Sense-making), rather than in the focused and more achievable way proposed
at training (see Chapter 2, Interventions). The same therapists were aware and very concerned that therapy
was not optimised.
Completeness assessment
Qualitative research contributed information to 15 out of 17 logic model components, whereas the
quantitative components contributed to nine. This was expected; some components were not amenable to
investigation in quantitative terms.
TABLE 27 Convergence coding matrix for programme theory elements
Theme Quantitative findings Qualitative findings Convergence code
Resources
Willingness and ability
of parents to take
children out of school,
travel and attend
twice per week
Large numbers of eligible
families (self-)excluded from
study because of geographical
distance from pool (see
Chapter 3, Recruitment and
participant flow)
Families unified in view that
twice-weekly travel to the
acute trust for AT is too
burdensome (see Chapter 5,
Balancing the demands of the
programme with work, school
and family life)
Agreement (on access
problems/burden of
treatment)
Available AT pool Percentage of missed sessions
were because of staff or the
pool not being available (see
Chapter 3, Delivery and
receipt of the aquatic therapy
and land-based therapy
interventions)
Pool closures and staffing
problems were discussed (see
Chapter 5, Operational work)
Agreement (on pool
availability as a frequent
reason for missed sessions)
Engaged NHS trust – Participating trusts not
interested in providing a more
intensive, open-ended AT
service for DMD (see
Chapter 5, Operational work)
Silence (issue appropriate only
for qualitative investigation)
continued
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TABLE 27 Convergence coding matrix for programme theory elements (continued )
Theme Quantitative findings Qualitative findings Convergence code
Pool hire and staff
costs
Estimated direct NHS costs
range from £1970 to £2734
over 6 months, based on
attendance; societal costs
range from £2541 to £3775
Physiotherapists noted that
financial pressures and
opportunity costs meant that
service was hard to justify (see
Chapter 5, Operational work)
Agreement: it could be hard
for AT to compete with other
paediatric treatments of
similar costs in QALY terms.
NHS costs are less than for
haemodialysis in children
aged over 6 months
(£10,296–46,352 assuming
three sessions per week) or
the cost of specialist services
for children with cystic
fibrosis, which range from
£2554 to £24,809 over
6 months depending on
complexity of care.220
However, the costs of
delivering the same
intervention in the community
could be substantially lower
Motivated
physiotherapists
– Motivated, but believed that
the acute trust was an
inappropriate setting, with
one finding it unnecessary
(see Chapter 5, Relational
work)
Silence (issue appropriate only
for qualitative investigation)
1-day training course Attended by six
physiotherapists from four
trusts (see Chapter 2, The
development of treatment
manuals and theory)
Attendees found it useful (see
Chapter 5, Appraisal work),
although not all optimised
treatment subsequently
Agreement (training
implemented and successful)
Manual – Found useful as a ‘starting
point’ or ‘menu’ of options.
Concern about prescriptive
use (see Chapter 5, Appraisal
work)
Silence (issue appropriate only
for qualitative investigation)
Activities
AT sessions Implemented in 6 out of 17
NHS trusts approached for
involvement (see Chapter 3,
Implementation of the
intervention and trial)
Treatment cost barrier to
the other 11 trusts, confirmed
in interviews (see Chapter 5,
Operational work)
Agreement (on difficulty of
funding AT in context of a
RCT)
Case management – Documentation resource
intensive (see Chapter 5,
Appraisal work)
Silence (issue appropriate only
for qualitative investigation)
Programme
maintenance
– Unsustainable in the long
term or at scale because of
opportunity cost (see Chapter 5,
Relational work)
Silence (issue appropriate only
for qualitative investigation)
Immediate outcomes
Eligible boys offered
AT (‘reach’)
348 boys identified at six
centres. Families of 17/66
eligible boys contacted about
RCT interested; 8/12
randomised received AT (see
Figure 10)
Distance from centre and
(in the context of RCT)
involvement in drug trials
confirmed as major reasons
for non-participation (see
Chapter 5, Comments on the
trial procedures)
Agreement (on extent and
reasons for failure of service
to reach families)
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TABLE 27 Convergence coding matrix for programme theory elements (continued )
Theme Quantitative findings Qualitative findings Convergence code
Twice-weekly sessions
delivered for 26 weeks
(‘dose delivered’)
203/349 scheduled sessions
took place for eight
participants. 69/146 missed
sessions were because of NHS
factors (unavailable pool/staff)
(see Chapter 3, Delivery and
receipt of the aquatic therapy
and land-based therapy
interventions)
Interviews confirmed that
closures for repairs were an
issue (see Chapter 5,
Operational work)
Agreement (on causes of
non-delivery)
Attendance at all
sessions (‘dose
received’)
63/146 missed sessions were
because of family factors
(e.g. illness) (see Chapter 3,
Delivery and receipt of the
aquatic therapy and land-based
therapy interventions)
Reasons for non-attendance
also included inconvenient
scheduling (see Chapter 5,
Balancing the demands of the
programme with work, school
and family life)
Dissonance: qualitative
findings problematise
quantitative findings
AT optimised for
individual boy (in
place of ‘fidelity’)
Independent rater considered
AT optimised for 3/8 boys,
with other programmes too
extensive/insufficiently
focused (see Chapter 4)
Only one boy had both
optimised treatment and
good attendance, but he also
had high pain and fatigue
Some physiotherapists
misunderstood the manual’s
purpose as prescriptively
demanding extensive rather
than focused programmes
(see Chapter 5, Sense-making)
One boy was dissatisfied with
the AT
Dissonance: qualitative
findings problematise
quantitative findings. Lack
of clarity from research
team/training on need for
focus may be responsible
for poor optimisation.
Good optimisation did not
necessarily lead to good
outcomes/satisfaction
Intermediate outcomes
Gross motor function The study is not powered to
detect important differences
in clinical/patient-important
outcomes
Some interviewees perceived
small gains (see Chapter 5,
Perceived improvement in
confidence, independence or
participation and Summary
of therapist views within
normalisation process theory)
Silence
Exercise tolerance The study is not powered to
detect important differences
in clinical/patient-important
outcomes
– Silence
Respiratory capacity The study is not powered to
detect important differences
in clinical/patient-important
outcomes
– Silence
Activities of daily living The study is not powered to
detect important differences
in clinical/patient-important
outcomes
Physical and social participation
and self-engagement
(enjoyment, accomplishment,
satisfaction)101 were noted and
valued by parents, most boys
(see Chapter 5, Perceived
improvement in confidence,
independence or participation)
and some physiotherapists
(see Chapter 5, Summary of
therapist views within
normalisation process theory)
Silence
QALY, quality-adjusted life-year.
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Summary
Figure 25 provides a summary of key points relating to the intervention implementation. Although families
are motivated to access AT, the distance from tertiary centres precludes many and adds to the existing
burden of disease management for those who engage. Pool availability is at a premium, not constant and
often at inconvenient times. Tertiary centres were not committed to delivery at scale or beyond the life of
the RCT, owing to the costs and opportunity costs being too great. Estimated direct NHS costs, based on a
service at an acute trust, range from £1970 to £2734 over 6 months; this would compete poorly with
other specialist paediatric services in terms of value for money, but the costs could be reduced considerably
by delivery in the community. Specialist physiotherapists are motivated to help patients and most see a
wider role for AT, but not with them or their NHS trusts as providers. The 1-day training course was well
received. The AT manual provides a good basis for a flexible but focused and realistic prescription. Only 6
out of 17 NHS trusts were able to deliver the trial, sometimes because of intervention costs. Documentation
for case management was burdensome and programme maintenance was unsustainable. About 40% of
scheduled sessions were missed because of a mixture of NHS and family factors, but the time of day affects
the ability of families to attend. Optimal therapy was delivered in three out of seven participants, but
optimal therapy did not necessarily lead to satisfaction or good outcomes.
INPUTS
• Twice-weekly attendance
   burdensome
• Pool availability unpredictable/
   at inconvenient times
• Acute trusts not engaged
• Pool hire/staff costs not scalable
• Specialist physiotherapists
   motivated, but role inappropriate
• 1-day training course successful
• Manual a good menu for flexible
   practice
ACTIVITIES
• AT sessions implemented
• Case management conducted
• Programme maintenance
   infeasible owing to opportunity
   cost
IMMEDIATE OUTCOMES
• Eligible population not reached
   (distance from pool)
• 58% of scheduled sessions
   delivered
• Half missed owing to NHS
   factors
   (’dose not always delivered’)
• Half missed owing to family
   factors
   (’dose not always received’)
• AT not usually optimised 
   (typically too many exercises)
FIGURE 25 Three columns from initial logic model showing threats to implementation. Italicised bullet points
illustrate the implementation problem.
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Chapter 8 Discussion
Summary of findings
Over 6 months, 348 boys were screened, most of whom could not be enrolled in the external pilot RCT as
they were already in trials; 13 consented and 12 were randomised (30% of target) to AT (n = 8) or control
(n = 4). The intention-to-treat analysis involved nine (AT, n = 8; control, n = 1) participants for all outcomes
except the routinely collected NSAA score, which was available for 10 participants. Of the 349 scheduled
sessions for which we have data, 203 (58.2%) expected sessions took place and 146 (41.8%) did not.
Where the reasons for session cancellation were reported (10% of sessions were unaccounted for), there
was a fairly even split between participant/family factors (43%) – sometimes related to inconvenient session
timing – and health-care provider factors (47%). An independent physiotherapist who assessed optimisation
of the interventions found that, based on capability and need, AT had been optimised for only three out
of eight boys, with the remainder receiving treatment that was too extensive and insufficiently focused
(revealed by qualitative research to be because of a misconception about the rigour with which the study
team intended the manual to be implemented).
Interviews with families revealed sometimes isolated parents attempting to ‘keep it as normal as possible’
while having ‘to fight . . . to put everything in place’ for their children. Many had multiple DMD boys. Parents
often shared the delivery of LBT with teaching assistants or, less frequently, community physiotherapists who
came into school. Some reported back pain and lack of confidence in delivery. Outside the study, some
parents had accessed at least one block of 4–6 weekly half-hour AT sessions since their sons had developed
mobility problems. Some would be able to apply for another block in 6 months’ time. They valued exercise in
warm water, reporting that their sons were unable to function for long in regular pools and that they felt
that the break between ‘blocks’ was unhelpful. Most parents perceived gains in function or social/water
confidence from the study AT, and valued closer working with the therapy team. Fatigue was a problem
for two boys attending morning sessions. One of them, who was the oldest in the study and the boy
experiencing the most rapid decline in function, also missed school as a result of his fatigue. This child was
the only one who had both optimised therapy and good attendance, but he reported dissatisfaction with
the AT and pain, although this resolved the same day. Attending AT at specialist centres involved long
journeys, sometimes 3-hour round trips through rush hour traffic, for parents who mostly lived 15 miles
away. All would have liked to have accessed AT at more local community pools.
Physiotherapists at two trusts questioned the value of the AT because of the opportunity cost to the trust.
The message delivered in AT training was that AT prescriptions should be focused on the needs and
capability of the individual, but many therapists thought that they had been asked to deliver stretches that
could be delivered on dry land, or a range of exercises regardless of relevance. As a result, some were
dissatisfied with the intervention. Participating physiotherapists believed that, in future, AT should be
delivered in community rather than tertiary settings. Host organisations did not normalise the ongoing
delivery of the intervention. Most of the physiotherapists were pleased with the new skills that they had
acquired and felt that they would advocate the use of more frequent and intensive AT in other, more
patient-convenient settings, where resources permitted.
Strengths and limitations
Development and implementation of the intervention
We have fully described not only what the intervention is and how it was developed, often poorly
reported,221 but also how implementation and context affected its feasibility and acceptability.131,222 There is
no standard way to develop complex interventions.223 We did not use formal consensus methods that, in
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any case, may not be important until finalising an intervention’s specifications.223 Our development group
contained too few parents of boys with DMD to reflect a broad range of concerns or to exercise an
effective voice, and no community physiotherapists. Future development of AT programmes should fully
and effectively involve these and other stakeholder groups, such as charities. Time prohibited iterative
testing and adjustment before the pilot224,225 may have improved the intervention. The study team made it
insufficiently clear to physiotherapists that they should generate a focused and achievable prescription to
guide intervention sessions, leading to suboptimal prescriptions in five boys. Although all participating
physiotherapists had been on a Chartered Society of Physiotherapy AT foundation course and received a
training video, we are not clear how many watched it and not all took up face-to-face training.
The pilot trial
Pilot trials are not designed or powered to provide estimates of clinical effect that are adequate for
decision-making.70,71 We measured key process variables,70 describing fidelity, dose and reach;132 the study
was not powered to test quantitatively for mechanisms of impact or the presence of contextual moderators.131
As a result of the shortfall in recruitment, data are also inadequate for sample size estimation.226 Although the
consent/assent process was procedurally correct, participant recall of it was poor (see Chapter 5, Appraisal
work), indicating that improvements are necessary in any further related research (see Chapter 9).
The decision to deliver AT outside its usual context of delivery by community physiotherapists in community
pools to delivery by specialists in specialist centres was taken for the best of reasons. The national
reorganisation of services in 2013 (see Chapter 3, Problems with the delivery of land-based therapy) left us
lacking in confidence that we would be able to approach and engage the right people to set up the study.
Although we have fully described the context of access and delivery, the evaluation we have delivered is of
a decontextualised intervention. Many of the barriers that we encountered in the delivery of AT may not be
encountered to the same extent if the intervention were to be delivered more locally to the service user and
in community settings.
The clinical assessments focused on physiological function and paid insufficient attention to participation
outcomes, the importance of which emerged during qualitative research and in consultation with PPI
representatives. Agreed approaches to the conceptualisation and measurement of participation have been
lacking,97,98,100 but two reviews and a conceptual framework100,227 now provide sound guidance for
future research.
The qualitative research
The use of qualitative methods successfully captured breakdowns in implementation and views on the
intervention131 and enabled us to recommend changes to the intervention. The use of a logic model,
published empirical evaluations and social science theory ensured that key uncertainties and important
questions were addressed.131 Iterative data collection enabled the exploration of emergent themes. We did
not use serial interviews to capture changes in the intervention or related experiences over time,131,228 or to
adequately explore the relationship between families, community physiotherapists and schools.
Optimisation
As physiotherapy is a process that is poorly understood by analytical reasoning and requires extensive
knowledge-based processing, it is not generally helpful to standardise it.136 The decision to evaluate
optimisation rather than fidelity of delivery was appropriate and ensures congruence with the intervention
theory.139,229,230 The use of an experienced independent physiotherapist with content expertise was
appropriate, but might have been improved by a second rater working blind to the assessment of the first.
Only two of the therapists took up the opportunity to respond to the independent assessment of their
work; protocolisation and better scheduling of this opportunity might help to bring out important nuances
in future optimisation exercises. We are unclear how adherent most participants were to their LBT
exercises; it is plausible that we have good-quality data only on those who were able to comply both with
their LBT prescription and with study procedures.
DISCUSSION
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Health economics
This study has shown that the potential investment costs for families could be greater than those to the
NHS. However, patients and carers were happy to commit to AT. Owing to the small numbers in this
study, these findings have focused on the cost of delivery of the intervention and the impact on families;
we have not been able to take into account variability in any assumptions, although we have reported
ranges when applicable. In addition, we have not been able to use information on the CHU-9D and
additional resource use owing to the small numbers and the lack of any meaningful interpretation.
Although we have not used the information the study showed, it was feasible to collect it in this population.
Triangulation protocol
We selected a different method appropriate to the commissioning brief,131 but did not implement methods
independently.231 A formal mixed-methods approach allowed the robust use of qualitative data used to
explain quantitative findings.
Generalisability
The sample size is inadequate for sample size estimation226 or theoretical development,174 but some
findings are generalisable for decision-making in the UK. Attempts to run RCTs on this topic will recruit
poorly and generate unrepresentative samples because of the prohibition of co-enrolment and competition
with industry studies.186 Equipoise is poor among parents, with most believing AT to be beneficial. Where
these conditions pertain, resentful demoralisation on the part of those randomised to the control arm
could have serious psychosocial effects (see Chapter 5, Sense-making). However, future commissioning
and evaluations are likely to involve local rather than central provision of services, as preferred by diffuse
populations,115 and less intensive AT services amenable to austerity conditions and patient preference.
Modifications in design, which are necessary to make a full-scale study feasible, are proposed below.
To avoid some of the problems with the intervention and trial delivery reported here, such a study would
have to be delivered in a community setting, meaning that, inevitably many of our findings would not
be transferable.
Evidence of feasibility
On the basis of our success criterion (see Chapter 2, Feasibility criterion), a full-scale study along traditional
frequentist lines is unlikely to be feasible. The main barrier to feasibility, namely the need for large
numbers, could be removed by the employment of a Bayesian design, which could recruit 40 participants
in a 2-year accrual window (see Chapter 3, Decision on the primary end point and sample size for a full-
scale trial). However, the prohibition on co-enrolment raises concerns that the resultant trial population
would be unrepresentative of the whole (see Chapter 3, Participant recruitment and the prohibition on
co-enrolment). The alternative is to address the co-enrolment prohibition (which applies only to RCTs) and
the absence of equipoise among parents (see Chapter 5, Comments on the trial procedures) by sacrificing
randomisation and evaluating AT using an observational design (see Chapter 9). The necessary step of
delivering AT closer to participants’ homes will increase the number of research and development
approvals and so, all things being equal, the costs of the study, thereby replacing one barrier (refusal of
consent because of participant travel time) with another (funder willingness to pay). The imperative to
understand exactly what was delivered in complex intervention research, in terms of dose and fidelity,68,131
can drive up research costs and presents a barrier to feasibility. Research-literate specialist physiotherapists
from tertiary centres may have the capability, opportunity and motivation to invest in trial procedures
necessary to assess the optimisation of AT (see Chapter 5, Comments on the trial procedures); there is no
guarantee that community physiotherapists will do so. Meanwhile, reliably assessing the delivery of LBT
data may require the co-operation of a community physiotherapist, a parent and a teaching assistant for
every boy (see Chapter 1, Introduction). Although the use of a tablet or smartphone application with
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short-messaging service reminders for these stakeholders may overcome the problems with paper-based
data collection observed in this study, the prospect of high-quality data still seems remote.
Implications for health professionals and families
The need for new models of aquatic therapy access
Patient and public involvement coauthors, James Parkin and Victoria Whitworth, provide the following
challenge for future research.
The ideal is open-ended, weekly, therapist-led AT, but the current service is sporadic 4- to 6-week blocks.
James Parkin found that he had to rebuild all his confidence when coming back to therapist-led AT after
breaks in service. Sustaining water confidence and self-esteem is very important to self-management. If
you have a big break, each time you go back, the likelihood is that you have physically deteriorated – so
the break just highlights the physical deterioration. It is easier, psychologically, to experience gradually
increasing difficulties over time, rather than perceive step changes in the decline of physical function. The
problem then is, how do we do approach the ideal?
Open-ended weekly AT, a priority for families, will be problematic to commission from NHS providers,
even in the context of future research studies. More feasible models of care that extend access to AT are
needed. The PPI coauthors suggest the following elements that are intended to augment the ‘blocks of
sessions’ model (see Chapter 1, Current aquatic therapy provision in the UK). Suggestions a–c are feasible,
based on their personal experience.
(a) The number of sessions in a NHS AT block might be extended if the numbers of children with
neuromuscular conditions in the pool could be increased to capacity, and the incremental cost to the
NHS could be minimised by parents being in the pool. The same amount of face-to-face physiotherapy
contact could be spread over a greater number of sessions, by leaving parents to practise exercises
and allowing more NHS pool time, while a physiotherapist rotates between clients. This model was
practised by James Parkin’s provider for many years, allowing increased access (6-week blocks
between 12-week intervals) and enabling NHS AT access three times, rather than twice per year.
(b) During routine NHS AT session blocks, parents are enabled to safely and effectively deliver AT,
through in-pool training and diagram sheets. It is then their responsibility to access warm water pools
between NHS session blocks. This merely extends the existing parental role of LBT delivery between
physiotherapy consultations.
(c) If parents of children with neuromuscular conditions were able to link with each other, then they
could share the high costs of warm-water pool hire documented by MDUK (see Chapter 1, Current
aquatic therapy provision in the UK), in order to do aquatic physiotherapy and other exercises
reguarly.64 James Parkin’s family was able to link with others in this way through a national charity,
to access AT at the most convenient time, Sunday afternoons, with their families.
(d) If parent-led weekend AT ‘clubs’ were feasible, then it is possible that community physiotherapists
could be attracted to that setting to monitor that treatment is being delivered optimally. This model
could reduce the administrative burden on the physiotherapist as the (non-NHS) pool management
would be responsible for safety, and the requirement for burdensome SOAP note taking during such
sessions (see Chapter 5, Appraisal work) could be reduced.
An obvious limitation of this model is that greater parental time in the pool is predicated on an adult-to-child
ratio that can assure safety; some of the parents we interviewed are on their own with more than one
DMD boy during pool visits while their partner, if they have one, is working. Such barriers need not be
insurmountable; in Leeds, children engage in 20-minute one-to-one tailored AT sessions with qualified
physiotherapists supported by volunteer student physiotherapists from Leeds Beckett University.232 The costs
to the family are £7 per session with the remainder of the £40 direct costs made up through charitable
donations. The Leeds service is based at the Penny Field School; coauthor and aquatic therapy specialist
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Heather Epps believes that, for some geographical pockets, training staff at special schools using the
manual and course that we have developed may be more efficient and sustainable than delivery through
the NHS. In Heather Epps’s catchment area, there are high numbers of boys with DMD at specialist schools.
At state-funded Valence School in Westerham, Kent, staff deliver an AT programme, with oversight by
NHS physiotherapists. The independent Treloar College in Holybourne, Hampshire, employs its own
physiotherapists to deliver AT. Special schools that employ technical instructors and physical therapy
assistants can deliver AT more cheaply than the NHS, but still work at a high level. Economies of scale could
be achieved if they were to serve neighbouring special schools with no pool of their own.
In the rest of this section, we provide general recommendations for the development of collaborative
services, based on the six principles for the future of health and social care services recently outlined by
NHS England.233
Person centred: personalised, co-ordinated and empowering
In theory, community physiotherapists are already delivering personalised care in the sense of working
with boys and their parents to develop and implement action plans, and to monitor progress,33 although
in practice this is often not the continuous process it should be (see Chapter 5, Environmental factors).
Fully personalised care involves shared decision-making to agree goals and to identify support needs.233,234
Physiotherapists may require training to deliver services that are flexible and responsive to help young
people achieve individually defined goals.235,236 Personalised care should also be minimally disruptive,16
given that it is unreasonable for schools to expect poor outcomes in students with a disability,237 efforts
should be made to schedule AT so as to minimise impact on school participation. The integrated model of
AT (see Figure 4)121 and models of developmentally appropriate health care238 highlight the rewards gained
when delivery focuses not only on narrow physiological outcomes but also on social and psychological
gains. Proper co-ordination is required (see Carers are identified, supported and involved), with 6-monthly
identification of key problems, safety issues, ideas for exercises and how to make them fun by specialists in
consultation with community physiotherapists, parents and teaching assistants.
Services that are created in partnership with citizens and communities
NHS England proposes that communities and local services can work together at all stages of the planning
cycle, from the identification of needs through to implementation and evaluation.233 Critically, if service
managers cannot deliver the ongoing physiotherapy service that parents desire, then they may be able to
support something else to happen.239,240 Use of national involvement standards for public involvement241
and sound evaluation principles242 will increase the chances that new service models will meet the needs of
service users and their families. At a minimum, stakeholders for the codesign or coproduction of future
services should include DMD family members, specialist and community physiotherapists, representatives of
schools and/or teaching assistants, community AT pool providers and third-sector organisations.
Focus is on equality and narrowing health inequalities
Participation is rarely equitable and more normally determined by location and income.64,96 Clear principles
are required to guide the coproduction of new services241 and these might be provided by the United
Nations Convention on the Rights of Persons with Disabilities, which urges state providers to promote ‘full
inclusion and participation in the community’ (Article 19), provide ‘services designed to minimize and
prevent further disabilities, including among children . . . as close as possible to people’s own communities’
(Article 25), and to promote recreation, leisure and sport (Article 30).243 At a national level, since the
Children and Families Act 2014244 and associated guidance,245 families can sometimes access AT via
Sections F (special educational provision required) and G (health provision reasonably required by learning
difficulties or disabilities) of an education, health and care plan.
Carers are identified, supported and involved
Models of coproduction239,240 and developmentally appropriate health care246,247 would suggest that service
managers now need to recognise parents and teaching assistants as assets and allow specialist and
community physiotherapists to build their capability for safe and effective delivery of LBT and AT outside
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the NHS. If the distribution of this work is to remain ‘joined up’ in how it works across roles
(physiotherapists, parents and teaching assistants) and organisations (tertiary centres, community providers
of physiotherapy, schools), then co-ordination is necessary.
New models of participation-based physiotherapy for disabled children see the therapist as a consultant,
who shares information and educates to build capacity for the work of rehabilitation in the child, family,
and community.248 To be family centred, the family should identify needs, but also share responsibility, and
health professionals should empower the family.88,249,250 Support for shared management support might
include effective training in, and printed information on, exercises that parents can perform safely and
effectively with their children, as well as improved signposting to services. Key worker, partnership and
skills training models of this kind reduce the stress experienced by parents of disabled children by helping
them to understand the service environment, and to understand services to understand their needs.198
Family-centred and shared-management approaches to physiotherapy for disabled children are emerging,
with associated models for implementation and evaluation.248,250,251 They stress that investment may be
needed to train physiotherapists in practical coaching and facilitation skills.251
This study identified that parents delivering physiotherapy to their children suffered injury as a result.
Work-related musculoskeletal disorders, especially back pain, are common among physical therapists and
parents of children with musculoskeletal disorders.252,253 It is particularly important that parents and teaching
assistants delivering LBT receive structured education and feedback on the safe delivery of exercises to their
sons. We also identified that not all parents habitually prioritise the delivery of LBT. Although this can be
seen as a function of burden of treatment, parents who are interested in habituating the evening delivery
of LBT to their sons may benefit from interventions such as written exercise instructions or behavioural
interventions with booster sessions and goal setting.254
Careful work is required to ensure that involvement and mutual responsibility works for parents and is not
received by them as part of the ‘growing demands’ for them ‘to organize and co-ordinate their own care’.113
Carer engagement should not be used as a staging post for rationing by denial, selection, deterrence or
dilution,255 not least because safety concerns (see Chapter 1, Physiotherapy) mean that carers need some
level of education in pathology and oversight and treatment.
Voluntary sector as a key partner and enabler
In the past, the voluntary sector has contributed to the costs of group AT sessions and they are currently
active in charting the location of warm water pools in the NHS, specialist schools, gyms, hospices and
other areas.64 They may also be persuaded to fund the training of community physiotherapists to deliver
AT, and to act as more effective co-ordinators of the distributed work of care, at least in the context of
further research. Perhaps the most important role for the voluntary sector is to build social capital for DMD
families. Social capital is defined as a ‘public good consisting of ties, trust and norms’, which is based on
social activities rather than private property.210 The social capital of families is often weakened on receipt of
a chronic disease diagnosis for their child.256 In theory, building social capital increases participation and
social inclusion for people with disabilities and their families257 through the removal of social and economic
barriers to participation in services and leisure activities.258 Charities can build social capital in two ways:
(1) through changing norms, expectations and attitudes about access to services, and (2) by enabling DMD
families to link into social networks of mutual support.
Social action as a key enabler
Social action is about ‘people coming together to help improve their lives and solve the problems that are
important in their communities’.259 If DMD families are able to link together, then other benefits should
follow, other than sharing the cost of hiring private warm-water pools (see The need for new models of
aquatic therapy access). Peer support groups are of practical importance for parents of disabled children in
terms of information, advice and improving relationships with professionals; they also offer an opportunity
to forge a community of shared experience.260
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A revised programme theory
Given our findings, it is necessary to revise our programme theory (see Chapter 1, Secondary objectives) to
inform future efforts to implement and evaluate AT. Changes and additions are in bold and a revised logic
model is presented (Figure 26).
Families will be motivated to access open-ended, once-weekly AT.
Clinical Commissioning Groups currently allocate resources for community physiotherapists to deliver 4- to
8-week blocks of AT, every 6 months at most (inputs and activities) within the existing roles, interactions
and relationships that characterise the management of DMD (context). Alteration of this usual provision
to teach parents key stretches and exercises, and action by the third sector to link parents, so that they can
combine resources and hire warm water pools (immediate outcomes), will enable the desired ongoing access
and bring about physiological benefits described in the treatment theory. It will also result in important gains
in dimensions of participation – physical, social and self-engagement (intermediate outcomes).
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Chapter 9 Further research
The research priorities should be as follows.
1. Families require more regular access to an enhanced AT service that enables them to learn and safely
deliver techniques between standard NHS session blocks. The present monograph reviews much of the
evidence and theory. A study combining intervention development and feasibility study phases of the
Medical Research Council Framework is needed to model process and outcomes and to test procedures
in community settings.68 Participatory action research to understand how the third sector, NHS specialist
and community physiotherapists, parents and teaching assistants in more than one location can
coproduce a scalable personalised, co-ordinated AT service. Families should be encouraged to link with
each other to build capacity for AT beyond limited NHS provision of intermittent session blocks, and
contribute to or lead the evaluation. Outcomes should be a new service protocol for evaluation,
measurement of participation and function, and participant views. An appropriate plan should be
provided, not only to identify successful elements of practice, but for knowledge brokering and scaling
up of successful intervention models,261–266 and theoretically informed methods of implementation
should be reported in line with appropriate guidance.267–269
2. The work of LBT is currently distributed but unco-ordinated, with parents and teaching assistants
sometimes injuring themselves or failing to deliver treatment; as a result, treatment is not routinely
optimised (see Chapter 5, Participation restriction). Taking into account what is known about barriers
to interagency working,270,271 stakeholders should produce materials and systems to ensure that
prescriptions are clear and regularly updated with specialist input, and that responsibility for training
and delivery is transparent. Motivational and scheduling barriers should be addressed through
problem-focused coaching. To facilitate evaluation, and for the convenience of parents, a means of
sharing prescriptions and document delivery should be developed. The resulting intervention should be
subject to evaluation through a series of iterative mini pilots.223–225
3. Recruitment to large-scale evaluations of AT is hindered by a small, diffuse population of boys with
DMD, an absence of parental equipoise and a prohibition on co-enrolment to randomised studies.
There are two potential solutions.
i. A small-scale Bayesian RCT recruiting around 40 boys with DMD over 2 years to a randomised
comparison (see Chapter 3, Decision on the primary end point and sample size for a full-scale trial)
of community-based enhanced AT versus no AT (or usual service provision), with NSAA score at
1 year as the primary outcome. Eligible participants would have to be identified well ahead of time
to facilitate implementation of an enhanced AT service in the area if necessary. Health professionals
who recruit should communicate the balance of benefits and risks associated with trial treatment,
stressing negative physiological outcomes such as pain and fatigue.272 Professionals should use
questions and feedback to ensure that the child understands that they are participating in research,
and that participation is voluntary; assent should be continuously renegotiated throughout
the trial.273
ii. If a RCT is deemed infeasible in the future then, understood as a quality improvement issue,274
well-developed interventions might be assessed using an interrupted time series design, a useful
approach for studying complex and subjective phenomena such as children’s participation.275
Alternative or supplementary patient-centred outcome assessments for such a study might include
the measure yourself medical outcome profile.276 The complexity of participation as a concept98 and
limitations with the ACTIVLIM148 as a measure of participation have recently been pointed out;277
researchers should agree dimensions of participation and corresponding validated instruments101,227
in consultation with service users.
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Chapter 10 Conclusions
A full-scale RCT based on frequentist methods is not feasible based on the trial protocol piloted in thisstudy. Before a full-scale RCT can be conducted, further formative work is required to develop an
intervention that can be delivered safely by community physiotherapists in settings that are more convenient
for families of boys with DMD. If such an intervention is delivered, specialist physiotherapists must help
focus clinical problems, propose related exercises and collaborate in the monitoring of intervention safety
and the disease condition’s development. Although absence of parent equipoise, access to pools and the
prohibition on study co-enrolment are likely to preclude a full-scale randomised trial run in the UK alone,
a RCT employing one of a number of novel Bayesian designs, designed for use in rare populations, may be
feasible in the future.
DOI: 10.3310/hta21270 HEALTH TECHNOLOGY ASSESSMENT 2017 VOL. 21 NO. 27
© Queen’s Printer and Controller of HMSO 2017. This work was produced by Hind et al. under the terms of a commissioning contract issued by the Secretary of State for Health.
This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals provided that
suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be addressed to: NIHR
Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton
SO16 7NS, UK.
93

Acknowledgements
We gratefully acknowledge the hard work, support and advice from the following: NoeleenGoulbourne (Sheffield Children’s NHS Foundation Trust); Alec Musson (Leeds Teaching Hospitals
NHS Trust); Jordan Butler (Great Ormond Street Hospital for Children NHS Foundation Trust); Anna Davies
(Heart of England NHS Foundation Trust); Victoria Darke, Nicholas Emery, Megan Hyne, Richa Kulshrestha,
Tessa Rowlands, Hilary Shepley and Sarah Turner (The Robert Jones and Agnes Hunt Orthopaedic Hospital
NHS Foundation Trust); and Catherine Howard, Emma Martin and Jenni Palmer (University Hospital
Southampton NHS Foundation Trust) for participant screening and data collection; Amanda Loban,
Lucy Carr and Katie Walker (University of Sheffield) for data management, administrative and clerical
support; and Paul Dimitri (Research and Development Director) and Gillian Gatenby (Research Directorate
Manager) at Sheffield Children’s NHS Foundation Trust for support on ethics and governance.
We offer special thanks to the members of our trial steering committee: Cathy White (Independent
Chairperson, Morriston Hospital), Alan Rigby (Independent Statistician, The Hull York Medical School),
Gita Ramdharry (Lecturer/Physiotherapist, Kingston University) and Laura Merry (Independent Parent
Representative).
Contributions of authors
Daniel Hind (Assistant Director), James Parkin (PPI Representative), Victoria Whitworth (PPI
Representative), Saleema Rex (Data Specialist), Tracey Young (Health Economist), Lisa Hampson
(Statistician), Jennie Sheehan (Clinical Specialist Neuromuscular Physiotherapist), Chin Maguire (Trial
Manager), Hannah Cantrill (Research Assistant), Elaine Scott (Study Manager), Marion Main (Senior
Physiotherapist), Michelle Geary (Specialist Paediatric Neurology Physiotherapist), Heather McMurchie
(Paediatric Neuromuscular Physiotherapist), Lindsey Pallant (Paediatric Neuromuscular Physiotherapist),
Daniel Woods (Specialist Children’s Physiotherapist), Jennifer Freeman (Associate Professor in Health
Informatics/eHealth), Tracey Willis (Consultant Paediatric Neurologist) and Peter Baxter (Consultant
Paediatric Neurologist) together produced the first draft of the report.
The following conceived or designed the work: Daniel Hind, Tracey Young, Chin Maguire, Elaine Scott,
Heather Epps (Aquatic Therapist), Marion Main, Michelle Geary, Heather McMurchie, Lindsey Pallant,
Daniel Woods, Jennifer Freeman, Ellen Lee (Statistician), Michelle Eagle (Consultant Physiotherapist),
Tracey Willis, Francesco Muntoni (Professor Paediatric Neurologist) and Peter Baxter.
The following were involved in the acquisition of data for the work: Daniel Hind, Saleema Rex, Tracey Young,
Elaine Scott, Heather Epps, Marion Main, Michelle Geary, Heather McMurchie, Lindsey Pallant, Daniel Woods,
Jennifer Freeman, Ellen Lee, Tracey Willis, Francesco Muntoni and Peter Baxter.
The following were involved in the analysis of data: Daniel Hind, James Parkin, Victoria Whitworth,
Saleema Rex, Tracey Young, Lisa Hampson, Jennie Sheehan, Elaine Scott, Jennifer Freeman, Ellen Lee and
Peter Baxter.
Daniel Hind, James Parkin, Victoria Whitworth, Saleema Rex, Tracey Young, Lisa Hampson, Jennie Sheehan,
Elaine Scott, Jennifer Freeman, Ellen Lee and Peter Baxter were involved in the interpretation of data for
the work.
Daniel Hind, Saleema Rex, Tracey Young, Lisa Hampson, Jennie Sheehan, Jennifer Freeman and Peter Baxter
drafted the monograph.
DOI: 10.3310/hta21270 HEALTH TECHNOLOGY ASSESSMENT 2017 VOL. 21 NO. 27
© Queen’s Printer and Controller of HMSO 2017. This work was produced by Hind et al. under the terms of a commissioning contract issued by the Secretary of State for Health.
This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals provided that
suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be addressed to: NIHR
Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton
SO16 7NS, UK.
95
Daniel Hind, Saleema Rex, Tracey Young, Lisa Hampson, Jennie Sheehan, Elaine Scott, Marion Main,
Michelle Geary, Heather McMurchie, Lindsey Pallant, Daniel Woods, Jennifer Freeman, Ellen Lee,
Tracey Willis and Peter Baxter critically revised the work for important intellectual content.
Daniel Hind, James Parkin, Victoria Whitworth, Saleema Rex, Tracey Young, Lisa Hampson, Jennie Sheehan,
Chin Maguire, Hannah Cantrill, Elaine Scott, Heather Epps, Marion Main, Michelle Geary, Heather McMurchie,
Lindsey Pallant, Daniel Woods, Jennifer Freeman, Ellen Lee, Michelle Eagle, Tracey Willis, Francesco Muntoni
and Peter Baxter were involved in the final approval of the version to be published.
All authors agree to be accountable for all aspects of the work in ensuring that questions relating to the
accuracy or integrity of any part of the work are appropriately investigated and resolved.
Publications
Hind D, Parkin J, Whitworth V, Rex S, Young T, Hampson L, et al. Aquatic therapy for boys with Duchenne
muscular dystrophy (DMD): an external pilot randomised controlled trial. Pilot Feasibil Stud 2017;3:16.
Data sharing statement
Requests for patient-level data and statistical code should be made to the corresponding author. Although
specific consent for data sharing was not obtained, the management group will consider the release of
data on a case-by-case basis following published guidelines.278 The data presented do not contain any
direct identifiers; we shall minimise indirect identifiers and remove free-text data to minimise the risk
of identification.
ACKNOWLEDGEMENTS
NIHR Journals Library www.journalslibrary.nihr.ac.uk
96
References
1. Drousiotou A, Ioannou P, Georgiou T, Mavrikiou E, Christopoulos G, Kyriakides T, et al. Neonatal
screening for Duchenne muscular dystrophy: a novel semiquantitative application of the
bioluminescence test for creatine kinase in a pilot national program in Cyprus. Genet Test
1998;2:55–60. http://dx.doi.org/10.1089/gte.1998.2.55
2. Bradley D, Parsons E. Newborn screening for Duchenne muscular dystrophy. Semin Neonatol
1998;3:34. https://doi.org/10.1016/S1084-2756(98)80146-2
3. Emery AE. Population frequencies of inherited neuromuscular diseases – a world survey.
Neuromuscul Disord 1991;1:19–29. https://doi.org/10.1016/0960-8966(91)90039-U
4. Angelis A, Tordrup D, Kanavos P. Socio-economic burden of rare diseases: a systematic review
of cost of illness evidence. Health Policy 2015;119:964–79. http://dx.doi.org/10.1016/
j.healthpol.2014.12.016
5. McKusick VA, Hartz PA. 300377.DYSTROPHIN; DMD. OMIM® – Online Mendelian Inheritance in
Man®. 2016. URL: www.omim.org/entry/300377 (accessed 30 March 2016).
6. Anderson L. Dystrophinopathies. In Karpati G, editor. Structural and Molecular Basis of Skeletal
Muscle Diseases. Basel: ISN Neuropath Press; 2002. pp. 6–19.
7. Emery AEH, Muntoni F, Quinlivan RCM. Molecular Pathology. In Emery AEH, Muntoni F,
Quinlivan RCM, editors. Duchenne Muscular Dystrophy. Oxford: Oxford University Press; 2015.
pp. 148–68. https://doi.org/10.1093/med/9780199681488.003.0009
8. Poysky J, Behavior in DMD Study Group. Behavior patterns in Duchenne muscular dystrophy: report
on the Parent Project Muscular Dystrophy behavior workshop 8–9 December 2006, Philadelphia,
USA. Neuromuscul Disord 2007;17:986–94. https://doi.org/10.1016/j.nmd.2007.06.465
9. Ricotti V, Ridout DA, Scott E, Quinlivan R, Robb SA, Manzur AY, Muntoni F, NorthStar Clinical
Network. Long-term benefits and adverse effects of intermittent versus daily glucocorticoids in
boys with Duchenne muscular dystrophy. J Neurol Neurosurg Psychiatr 2013;84:698–705.
http://dx.doi.org/10.1136/jnnp-2012-303902
10. Baiardini I, Minetti C, Bonifacino S, Porcu A, Klersy C, Petralia P, et al. Quality of life in Duchenne
muscular dystrophy: the subjective impact on children and parents. J Child Neurol 2011;26:707–13.
http://dx.doi.org/10.1177/0883073810389043
11. Landfeldt E, Lindgren P, Bell CF, Guglieri M, Straub V, Lochmüller H, Bushby K. Quantifying
the burden of caregiving in Duchenne muscular dystrophy. J Neurol 2016;263:906–15.
http://dx.doi.org/10.1007/s00415-016-8080-9
12. Kohler M, Clarenbach CF, Böni L, Brack T, Russi EW, Bloch KE. Quality of life, physical disability,
and respiratory impairment in Duchenne muscular dystrophy. Am J Respir Crit Care Med
2005;172:1032–6. https://doi.org/10.1164/rccm.200503-322OC
13. Simon VA, Resende MB, Simon MA, Zanoteli E, Reed UC. Duchenne muscular dystrophy:
quality of life among 95 patients evaluated using the Life Satisfaction Index for Adolescents.
Arq Neuropsiquiatr 2011;69:19–22. https://doi.org/10.1590/S0004-282X2011000100005
14. Uzark K, King E, Cripe L, Spicer R, Sage J, Kinnett K, et al. Health-related quality of life in
children and adolescents with Duchenne muscular dystrophy. Pediatrics 2012;130:e1559–66.
http://dx.doi.org/10.1542/peds.2012-0858
DOI: 10.3310/hta21270 HEALTH TECHNOLOGY ASSESSMENT 2017 VOL. 21 NO. 27
© Queen’s Printer and Controller of HMSO 2017. This work was produced by Hind et al. under the terms of a commissioning contract issued by the Secretary of State for Health.
This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals provided that
suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be addressed to: NIHR
Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton
SO16 7NS, UK.
97
15. Bray P, Bundy AC, Ryan MM, North KN, Burns J. Health status of boys with Duchenne muscular
dystrophy: a parent’s perspective. J Paediatr Child Health 2011;47:557–62. http://dx.doi.org/
10.1111/j.1440-1754.2011.02022.x
16. Bray P, Bundy AC, Ryan MM, North KN, Everett A. Health-related quality of life in boys with
Duchenne muscular dystrophy: agreement between parents and their sons. J Child Neurol
2010;25:1188–94. http://dx.doi.org/10.1177/0883073809357624
17. Chen JY, Chen SS, Jong YJ, Yang YH, Chang YY. A comparison of the stress and coping
strategies between the parents of children with Duchenne muscular dystrophy and children with
a fever. J Pediatr Nurs 2002;17:369–79. https://doi.org/10.1053/jpdn.2002.123525
18. Chen JY, Clark MJ. Family function in families of children with Duchenne muscular dystrophy. Fam
Community Health 2007;30:296–304. http://dx.doi.org/10.1097/01.FCH.0000290542.10458.f8
19. Bendixen RM, Senesac C, Lott DJ, Vandenborne K. Participation and quality of life in children with
Duchenne muscular dystrophy using the international classification of functioning, disability, and
health. Health Qual Life Outcomes 2012;10:43. https://doi.org/10.1186/1477-7525-10-43
20. Chen JY. Mediators affecting family function in families of children with Duchenne muscular dystrophy.
Kaohsiung J Med Sci 2008;24:514–22. http://dx.doi.org/10.1016/S1607-551X(09)70010-5
21. Read J, Kinali M, Muntoni F, Weaver T, Garralda ME. Siblings of young people with Duchenne
muscular dystrophy – a qualitative study of impact and coping. Eur J Paediatr Neurol
2011;15:21–8. http://dx.doi.org/10.1016/j.ejpn.2010.07.006
22. van Wijk E, Messelink BJ, Heijnen L, de Groot IJ. Prevalence and psychosocial impact of lower
urinary tract symptoms in patients with Duchenne muscular dystrophy. Neuromuscul Disord
2009;19:754–8. http://dx.doi.org/10.1016/j.nmd.2009.07.009
23. Pangalila RF, van den Bos GA, Stam HJ, van Exel NJ, Brouwer WB, Roebroeck ME. Subjective
caregiver burden of parents of adults with Duchenne muscular dystrophy. Disabil Rehabil
2012;34:988–96. http://dx.doi.org/10.3109/09638288.2011.628738
24. Landfeldt E, Lindgren P, Bell CF, Schmitt C, Guglieri M, Straub V, et al. The burden of Duchenne
muscular dystrophy: an international, cross-sectional study. Neurology 2014;83:529–36.
http://dx.doi.org/10.1212/WNL.0000000000000669
25. Rosenberg T, Jacobs HK, Thompson R, Horne JM. Cost-effectiveness of neonatal screening for
Duchenne muscular dystrophy – how does this compare to existing neonatal screening for metabolic
disorders? Soc Sci Med 1993;37:541–7. https://doi.org/10.1016/0277-9536(93)90289-G
26. Koch SJ, Arego DE, Bowser B. Outpatient rehabilitation for chronic neuromuscular diseases.
Am J Phys Med 1986;65:245–57.
27. van der Riet AA, van Hout BA, Rutten FF. Cost effectiveness of DNA diagnosis for four monogenic
diseases. J Med Genet 1997;34:741–5. https://doi.org/10.1136/jmg.34.9.741
28. Bushby K, Finkel R, Birnkrant DJ, Case LE, Clemens PR, Cripe L, et al. Diagnosis and management
of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care. Lancet Neurol
2010;9:177–89. http://dx.doi.org/10.1016/S1474-4422(09)70272-8
29. Eagle M. Report on the muscular dystrophy campaign workshop: exercise in neuromuscular
diseases Newcastle, January 2002. Neuromuscul Disord 2002;12:975–83. https://doi.org/10.1016/
S0960-8966(02)00136-0
30. Markert CD, Case LE, Carter GT, Furlong PA, Grange RW. Exercise and Duchenne muscular
dystrophy: where we have been and where we need to go. Muscle Nerve 2012;45:746–51.
http://dx.doi.org/10.1002/mus.23244
REFERENCES
NIHR Journals Library www.journalslibrary.nihr.ac.uk
98
31. Allen DG. Eccentric muscle damage: mechanisms of early reduction of force. Acta Physiol Scand
2001;171:311–19. https://doi.org/10.1046/j.1365-201x.2001.00833.x
32. Vignos PJ, Wagner MB, Karlinchak B, Katirji B. Evaluation of a program for long-term treatment
of Duchenne muscular dystrophy. Experience at the University Hospitals of Cleveland. J Bone Joint
Surg Am 1996;78:1844–52. https://doi.org/10.2106/00004623-199612000-00007
33. Ainslie T. The Concise Guide to Physiotherapy – Volume 2: Treatment. London: Elsevier; 2012.
34. Jenkins L, Hyde S, Posselt H. A Home Exercise Book: Physiotherapy Management for Duchenne
Muscular Dystrophy. London: MDUK; 2009.
35. Skalsky AJ, McDonald CM. Prevention and management of limb contractures in neuromuscular
diseases. Phys Med Rehabil Clin N Am 2012;23:675–87. http://dx.doi.org/10.1016/j.pmr.2012.
06.009
36. Jansen M, van Alfen N, Geurts ACH, de Groot IJM. Assisted bicycle training delays functional
deterioration in boys with Duchenne muscular dystrophy: the randomized controlled trial ‘no use is
disuse’. Neurorehabil Neural Repair 2013;27:816–27. https://doi.org/10.1177/1545968313496326
37. Vignos PJ. Physical models of rehabilitation in neuromuscular disease. Muscle Nerve
1983;6:323–38. http://dx.doi.org/10.1002/mus.880060502
38. Lovering RM, Brooks SV. Eccentric exercise in aging and diseased skeletal muscle: good or bad?
J Appl Physiol 2014;116:1439–45. http://dx.doi.org/10.1152/japplphysiol.00174.2013
39. Hyde SA, Fløytrup I, Glent S, Kroksmark A-K, Salling B, Steffensen BF, et al. A randomized
comparative study of two methods for controlling Tendo Achilles contracture in Duchenne muscular
dystrophy. Neuromuscul Disord 2000;10:257–63. https://doi.org/10.1016/S0960-8966(99)00135-2
40. Kelly M, Darrah J. Aquatic exercise for children with cerebral palsy. Dev Med Child Neurol
2005;47:838–42. https://doi.org/10.1017/S0012162205001775
41. Verhagen AP, Cardoso JR, Bierma-Zeinstra SM. Aquatic exercise and balneotherapy in
musculoskeletal conditions. Best Pract Res Clin Rheumatol 2012;26:335–43. http://dx.doi.org/
10.1016/j.berh.2012.05.008
42. Kamioka H, Tsutani K, Okuizumi H, Mutoh Y, Ohta M, Handa S, et al. Effectiveness of aquatic
exercise and balneotherapy: a summary of systematic reviews based on randomized controlled
trials of water immersion therapies. J Epidemiol 2010;20:2–12. https://doi.org/10.2188/
jea.JE20090030
43. ATACP. Guidance on Good Practice in Aquatic Physiotherapy. London: ATACP; 2015.
44. Stillwell B. The subjective experiences of those afraid in water. Int J Aquat Res Educ 2011;5:51–60.
45. Nicol K, Schmidt-Hansberg M, McMillan J. Biomechanical Principles Applied to the Halliwick
Method of Teaching Swimming to Physically Handicapped Individuals. In Teraud J, Bedingfield E,
editors. International Series on Sport Sciences Volume 8, Swimming III. Baltimore, MD: University
Park Press; 1979. pp. 173–81.
46. Johan Lambeck B, Stanat F, Kinnaird D. The Halliwick Concept. In Cole A, Becker B, editors.
Comprehensive Aquatic Therapy. Philadelphia, PA: Elsevier; 2004. pp. 73–98.
47. Becker BE. Aquatic therapy: scientific foundations and clinical rehabilitation applications.
PMR 2009;1:859–72. https://doi.org/10.1016/j.pmrj.2009.05.017
48. Epstein M. Renal effects of head-out water immersion in humans: a 15-year update. Physiol Rev
1992;72:563–621.
49. Bishop PA, Frazier S, Smith J, Jacobs D. Physiologic responses to treadmill and water running.
Phys Sportsmed 1989;17:87–94. http://dx.doi.org/10.1080/00913847.1989.11709707
DOI: 10.3310/hta21270 HEALTH TECHNOLOGY ASSESSMENT 2017 VOL. 21 NO. 27
© Queen’s Printer and Controller of HMSO 2017. This work was produced by Hind et al. under the terms of a commissioning contract issued by the Secretary of State for Health.
This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals provided that
suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be addressed to: NIHR
Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton
SO16 7NS, UK.
99
50. Wilder RP, Brennan DK. Physiological responses to deep water running in athletes. Sports Med
1993;16:374–80. https://doi.org/10.2165/00007256-199316060-00003
51. Balldin UI, Lundgren CE, Lundvall J, Mellander S. Changes in the elimination of 133 xenon from
the anterior tibial muscle in man induced by immersion in water and by shifts in body position.
Aerosp Med 1971;42:489–93.
52. Martin WH, Montgomery J, Snell PG, Corbett JR, Sokolov JJ, Buckey JC, et al. Cardiovascular
adaptations to intense swim training in sedentary middle-aged men and women. Circulation
1987;75:323–30. https://doi.org/10.1161/01.CIR.75.2.323
53. Harrison R, Hillman M, Bulstrode S. Loading of the lower limb when walking partially immersed:
implications for clinical practice. Physiotherapy 1992;78:164–6. https://doi.org/10.1016/
S0031-9406(10)61377-6
54. ATACP. Guidance on Good Practice in Hydrotherapy. London: Chartered Society of
Physiotherapy; 2006.
55. ATACP. About the Aquatic Therapy Association of Chartered Physiotherapists (ATACP). 2014.
URL: http://atacp.csp.org.uk/about-atacp (accessed 16 March 2016).
56. ATACP. Foundation Course in Aquatic Physiotherapy. London: Chartered Society of
Physiotherapy; 2010.
57. Bartels EM, Lund H, Hagen KB, Dagfinrud H, Christensen R, Danneskiold-Samsøe B. Aquatic
exercise for the treatment of knee and hip osteoarthritis. Cochrane Database Syst Rev
2007;4:CD005523. https://doi.org/10.1002/14651858.cd005523.pub2
58. Hall J, Swinkels A, Briddon J, McCabe CS. Does aquatic exercise relieve pain in adults with
neurologic or musculoskeletal disease? A systematic review and meta-analysis of randomized
controlled trials. Arch Phys Med Rehabil 2008;89:873–83. http://dx.doi.org/10.1016/
j.apmr.2007.09.054
59. Pittler MH, Karagülle MZ, Karagülle M, Ernst E. Spa therapy and balneotherapy for treating low
back pain: meta-analysis of randomized trials. Rheumatology 2006;45:880–4. https://doi.org/
10.1093/rheumatology/kel018
60. Dumas H, Francesconi S. Aquatic therapy in pediatrics: annotated bibliography. Phys Occup Ther
Pediatr 2001;20:63–78. https://doi.org/10.1080/j006v20n04_05
61. Attermeier S, Dulcy FH, Harris SR, Martin K. Aquatics for disabled persons. Phys Occup Ther
Pediatr 1983;3:83–92. https://doi.org/10.1080/J006v03n01_07
62. Getz M, Hutzler Y, Vermeer A. Effects of aquatic interventions in children with neuromotor
impairments: a systematic review of the literature. Clin Rehabil 2006;20:927–36. https://doi.org/
10.1177/0269215506070693
63. Ciafaloni E, Moxley RT. Treatment options for Duchenne muscular dystrophy. Curr Treat Options
Neurol 2008;10:86–93. https://doi.org/10.1007/s11940-008-0010-4
64. MDUK. Hydrotherapy in the UK: The Urgent Need for Increased Access. London: MDUK; 2015.
65. Eldridge S, Bond C, Campbell M, Lancaster G, Thabane L, Hopwell S. Definition and reporting
of pilot and feasibility studies. Trials 2013;14(Suppl. 1):O18. https://doi.org/10.1186/
1745-6215-14-S1-O18
66. Whitehead AL, Sully BG, Campbell MJ. Pilot and feasibility studies: is there a difference from
each other and from a randomised controlled trial? Contemp Clin Trials 2014;38:130–3.
http://dx.doi.org/10.1016/j.cct.2014.04.001
REFERENCES
NIHR Journals Library www.journalslibrary.nihr.ac.uk
100
67. Baxter P. HTA – 12/144/04: What is the Clinical Effectiveness of Hydrotherapy in Maintaining
Physical Function in People with Duchenne Muscular Dystrophy? 2014. URL: www.nets.nihr.ac.uk/
projects/hta/1214404 (accessed 18 March 2016).
68. Craig P, Dieppe P, Macintyre S, Michie S, Nazareth I, Petticrew M, et al. Developing and
Evaluating Complex Interventions: New Guidance. London: Medical Research Council; 2008.
URL: www.mrc.ac.uk/complexinterventionsguidance (accessed 9 February 2017).
69. Abend G. The meaning of ‘theory.’ Sociol Theory 2008;26:173–99. https://doi.org/10.1111/
j.1467-9558.2008.00324.x
70. Thabane L, Ma J, Chu R, Cheng J, Ismaila A, Rios LP, et al. A tutorial on pilot studies: the what,
why and how. BMC Med Res Methodol 2010;10:1. http://dx.doi.org/10.1186/1471-2288-10-1
71. Lancaster GA, Dodd S, Williamson PR. Design and analysis of pilot studies: recommendations for
good practice. J Eval Clin Pract 2004;10:307–12. http://dx.doi.org/10.1111/j.2002.384.doc.x
72. Ricotti V, Ridout DA, Pane M, Main M, Mayhew A, Mercuri E, et al. The NorthStar Ambulatory
Assessment in Duchenne muscular dystrophy: considerations for the design of clinical trials.
J Neurol Neurosurg Psychiatr 2016;87:149–55. http://dx.doi.org/10.1136/jnnp-2014-309405
73. Epps H, Ginnelly L, Utley M, Southwood T, Gallivan S, Sculpher M, Woo P. Is hydrotherapy
cost-effective? A randomised controlled trial of combined hydrotherapy programmes compared
with physiotherapy land techniques in children with juvenile idiopathic arthritis. Health Technol
Assess 2005;9(39). https://doi.org/10.3310/hta9390
74. Dijkers MP. Reporting on interventions: issues and guidelines for rehabilitation researchers. Arch
Phys Med Rehabil 2015;96:1170–80. https://doi.org/10.1016/j.apmr.2015.01.017
75. Dijkers M, Hart T, Whyte J, Zanca JM, Packel A, Tsaousides T. Rehabilitation treatment
taxonomy: implications and continuations. Arch Phys Med Rehabil 2014;95(Suppl. 1):45–54.e2.
http://dx.doi.org/10.1016/j.apmr.2013.05.033
76. Klingler W, Jurkat-Rott K, Lehmann-Horn F, Schleip R. The role of fibrosis in Duchenne muscular
dystrophy. Acta Myol 2012;31:184–95.
77. Neufer PD. The effect of detraining and reduced training on the physiological adaptations
to aerobic exercise training. Sports Med 1989;8:302–20. https://doi.org/10.2165/
00007256-198908050-00004
78. Weston CFM, O’Hare JP, Evans JM, Corrall RJM. Haemodynamic changes in man during
immersion in water at different temperatures. Clin Sci 1987;73:613–16. https://doi.org/
10.1042/cs0730613
79. Wolpe J. Psychotherapy by Reciprocal Inhibition. Stanford, CA: Stanford University Press; 1958.
80. Watts FN. Habituation model of systematic desensitization. Psychol Bull 1979;86:627–37.
https://doi.org/10.1037/0033-2909.86.3.627
81. Waters WF, McDonald DG, Koresko RL. Psychophysiological responses during analogue systematic
desensitization and non-relaxation control procedures. Behav Res Ther 1972;10:381–93.
https://doi.org/10.1016/0005-7967(72)90061-7
82. Smith M. Evaluability Assessment: A Practical Approach. Waltham, MA: MA Kluwer; 1989.
https://doi.org/10.1007/978-94-015-7827-1
83. Donaldson S, Lipsey M. Roles for Theory in Contemporary Evaluation Practice: Developing
Practical Knowledge. In Shaw I, Greene J, Mark M, editors. The Handbook of Evaluation:
Policies, Programs, and Practices. London: Sage; 2006. pp. 56–75. https://doi.org/10.4135/
9781848608078.n2
DOI: 10.3310/hta21270 HEALTH TECHNOLOGY ASSESSMENT 2017 VOL. 21 NO. 27
© Queen’s Printer and Controller of HMSO 2017. This work was produced by Hind et al. under the terms of a commissioning contract issued by the Secretary of State for Health.
This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals provided that
suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be addressed to: NIHR
Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton
SO16 7NS, UK.
101
84. Coryn CLS, Noakes LA, Westine CD, Schroter DC. A systematic review of theory-driven evaluation
practice from 1990 to 2009. Am J Eval 2010;32:199–226. https://doi.org/10.1177/
1098214010389321
85. Leeuw FL, Donaldson SI. Theory in evaluation: reducing confusion and encouraging debate.
Evaluation 2015;21:467–80. https://doi.org/10.1177/1356389015607712
86. Funnell SC, Rogers PJ. Purposeful Program Theory: Effective Use of Theories of Change and Logic
Models. San Francisco, CA: Jossey-Bass; 2011.
87. Capjon H, Bjørk IT. Rehabilitation after multilevel surgery in ambulant spastic children with cerebral
palsy: children and parent experiences. Dev Neurorehabil 2010;13:182–91. http://dx.doi.org/
10.3109/17518421003606151
88. Wiart L, Ray L, Darrah J, Magill-Evans J. Parents’ perspectives on occupational therapy and
physical therapy goals for children with cerebral palsy. Disabil Rehabil 2010;32:248–58.
89. Christy JB, Saleem N, Turner PH, Wilson J. Parent and therapist perceptions of an intense
model of physical therapy. Pediatr Phys Ther 2010;22:207–13. http://dx.doi.org/10.1097/
PEP.0b013e3181db8151
90. Redmond R, Parrish M. Variables influencing physiotherapy adherence among young adults with
cerebral palsy. Qual Health Res 2008;18:1501–10. http://dx.doi.org/10.1177/1049732308325538
91. Tregaskis C. Social Model Theory: the story so far .... Disabil Soc 2002;17:457–70. https://doi.org/
10.1080/09687590220140377
92. Morris J. Impairment and disability: constructing an ethics of care that promotes human rights.
Hypatia 2001;16:1–16. https://doi.org/10.1111/j.1527-2001.2001.tb00750.x
93. World Health Organization. International Classification of Functioning, Disability and Health
Children & Youth Version. Geneva: World Health Organization; 2007.
94. Koutsogeorgou E, Leonardi M, Bickenbach JE, Cerniauskaite M, Quintas R, Raggi A. Social capital,
disability, and usefulness of the International Classification of Functioning, Disability and Health
for the development and monitoring of policy interventions. Disabil Soc 2014;29:1104–16.
https://doi.org/10.1080/09687599.2014.910106
95. Erikson E. Identity: Youth and Crisis. New York, NY: W.W. Norton & Company; 1968.
96. Novak I. Evidence to practice commentary: advancing the evidence and the right to participation.
Phys Occup Ther Pediatr 2013;33:421–5. https://doi.org/10.3109/01942638.2013.834179
97. Granlund M. Participation – challenges in conceptualization, measurement and intervention.
Child Care Health Dev 2013;39:470–3. https://doi.org/10.1111/cch.12080
98. Raghavendra P. Participation of children with disabilities: measuring subjective and objective
outcomes. Child Care Health Dev 2013;39:461–5. http://dx.doi.org/10.1111/cch.12084
99. Shikako-Thomas K, Kolehmainen N, Ketelaar M, Bult M, Law M. Promoting leisure participation
as part of health and well-being in children and youth with cerebral palsy. J Child Neurol
2014;29:1125–33. http://dx.doi.org/10.1177/0883073814533422
100. Kanagasabai PS, Mulligan H, Mirfin-Veitch B, Hale LA. Association between motor functioning
and leisure participation of children with physical disability: an integrative review. Dev Med Child
Neurol 2014;56:1147–62. http://dx.doi.org/10.1111/dmcn.12570
101. Kang L-J, Palisano RJ, King GA, Chiarello LA. A multidimensional model of optimal participation
of children with physical disabilities. Disabil Rehabil 2014;36:1735–41. https://doi.org/10.3109/
09638288.2013.863392
REFERENCES
NIHR Journals Library www.journalslibrary.nihr.ac.uk
102
102. King G, McDougall J, DeWit D, Hong S, Miller L, Offord D, et al. Pathways to children’s academic
performance and prosocial behaviour: roles of physical health status, environmental, family, and
child factors. Int J Disabil Dev Educ 2005;52:313–44. https://doi.org/10.1080/10349120500348680
103. Reijntjes A, Stegge H, Meerum Terwogt M. Children’s coping with peer rejection: the role of
depressive symptoms, social competence, and gender. Infant Child Dev 2006;15:89–107.
https://doi.org/10.1002/icd.435
104. Law M, King G, King S, Kertoy M, Hurley P, Rosenbaum P, et al. Patterns of participation in
recreational and leisure activities among children with complex physical disabilities. Dev Med Child
Neurol 2006;48:337–42. https://doi.org/10.1017/S0012162206000740
105. Bennett KS, Hay DA. The role of family in the development of social skills in children with physical
disabilities. Int J Disabil Dev Educ 2007;54:381–97. https://doi.org/10.1080/10349120701654555
106. King G, Law M, Hanna S, King S, Hurley P, Rosenbaum P, et al. Predictors of the leisure and
recreation participation of children with physical disabilities: a structural equation modeling
analysis. Child Heal Care 2006;35:209–34. https://doi.org/10.1207/s15326888chc3503_2
107. Majnemer A, Shevell M, Law M, Birnbaum R, Chilingaryan G, Rosenbaum P, Poulin C.
Participation and enjoyment of leisure activities in school-aged children with cerebral palsy.
Dev Med Child Neurol 2008;50:751–8. http://dx.doi.org/10.1111/j.1469-8749.2008.03068.x
108. LaForme Fiss A, Chiarello LA, Bartlett D, Palisano RJ, Jeffries L, Almasri N, Chang HJ. Family
ecology of young children with cerebral palsy. Child Care Health Dev 2014;40:562–71.
http://dx.doi.org/10.1111/cch.12062
109. Lawlor K, Mihaylov S, Welsh B, Jarvis S, Colver A. A qualitative study of the physical, social and
attitudinal environments influencing the participation of children with cerebral palsy in northeast
England. Pediatr Rehabil 2006;9:219–28. https://doi.org/10.1080/13638490500235649
110. Law M, Haight M, Milroy B, Willms D, Stewart D, Rosenbaum P. Environmental factors affecting
the occupations of children with physical disabilities. J Occup Sci 1999;6:102–10. https://doi.org/
10.1080/14427591.1999.9686455
111. Shikako-Thomas K, Majnemer A, Law M, Lach L. Determinants of participation in leisure activities
in children and youth with cerebral palsy: systematic review. Phys Occup Ther Pediatr
2008;28:155–69. https://doi.org/10.1080/01942630802031834
112. Anaby D, Hand C, Bradley L, DiRezze B, Forhan M, DiGiacomo A, Law M. The effect of the
environment on participation of children and youth with disabilities: a scoping review. Disabil
Rehabil 2013;35:1589–98. http://dx.doi.org/10.3109/09638288.2012.748840
113. May CR, Eton DT, Boehmer K, Gallacher K, Hunt K, MacDonald S, et al. Rethinking the patient:
using Burden of Treatment Theory to understand the changing dynamics of illness. BMC Health
Serv Res 2014;14:281. http://dx.doi.org/10.1186/1472-6963-14-281
114. Tran VT, Barnes C, Montori VM, Falissard B, Ravaud P. Taxonomy of the burden of treatment:
a multi-country web-based qualitative study of patients with chronic conditions. BMC Med
2015;13:115. http://dx.doi.org/10.1186/s12916-015-0356-x
115. May C, Montori VM, Mair FS. We need minimally disruptive medicine. BMJ 2009;339:b2803.
http://dx.doi.org/10.1136/bmj.b2803
116. Mair FS, May CR. Thinking about the burden of treatment. BMJ 2014;349:g6680. https://doi.org/
10.1136/bmj.g6680
117. Hexem KR, Bosk AM, Feudtner C. The dynamic system of parental work of care for children with
special health care needs: a conceptual model to guide quality improvement efforts. BMC Pediatr
2011;11:95. http://dx.doi.org/10.1186/1471-2431-11-95
DOI: 10.3310/hta21270 HEALTH TECHNOLOGY ASSESSMENT 2017 VOL. 21 NO. 27
© Queen’s Printer and Controller of HMSO 2017. This work was produced by Hind et al. under the terms of a commissioning contract issued by the Secretary of State for Health.
This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals provided that
suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be addressed to: NIHR
Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton
SO16 7NS, UK.
103
118. Eton DT, Ridgeway JL, Egginton JS, Tiedje K, Linzer M, Boehm DH, et al. Finalizing a measurement
framework for the burden of treatment in complex patients with chronic conditions. Patient Relat
Outcome Meas 2015;6:117–26. http://dx.doi.org/10.2147/PROM.S78955
119. May CR, Mair F, Finch T, MacFarlane A, Dowrick C, Treweek S, et al. Development of a theory
of implementation and integration: Normalization Process Theory. Implement Sci 2009;4:29.
http://dx.doi.org/10.1186/1748-5908-4-29
120. May C, Finch T. Implementing, embedding, and integrating practices: an outline of Normalization
Process Theory. Sociology 2009;43:535–54. https://doi.org/10.1177/0038038509103208
121. Dulcy FH. Aquatic programs for disabled children: an overview and an analysis of the problems.
Phys Occup Ther Pediatr 1983;3:1–20. https://doi.org/10.1080/j006v03n01_01
122. Dulcy FH. A theoretical aquatic service intervention model for disabled children. Phys Occup Ther
Pediatr 1983;3:21–38. https://doi.org/10.1080/J006v03n01_02
123. McLaughlin JA, Jordan GB. Logic models: a tool for telling your program’s performance story.
Eval Program Plann 1999;22:65–72. https://doi.org/10.1016/S0149-7189(98)00042-1
124. W.K. Kellogg Foundation. Logic Model Development Guide. 2004. URL: www.wkkf.org/
knowledge-center/resources/2006/02/WK-Kellogg-Foundation-Logic-Model-Development-Guide.
aspx (accessed 9 February 2017).
125. Tahan H. Essential activities and knowledge domains of case management: new insights from
the CCMC role and functions study. Case Manager 2006;17:45–8. https://doi.org/10.1016/
j.casemgr.2006.03.005
126. Brault GL, Kissinger LD. Case management: ambiguous at best. J Pediatr Health Care 1991;5:179–83.
https://doi.org/10.1016/0891-5245(91)90058-X
127. Scheirer MA, Dearing JW. An agenda for research on the sustainability of public health programs.
Am J Public Health 2011;101:2059–67. http://dx.doi.org/10.2105/AJPH.2011.300193
128. Fleiszer AR, Semenic SE, Ritchie JA, Richer MC, Denis JL. The sustainability of healthcare innovations:
a concept analysis. J Adv Nurs 2015;71:1484–98. http://dx.doi.org/10.1111/jan.12633
129. Rogers E. Elements of Diffusion. In Rogers E, editor. Diffusion of Innovations. New York, NY: Free
Press; 2003. pp. 1–38.
130. Gruen RL, Elliott JH, Nolan ML, Lawton PD, Parkhill A, McLaren CJ, Lavis JN. Sustainability
science: an integrated approach for health-programme planning. Lancet 2008;372:1579–89.
http://dx.doi.org/10.1016/S0140-6736(08)61659-1
131. Moore GF, Audrey S, Barker M, Bond L, Bonell C, Hardeman W, et al. Process evaluation of complex
interventions: Medical Research Council guidance. BMJ 2015;350:h1258. http://dx.doi.org/10.1136/
bmj.h1258
132. Linnan L, Steckler A. Process Evaluation for Public Health Interventions and Research: An
Overview. 1st edn. San Francisco, CA: Jossey-Bass; 2002.
133. Baranowski T, Stables G. Process evaluations of the 5-a-day projects. Health Educ Behav
2000;27:157–66. https://doi.org/10.1177/109019810002700202
134. McGraw SA, Stone EJ, Osganian SK, Elder JP, Perry CL, Johnson CC, et al. Design of process
evaluation within the Child and Adolescent Trial for Cardiovascular Health (CATCH). Health Educ Q
1994;(Suppl. 2):5–26. https://doi.org/10.1177/10901981940210S103
135. Dusenbury L, Brannigan R, Falco M, Hansen WB. A review of research on fidelity of
implementation: implications for drug abuse prevention in school settings. Health Educ Res
2003;18:237–56. https://doi.org/10.1093/her/18.2.237
REFERENCES
NIHR Journals Library www.journalslibrary.nihr.ac.uk
104
136. Wears RL. Standardisation and its discontents. Cogn Technol Work 2015;17:89–94.
http://dx.doi.org/10.1007/s10111-014-0299-6
137. Hawe P, Shiell A, Riley T. Complex interventions: how ‘out of control’ can a randomised
controlled trial be? BMJ 2004;328:1561–3. http://dx.doi.org/10.1136/bmj.328.7455.1561
138. Hawe P. Minimal, negligible and negligent interventions. Soc Sci Med 2015;138:265–8.
https://doi.org/10.1016/j.socscimed.2015.05.025
139. Haynes A, Brennan S, Redman S, Williamson A, Gallego G, Butow P, CIPHER team. Figuring out
fidelity: a worked example of the methods used to identify, critique and revise the essential
elements of a contextualised intervention in health policy agencies. Implement Sci 2016;11:23.
http://dx.doi.org/10.1186/s13012-016-0378-6
140. Schulz KF, Altman DG, Moher D. CONSORT 2010 Statement: updated guidelines for reporting
parallel group randomised trials. BMJ 2010;11:32.
141. Pane M, Mazzone ES, Sivo S, Sormani MP, Messina S, D’Amico A, et al. Long term natural history
data in ambulant boys with Duchenne muscular dystrophy: 36-month changes. PLOS ONE
2014;9:6–11. https://doi.org/10.1371/journal.pone.0108205
142. Hind D, Parkin J, Whitworth V, Rex S, Young T, Hampson L, et al. Aquatic therapy for boys with
Duchenne muscular dystrophy (DMD): an external pilot randomised controlled trial. Pilot Feasibil
Stud 2017;3:16. http://dx.doi.org/10.1186/s40814-017-0132-0
143. McDonald CM, Henricson EK, Han JJ, Abresch RT, Nicorici A, Elfring GL, et al. The 6-minute walk
test as a new outcome measure in Duchenne muscular dystrophy. Muscle Nerve 2010;41:500–10.
http://dx.doi.org/10.1002/mus.21544
144. Scott E, Eagle M, Mayhew A, Freeman J, Main M, Sheehan J, et al. Development of a functional
assessment scale for ambulatory boys with Duchenne muscular dystrophy. Physiother Res Int
2012;17:101–9. http://dx.doi.org/10.1002/pri.520
145. Mayhew A, Cano S, Scott E, Eagle M, Bushby K, Muntoni F, et al. Moving towards meaningful
measurement: Rasch analysis of the North Star Ambulatory Assessment in Duchenne muscular
dystrophy. Dev Med Child Neurol 2011;53:535–42. https://doi.org/10.1111/j.1469-8749.
2011.03939.x
146. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al. Standardisation of
spirometry. Eur Respir J 2005;26:319–38. https://doi.org/10.1183/09031936.05.00034805
147. Stevens K. Assessing the performance of a new generic measure of health-related quality of life
for children and refining it for use in health state valuation. Appl Health Econ Health Policy
2011;9:157–69. http://dx.doi.org/10.2165/11587350-000000000-00000
148. Vandervelde L, Van den Bergh PY, Goemans N, Thonnard JL. ACTIVLIM: a Rasch-built measure of
activity limitations in children and adults with neuromuscular disorders. Neuromuscul Disord
2007;17:459–69. https://doi.org/10.1016/j.nmd.2007.02.013
149. Brouwer WB, van Exel NJ, van Gorp B, Redekop WK. The CarerQol instrument: a new instrument
to measure care-related quality of life of informal caregivers for use in economic evaluations.
Qual Life Res 2006;15:1005–21. http://dx.doi.org/10.1007/s11136-005-5994-6
150. Robertson RJ, Goss FL, Boer NF, Peoples JA, Foreman AJ, Dabayebeh IM, et al. Children’s OMNI
scale of perceived exertion: mixed gender and race validation. Med Sci Sports Exerc 2000;32:452–8.
https://doi.org/10.1097/00005768-200002000-00029
151. Browne RH. On the use of a pilot sample for sample size determination. Stat Med 1995;14:1933–40.
https://doi.org/10.1002/sim.4780141709
DOI: 10.3310/hta21270 HEALTH TECHNOLOGY ASSESSMENT 2017 VOL. 21 NO. 27
© Queen’s Printer and Controller of HMSO 2017. This work was produced by Hind et al. under the terms of a commissioning contract issued by the Secretary of State for Health.
This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals provided that
suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be addressed to: NIHR
Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton
SO16 7NS, UK.
105
152. O’Cathain A, Thomas KJ, Drabble SJ, Rudolph A, Goode J, Hewison J. Maximising the value
of combining qualitative research and randomised controlled trials in health research: the
QUAlitative Research in Trials (QUART) study – a mixed methods study. Health Technol Assess
2014;18(38). http://dx.doi.org/10.3310/hta18380
153. O’Cathain A, Goode J, Drabble SJ, Thomas KJ, Rudolph A, Hewison J. Getting added value from
using qualitative research with randomized controlled trials: a qualitative interview study. Trials
2014;15:215. https://doi.org/10.1186/1745-6215-15-215
154. O’Cathain A, Hoddinott P, Lewin S, Thomas KJ, Young B, Adamson J, et al. Maximising the
impact of qualitative research in feasibility studies for randomised controlled trials: guidance for
researchers. Pilot Feasibility Stud 2015;1:32. https://doi.org/10.1186/s40814-015-0026-y
155. Creswell JW. Research Design. 4th edn. London: Sage; 2014.
156. Carter SM, Little M. Taking action: epistemologies, methodologies, and methods in qualitative
research. Qual Health Res 2007;17:1316–28. https://doi.org/10.1177/1049732307306927
157. Cherryholmes CH. Notes on pragmatism and scientific realism. Educ Res 1992;21:13–17.
https://doi.org/10.3102/0013189X021006013
158. Eakin JM. Educating critical qualitative health researchers in the land of the randomized controlled
trial. Qual Inq 2016;22:107–18. https://doi.org/10.1177/1077800415617207
159. Peirce CS. Review of Nichols’ A treatise on Cosmology. In Thayer HS, editor. Meaning and Action:
A Critical History of Pragmatism. Indianapolis, IN: Hackett; 1984. pp. 493–5.
160. Dewey J. The Development of American Pragmatism. In Thayer H, editor. Pragmatism: The Classic
Writings. Indianapolis, IN: Hackett; 1989. pp. 23–40.
161. Burawoy M. The extended case method. Sociol Theory 1998;16:4–33. https://doi.org/10.1111/
0735-2751.00040
162. Timmermans S, Tavory I. Theory construction in qualitative research: from grounded theory to
abductive analysis. Sociol Theory 2012;30:167–86. https://doi.org/10.1177/0735275112457914
163. O’Brien BC, Harris IB, Beckman TJ, Reed DA, Cook DA. Standards for reporting qualitative
research: a synthesis of recommendations. Acad Med 2014;89:1245–51. http://dx.doi.org/
10.1097/ACM.0000000000000388
164. Yin RK. Designing Case Studies: Identifying Your Case(s) and Establishing the Logic of Your Case
Study. In Yin RK, editor. Case Study Research: Design and Methods. London: Sage; 2014.
pp. 27–70.
165. Finch TL, Rapley T, Girling M, Mair FS, Murray E, Treweek S, et al. Improving the normalization of
complex interventions: measure development based on normalization process theory (NoMAD):
study protocol. Implement Sci 2013;8:43. http://dx.doi.org/10.1186/1748-5908-8-43
166. Murray E, Treweek S, Pope C, MacFarlane A, Ballini L, Dowrick C, et al. Normalisation process
theory: a framework for developing, evaluating and implementing complex interventions. BMC
Med 2010;8:63. http://dx.doi.org/10.1186/1741-7015-8-63
167. May CR, Finch T, Ballini L, MacFarlane A, Mair F, Murray E, et al. Evaluating complex interventions
and health technologies using normalization process theory: development of a simplified
approach and web-enabled toolkit. BMC Health Serv Res 2011;11:245. http://dx.doi.org/10.1186/
1472-6963-11-245
168. Cane J, O’Connor D, Michie S. Validation of the theoretical domains framework for use in
behaviour change and implementation research. Implement Sci 2012;7:37. http://dx.doi.org/
10.1186/1748-5908-7-37
REFERENCES
NIHR Journals Library www.journalslibrary.nihr.ac.uk
106
169. NHS Employers. Agenda for Change Pay Bands and Spine Points from April 2016. 2016.
URL: www.nhsemployers.org/~/media/Employers/Documents/Pay and reward/AfC pay bands from
1 April 2016_FINAL.pdf (accessed 16 May 2016).
170. Mahon A, Glendinning C, Clarke K, Craig G. Researching children: methods and ethics. Child Soc
1996;10:145–54. https://doi.org/10.1002/(SICI)1099-0860(199606)10:2<145::AID-CHI19>3.0.
CO;2-H
171. Francis JJ, Johnston M, Robertson C, Glidewell L, Entwistle V, Eccles MP, Grimshaw JM. What is
an adequate sample size? Operationalising data saturation for theory-based interview studies.
Psychol Health 2010;25:1229–45. http://dx.doi.org/10.1080/08870440903194015
172. Guest G. How many interviews are enough?: an experiment with data saturation and variability.
Field Methods 2006;18:59–82https://doi.org/10.1177/1525822X05279903
173. O’Reilly M, Parker N. ‘Unsatisfactory saturation’: a critical exploration of the notion of saturated
sample sizes in qualitative research. Qual Res 2012;13:190–7. https://doi.org/10.1177/
1468794112446106
174. Malterud K, Siersma VD, Guassora AD. Sample size in qualitative interview studies: guided by
information power [published online ahead of print November 27 2015]. Qual Health Res 2015.
175. Ritchie J, Spencer L. Qualitative Data Analysis for Applied Policy Research. In Bryman A, Burgess RG,
editors. Analyzing Qualitative Data. Abingdon: Routledge; 1994. pp. 173–94. https://doi.org/
10.4324/9780203413081_chapter_9
176. Dixon-Woods M. Using framework-based synthesis for conducting reviews of qualitative studies.
BMC Med 2011;9:39. http://dx.doi.org/10.1186/1741-7015-9-39
177. Morrow SL. Quality and trustworthiness in qualitative research in counseling psychology. J Couns
Psychol 2005;52:250–60. https://doi.org/10.1037/0022-0167.52.2.250
178. Pfadenhauer LM, Mozygemba K, Gerhardus A, Hofmann B, Booth A, Lysdahl KB, et al. Context
and implementation: a concept analysis towards conceptual maturity. Z Evid Fortbild Qual
Gesundhwes 2015;109:103–14. http://dx.doi.org/10.1016/j.zefq.2015.01.004
179. Shoveller J, Viehbeck S, Di Ruggiero E, Greyson D, Thomson K, Knight R. A critical examination of
representations of context within research on population health interventions. Crit Public Health
2015;1596:1–14.
180. Greenhalgh T, Russell J. Why do evaluations of eHealth programs fail? An alternative set of
guiding principles. PLOS Med 2010;7:e1000360. http://dx.doi.org/10.1371/journal.pmed.1000360
181. Morgan H, Thomson G, Crossland N, Dykes F, Hoddinott P. Combining PPI with qualitative research
to engage ‘harder-to-reach’ populations: service user groups as co-applicants on a platform study
for a trial. Res Involv Engagem 2016;2:7. https://doi.org/10.1186/s40900-016-0023-1
182. Staley K, Doherty C. It’s not evidence, it’s insight: bringing patients’ perspectives into health
technology appraisal at NICE. Res Involv Engagem 2016;2:4. https://doi.org/10.1186/
s40900-016-0018-y
183. O’Cathain A, Murphy E, Nicholl J. Why, and how, mixed methods research is undertaken in
health services research in England: a mixed methods study. BMC Health Serv Res 2007;7:85.
https://doi.org/10.1186/1472-6963-7-85
184. Farmer T, Robinson K, Elliott SJ, Eyles J. Developing and implementing a triangulation protocol
for qualitative health research. Qual Health Res 2006;16:377–94. https://doi.org/10.1177/
1049732305285708
185. Simmons T. Attributing the Costs of Health and Social Care Research & Development (AcoRD).
London: Department of Health; 2012.
DOI: 10.3310/hta21270 HEALTH TECHNOLOGY ASSESSMENT 2017 VOL. 21 NO. 27
© Queen’s Printer and Controller of HMSO 2017. This work was produced by Hind et al. under the terms of a commissioning contract issued by the Secretary of State for Health.
This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals provided that
suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be addressed to: NIHR
Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton
SO16 7NS, UK.
107
186. Myles PS, Williamson E, Oakley J, Forbes A. Ethical and scientific considerations for patient
enrollment into concurrent clinical trials. Trials 2014;15:470. http://dx.doi.org/10.1186/
1745-6215-15-470
187. Great Britain. Health and Social Care Act 2012. London: The Stationery Office; 2012.
188. Checkland K, Mcdermott I, Coleman A, Perkins N, Checkland KH. Complexity in the new NHS:
longitudinal case studies of CCGs in England. BMJ Open 2016;6:e010199. https://doi.org/
10.1136/bmjopen-2015-010199
189. McDonald CM, Henricson EK, Han JJ, Abresch RT, Nicorici A, Atkinson L, et al. The 6-minute
walk test in Duchenne/Becker muscular dystrophy: longitudinal observations. Muscle Nerve
2010;42:966–74. http://dx.doi.org/10.1002/mus.21808
190. Mayhew AG, Cano SJ, Scott E, Eagle M, Bushby K, Manzur A, Muntoni F, North Star Clinical
Network for Neuromuscular Disease. Detecting meaningful change using the North Star
Ambulatory Assessment in Duchenne muscular dystrophy. Dev Med Child Neurol
2013;55:1046–52. http://dx.doi.org/10.1111/dmcn.12220
191. Lauruschkus K, Nordmark E, Hallström I. ‘It’s fun, but?…’ Children with cerebral palsy and their
experiences of participation in physical activities. Disabil Rehabil 2014;8288:1–7.
192. Webb CL. Parents’ perspectives on coping with Duchenne muscular dystrophy. Child Care Health
Dev 2005;31:385–96. https://doi.org/10.1111/j.1365-2214.2005.00518.x
193. Bushby K, Finkel R, Birnkrant DJ, Case LE, Clemens PR, Cripe L, et al. Diagnosis and management
of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial
management. Lancet Neurol 2010;9:77–93. https://doi.org/10.1016/S1474-4422(09)70271-6
194. Kieny P, Chollet S, Delalande P, Le Fort M, Magot A, Pereon Y, Perrouin Verbe B. Evolution of life
expectancy of patients with Duchenne muscular dystrophy at AFM Yolaine de Kepper centre
between 1981 and 2011. Ann Phys Rehabil Med 2013;56:443–54. http://dx.doi.org/10.1016/
j.rehab.2013.06.002
195. Redmond B, Richardson V. Just getting on with it: exploring the service needs of mothers who
care for young children with severe/profound and life-threatening intellectual disability. J Appl Res
Intellect Disabil 2003;16:205–18. https://doi.org/10.1046/j.1468-3148.2003.00165.x
196. Beresford BA. Resources and strategies: how parents cope with the care of a disabled child.
J Child Psychol Psychiatry 1994;35:171–209. https://doi.org/10.1111/j.1469-7610.1994.tb01136.x
197. Read J. There was never really any choice: the experience of mothers of disabled children in
the United Kingdom. Women’s Stud Int Forum 1991;14:561–71. https://doi.org/10.1016/
0277-5395(91)90026-E
198. Sloper P. Models of service support for parents of disabled children. What do we know? What do
we need to know? Child Care Health Dev 1999;25:85–99. https://doi.org/10.1046/j.1365-2214.
1999.25220120.x
199. Beresford B. The needs of disabled children and their families. Soc Care Res 1995;76:1–4.
200. McKeever P, Miller KL. Mothering children who have disabilities: a Bourdieusian interpretation
of maternal practices. Soc Sci Med 2004;59:1177–91. http://dx.doi.org/10.1016/
j.socscimed.2003.12.023
201. Leiter V. The consequences of caring: effects of mothering a child with special needs. J Fam Issues
2004;25:379–403. https://doi.org/10.1177/0192513X03257415
202. Brett J. The experience of disability from the perspective of parents of children with profound
impairment: is it time for an alternative model of disability? Disabil Soc 2002;17:825–43.
https://doi.org/10.1080/0968759022000039109
REFERENCES
NIHR Journals Library www.journalslibrary.nihr.ac.uk
108
203. Shippee ND, Shah ND, May CR, Mair FS, Montori VM. Cumulative complexity: a functional,
patient-centered model of patient complexity can improve research and practice. J Clin Epidemiol
2012;65:1041–51. http://dx.doi.org/10.1016/j.jclinepi.2012.05.005
204. Trute B. Grandparents of children with developmental disabilities: intergenerational support
and family well-being. Fam Soc J Contemp Soc Serv 2003;84:119–26. https://doi.org/10.1606/
1044-3894.87
205. Knussen C, Sloper P. Stress in families of children with disability: a review of risk and resistance
factors. J Ment Heal 1992;1:241–56. https://doi.org/10.3109/09638239209005457
206. Beresford B. Positively Parents – Caring for a Severely Disabled Child. London: Social Policy
Research Unit, University of York; 1994.
207. Clarke L, Cairns H. Grandparents and the Care of Children: The Research Evidence. In Broad B,
editor. Kinship Care: The Placement Choice for Children and Young People. Lyme Regis: Russell
House Publishing; 2001. pp. 11–20.
208. Wheelock J, Jones K. ‘Grandparents are the next best thing’: informal childcare for working
parents in urban Britain. J Soc Policy 2002;31:441–63. https://doi.org/10.1017/
S0047279402006657
209. Mitchell W. Research review: the role of grandparents in intergenerational support for families
with disabled children: a review of the literature. Child Fam Soc Work 2007;12:94–101.
https://doi.org/10.1111/j.1365-2206.2006.00421.x
210. Putnam RD. The prosperous community: social capital and public life. Am Prospect 1993;13:35–42.
211. Granovetter MS. The strength of weak ties. Am J Sociol 1973;78:1360–80. https://doi.org/
10.1086/225469
212. Kersten P. Principles of physiotherapy assessment and outcome measures. In Stokes M, editor.
Physical Management in Neurological Rehabilitation. London: Elsevier; 2004. pp. 29–46.
https://doi.org/10.1016/B978-072343285-2.50007-3
213. Green LW. From research to ‘best practices’ in other settings and populations. Am J Health Behav
2001;25:165–78. https://doi.org/10.5993/AJHB.25.3.2
214. Weintraub M. Selecting Patients for a Clinical Trial Part A: The Outpatient. In Buncher C, Tsay J,
editors. Statistics in the Pharmaceutical Industry. Boca Raton, FL: Chapman & Hall/CRC; 1993.
pp. 118–30.
215. Mallinson S. Listening to respondents: a qualitative assessment of the Short-Form 36 Health
Status Questionnaire. Soc Sci Med 2002;54:11–21. https://doi.org/10.1016/S0277-9536(01)
00003-X
216. Curtis L, Burns A. Unit Costs of Health and Social Care. Canterbury: Personal Social Services
Research Unit; 2015.
217. Aneurin Bevan Health Board. Closure of the Hydrotherapy Pool at Llanfrechfa Grange Hospital:
Minutes 22 May 2013. 2013. URL: www.wales.nhs.uk/sitesplus/documents/866/
3.11%20Hydrotherapy%20Pool.pdf (accessed 16 May 2016).
218. Office for National Statistics. Annual Survey of Hours and Earnings. London: Office for National
Statistics; 2015. URL: www.ons.gov.uk/employmentandlabourmarket/peopleinwork/
earningsandworkinghours/bulletins/annualsurveyofhoursandearnings/2015provisionalresults
(accessed 9 February 2017).
219. Automobile Association. Guide to Car Running Costs. 2015. URL: www.theaa.com/motoring_
advice/running_costs/advice_rcosts_guide.html (accessed 24 May 2016).
DOI: 10.3310/hta21270 HEALTH TECHNOLOGY ASSESSMENT 2017 VOL. 21 NO. 27
© Queen’s Printer and Controller of HMSO 2017. This work was produced by Hind et al. under the terms of a commissioning contract issued by the Secretary of State for Health.
This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals provided that
suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be addressed to: NIHR
Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton
SO16 7NS, UK.
109
220. Department of Health. Reference Costs Guidance 2015–16. London: Department of Health;
2016. URL: www.gov.uk/government/uploads/system/uploads/attachment_data/file/497127/
Reference_costs_guidance_2015-16.pdf (accessed 9 February 2017).
221. Hoffmann TC, Glasziou PP, Boutron I, Milne R, Perera R, Moher D, et al. Better reporting of
interventions: template for intervention description and replication (TIDieR) checklist and guide.
BMJ 2014;348:g1687. https://doi.org/10.1136/bmj.g1687
222. Parry G, Power M. To RCT or not to RCT? The ongoing saga of randomised trials in quality
improvement. BMJ Qual Saf 2016;25:221–3. http://dx.doi.org/10.1136/bmjqs-2015-004862
223. Hoddinott P. A new era for intervention development studies. Pilot Feasibility Stud 2015;1:36.
224. Asch DA, Rosin R. Innovation as discipline, not fad. N Engl J Med 2015;373:592–4.
http://dx.doi.org/10.1056/NEJMp1506311
225. Volpp KG, Terwiesch C, Troxel AB, Mehta S, Asch DA. Making the RCT more useful for
innovation with evidence-based evolutionary testing. Healthcare 2013;1:4–7. http://dx.doi.org/
10.1016/j.hjdsi.2013.04.007
226. Sim J, Lewis M. The size of a pilot study for a clinical trial should be calculated in relation to
considerations of precision and efficiency. J Clin Epidemiol 2012;65:301–8. http://dx.doi.org/
10.1016/j.jclinepi.2011.07.011
227. Imms C, Adair B, Keen D, Ullenhag A, Rosenbaum P, Granlund M. ‘Participation’: a systematic
review of language, definitions, and constructs used in intervention research with children with
disabilities. Dev Med Child Neurol 2016;58:29–38. http://dx.doi.org/10.1111/dmcn.12932
228. Murray SA, Kendall M, Carduff E, Worth A, Harris FM, Lloyd A, et al. Use of serial qualitative
interviews to understand patients’ evolving experiences and needs. BMJ 2009;339:b3702.
http://dx.doi.org/10.1136/bmj.b3702
229. Weiss CH. Theory-based evaluation: past, present, and future. New Dir Eval 1997;1997:41–55.
https://doi.org/10.1002/ev.1086
230. Saunders RP, Evans MH, Joshi P. Developing a process-evaluation plan for assessing health
promotion program implementation: a how-to guide. Health Promot Pract 2005;6:134–47.
https://doi.org/10.1177/1524839904273387
231. Caracelli VJ, Riggin L. Mixed-method evaluation: developing quality criteria through concept
mapping. Am J Eval 1994;15:139–52. https://doi.org/10.1177/109821409401500204
232. Special Needs and Parent Support. Our Costs. 2016. URL: https://snapsyorkshire.org/pricing-page/
(accessed 4 July 2016).
233. Jones P. New Care Models: Empowering Patients and Communities – A Call to Action for a
Directory of Support. London: NHS England; 2015.
234. Coulter A, Roberts S, Dixon A. Delivering Better Services for People with Long-Term Conditions:
Building the House of Care. London: The King’s Fund; 2013.
235. McDonagh JE, Minnaar G, Kelly K, O’Connor D, Shaw KL. Unmet education and training needs in
adolescent health of health professionals in a UK children’s hospital. Acta Paediatr 2006;95:715–19.
https://doi.org/10.1080/08035250500449858
236. Sawyer SM. Developmentally appropriate healthcare for young people with chronic illness:
questions of philosophy, policy, and practice. Pediatr Pulmonol 2003;36:363–5. https://doi.org/
10.1002/ppul.10369
REFERENCES
NIHR Journals Library www.journalslibrary.nihr.ac.uk
110
237. Vaz S, Cordier R, Falkmer M, Ciccarelli M, Parsons R, McAuliffe T, Falkmer T. Should schools
expect poor physical and mental health, social adjustment, and participation outcomes in students
with disability? PLOS ONE 2015;10:e0126630. http://dx.doi.org/10.1371/journal.pone.0126630
238. Farre A, Wood V, McDonagh JE, Parr JR, Reape D, Rapley T, Transition Collaborative Group.
Health professionals’ and managers’ definitions of developmentally appropriate healthcare
for young people: conceptual dimensions and embedded controversies. Arch Dis Child
2016;101:628–33. http://dx.doi.org/10.1136/archdischild-2015-309473
239. Batalden M, Batalden P, Margolis P, Seid M, Armstrong G, Opipari-Arrigan L, et al. Coproduction
of healthcare service. BMJ Qual Saf 2016;25:509–17. https://doi.org/10.1136/bmjqs-2015-004315
240. Ocloo J, Matthews R. From tokenism to empowerment: progressing patient and public
involvement in healthcare improvement. BMJ Qual Saf 2016;25:626–32. http://dx.doi.org/
10.1136/bmjqs-2015-004839
241. Faulkner A, Yiannoullou S, Kalathil J, Crepaz-Keay D, Singer F, James N, et al. Involvement for
Influence. 4PI National Involvement Standards. London: National Survivor User Network; 2015.
242. Health Foundation. Evaluation: What to Consider. London: Health Foundation; 2015.
243. United Nations. Convention on the Rights of Persons with Disability. 2006. URL: www.un.org/
development/desa/disabilities/convention-on-the-rights-of-persons-with-disabilities/
convention-on-the-rights-of-persons-with-disabilities-2.html (accessed 20 March 2016).
244. UK Government. Children and Families Act 2014. London: Her Majesty’s Stationery Office.
URL: www.legislation.gov.uk/ukpga/2014/6/contents/enacted (accessed 29 June 2016).
245. Department for Education, Department of Health. Special Educational Needs and Disability Code
of Practice: 0 to 25 years: Statutory Guidance for Organisations which Work with and Support
Children and Young People who have Special Educational Needs or Disabilities. London:
Department for Education; 2015.
246. Department of Health. You’re Welcome: Quality Criteria for Young People Friendly Services. 2011.
URL: www.dh.gov.uk/en/Publicationsandstatistics/Publications/ (accessed 8 March 2016).
247. Suris JC, Michaud PA, Viner R. The adolescent with a chronic condition. Part I: developmental
issues. Arch Dis Child 2004;89:938–42. http://dx.doi.org/10.1136/adc.2003.045369
248. Palisano RJ, Chiarello LA, King GA, Novak I, Stoner T, Fiss A. Participation-based therapy for
children with physical disabilities. Disabil Rehabil 2012;34:1041–52. http://dx.doi.org/10.3109/
09638288.2011.628740
249. Øien I, Fallang B, Østensjø S. Goal-setting in paediatric rehabilitation: perceptions of parents
and professional. Child Care Health Dev 2010;36:558–65. http://dx.doi.org/10.1111/
j.1365-2214.2009.01038.x
250. An M, Palisano RJ. Family-professional collaboration in pediatric rehabilitation: a practice model.
Disabil Rehabil 2014;36:434–40. https://doi.org/10.3109/09638288.2013.797510
251. Baldwin P, King G, Evans J, McDougall S, Tucker MA, Servais M. Solution-focused coaching in
pediatric rehabilitation: an integrated model for practice. Phys Occup Ther Pediatr
2013;33:467–83. http://dx.doi.org/10.3109/01942638.2013.784718
252. Bork BE, Cook TM, Rosecrance JC, Engelhardt KA, Thomason ME, Wauford IJ, Worley RK.
Work-related musculoskeletal disorders among physical therapists. Phys Ther 1996;76:827–35.
https://doi.org/10.1093/ptj/76.8.827
253. Kavlak E, Altug˘ F, Büker N, S¸enol H. Musculoskeletal system problems and quality of life of
mothers of children with cerebral palsy with different levels of disability. J Back Musculoskelet
Rehabil 2015;28:803–10. http://dx.doi.org/10.3233/BMR-150588
DOI: 10.3310/hta21270 HEALTH TECHNOLOGY ASSESSMENT 2017 VOL. 21 NO. 27
© Queen’s Printer and Controller of HMSO 2017. This work was produced by Hind et al. under the terms of a commissioning contract issued by the Secretary of State for Health.
This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals provided that
suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be addressed to: NIHR
Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton
SO16 7NS, UK.
111
254. Peek K, Sanson-Fisher R, Mackenzie L, Carey M. Interventions to aid patient adherence to
physiotherapist prescribed self-management strategies: a systematic review. Physiotherapy
2015;102:127–35. https://doi.org/10.1016/j.physio.2015.10.003
255. Klein R, Maybin J. Thinking About Rationing. London: The King’s Fund; 2012.
256. Buchner T, Smyth F, Biewer G, Shevlin M, Ferreira MAV, Toboso Martín M, et al. Paving the way
through mainstream education: the interplay of families, schools and disabled students. Res Pap
Educ 2015;30:411–26. https://doi.org/10.1080/02671522.2014.989175
257. Simeonsson RJ, Carlson D, Huntington GS, McMillen JS, Brent JL. Students with disabilities:
a national survey of participation in school activities. Disabil Rehabil 2001;23:49–63.
https://doi.org/10.1080/096382801750058134
258. Bolin K, Lindgren B, Lindström M, Nystedt P. Investments in social capital – implications of social
interactions for the production of health. Soc Sci Med 2003;56:2379–90. https://doi.org/10.1016/
S0277-9536(02)00242-3
259. Cabinet Office. Social Action: Harnessing the Potential: A Discussion Paper. London: Cabinet
Office; 2015.
260. Solomon M, Pistrang N, Barker C. The benefits of mutual support groups for parents of children
with disabilities. Am J Community Psychol 2001;29:113–32. https://doi.org/10.1023/
A:1005253514140
261. Rimmer JH, Vanderbom KA, Graham ID. A new framework and practice center for adapting,
translating, and scaling evidence-based health/wellness programs for people with disabilities.
J Neurol Phys Ther 2016;40:107–14. http://dx.doi.org/10.1097/NPT.0000000000000124
262. Milat AJ, Bauman A, Redman S. Narrative review of models and success factors for scaling up public
health interventions. Implement Sci 2015;10:113. https://doi.org/10.1186/s13012-015-0301-6
263. Wensing M, Bosch M, Grol R. Developing and selecting interventions for translating knowledge to
action. CMAJ 2010;182:E85–8. https://doi.org/10.1503/cmaj.081233
264. Gagnon ML. Moving knowledge to action through dissemination and exchange. J Clin Epidemiol
2011;64:25–31. http://dx.doi.org/10.1016/j.jclinepi.2009.08.013
265. Lomas J. The in-between world of knowledge brokering. BMJ 2007;334:129–32. https://doi.org/
10.1136/bmj.39038.593380.AE
266. Barker PM, Reid A, Schall MW. A framework for scaling up health interventions: lessons from
large-scale improvement initiatives in Africa. Implement Sci 2016;11:12. http://dx.doi.org/
10.1186/s13012-016-0374-x
267. Proctor EK, Powell BJ, McMillen JC. Implementation strategies: recommendations for specifying
and reporting. Implement Sci 2013;8:139. https://doi.org/10.1186/1748-5908-8-139
268. Nilsen P. Making sense of implementation theories, models and frameworks. Implement Sci
2015;10:1–13. https://doi.org/10.1186/s13012-015-0242-0
269. Pinnock H, Epiphaniou E, Sheikh A, Griffiths C, Eldridge S, Craig P, Taylor SJ. Developing
standards for reporting implementation studies of complex interventions (StaRI): a systematic
review and e-Delphi. Implement Sci 2015;10:42. http://dx.doi.org/10.1186/s13012-015-0235-z
270. Sloper P. Facilitators and barriers for co-ordinated multi-agency services. Child Care Health Dev
2004;30:571–80. https://doi.org/10.1111/j.1365-2214.2004.00468.x
271. Cameron A, Lart R. Factors promoting and obstacles hindering joint working: a systematic
review of the research evidence. J Integr Care 2003;11:9–17. https://doi.org/10.1108/
14769018200300013
REFERENCES
NIHR Journals Library www.journalslibrary.nihr.ac.uk
112
272. Peay HL, Scharff H, Tibben A, Wilfond B, Bowie J, Johnson J, et al. ‘Watching time tick by…’:
Decision making for Duchenne muscular dystrophy trials. Contemp Clin Trials 2016;46:1–6.
http://dx.doi.org/10.1016/j.cct.2015.11.006
273. Lambert V, Glacken M. Engaging with children in research: theoretical and practical implications
of negotiating informed consent/assent. Nurs Ethics 2011;18:781–801. https://doi.org/10.1177/
0969733011401122
274. Portela MC, Pronovost PJ, Woodcock T, Carter P, Dixon-Woods M. How to study improvement
interventions: a brief overview of possible study types. BMJ Qual Saf 2015;24:325–36.
https://doi.org/10.1136/bmjqs-2014-003620
275. Anaby D, Lal S, Huszczynski J, Maich J, Rogers J, Law M. Interrupted time series design: a useful
approach for studying interventions targeting participation. Phys Occup Ther Pediatr 2014;34:457–70.
http://dx.doi.org/10.3109/01942638.2013.866612
276. Paterson C. Measuring outcomes in primary care: a patient generated measure, MYMOP,
compared with the SF-36 health survey. BMJ 1996;312:1016–20. https://doi.org/10.1136/
bmj.312.7037.1016
277. Raggi A, Leonardi M. Assessing activity limitations in patients with neuromuscular diseases:
is the ACTIVLIM questionnaire linked to ICF and ICF-CY? Int J Rehabil Res 2009;32:148–53.
https://doi.org/10.1097/MRR.0b013e32831e4573
278. Tudur Smith C, Hopkins C, Sydes MR, Woolfall K, Clarke M, Murray G, Williamson P. How should
individual participant data (IPD) from publicly funded clinical trials be shared? BMC Med
2015;13:298. http://dx.doi.org/10.1186/s12916-015-0532-z
DOI: 10.3310/hta21270 HEALTH TECHNOLOGY ASSESSMENT 2017 VOL. 21 NO. 27
© Queen’s Printer and Controller of HMSO 2017. This work was produced by Hind et al. under the terms of a commissioning contract issued by the Secretary of State for Health.
This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals provided that
suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be addressed to: NIHR
Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton
SO16 7NS, UK.
113

Appendix 1 Changes to protocol
Changes to protocol Progress report Date Approved by
Protocol Version 2 (11 June 2014)
This protocol amendment was in relation to the
following: the exclusion criterion ‘involvement in
another randomised controlled trial’ was added and
it was stated that their GP will be informed of the
participant’s involvement via post. Both were added
as a result of the original ethical review process
1 (31 October 2014) 4 July 2014 NRES Committee
East of England –
Cambridge South
Protocol Version 3 (15 August 2014)
This protocol amendment was in relation to the
following: it was clarified that the 6MWD should be
completed only once at baseline and 26 weeks. The
NSAA score and FVC for visit 1 are both routine
measurements and are completed each time a
participant attended clinic; therefore, the protocol
was updated to state a NSAA or FVC completed up
to 4 weeks before consent could be used as the data
for visit 1. The pain VAS and urine dipstick would
now be completed before and after each AT session.
The chief investigator was removed as being blind
from treatment allocation. Inclusion criterion 3 was
amended to clarify what classed as ‘no major
changes to drug, dosage or frequency’. Renal failure
was listed as a contraindication and precaution in
error, and was therefore removed as a precaution.
Transient conditions in Table 2 were amended to
clarify that participants should be excluded until the
condition resolved. The window for trial interventions
to begin was extended to within 2–4 weeks of the
date of randomisation. It was clarified that ‘receipt of
intervention’ and ‘the number of sessions attended’
would be feasibility outcomes for the study and not
protocol non-compliance. The trial interventions
section relating to the control group was amended to
clarify that the research physiotherapists would
prescribe the LBT and inform the community
physiotherapist about the combination of exercises
prescribed; in addition, parents would post the
completed LBT forms to the university team or hand
them to the research physiotherapist. Participants
were also asked to take their LBT prescription to the
community physiotherapist so that the community
physiotherapist can note any changes. The process of
sending up to three reminder letters to parents was
outlined. Data handling and record keeping were
clarified, for example regarding the qualitative
element of the trial in which researchers would
contact the participants. The words ‘and SARs’ were
removed from the description about SUSARs. Finally
the sentence ‘The Medicines for Human Use (Clinical
Trials) Regulations 2004 SI: 1031 plus subsequent
amendments’ was replaced with ‘This clinical trial will
be conducted in accordance with Good Clinical
Practice Guidelines and CTRU standard operating
procedures’ as the trial was not a CTIMP
2 (1 May 2015) 26 November 2014 NRES Committee
East of England –
Cambridge South
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Changes to protocol Progress report Date Approved by
Protocol Version 4 (9 January 2015)
This protocol amendment was in relation to the
following: one of the clinical outcomes that the trial
intended to measure was whether or not myoglobin
was present in the urine of participants who
underwent AT. This outcome was removed because
of the following reasons: clinically, it was felt that
pain and exertion were the most important key
outcomes before/after AT sessions, these were
already being measured for the trial; research
physiotherapists who routinely administer
physiotherapy and AT advised that taking urine
samples for dipstick testing is not a standard measure
taken for children who undergo AT routinely;
biochemistry colleagues advised that such testing was
unlikely to detect myoglobinuria immediately after
exercise such as AT; both the research ethics
committee and NIHR expressed concerns about the
burden of this testing for participants and their
families
2 (1 May 2015) 30 January 2015 NRES Committee
East of England –
Cambridge South
Protocol Version 5 (30 October 2015)
The references were updated in section 6.4 of the
protocol
Approved after final
progress report
submitted
n/a NRES Committee
East of England –
Cambridge South
Protocol Version 6 (18 November 2015)
This protocol amendment was in relation to the
following: Version 5 of the protocol allowed the
collection of a post-AT session OMNI score to
measure the level of exertion in boys after their
AT session. The physiotherapists delivering the
intervention felt that it was clinically important to
measure their pre-AT levels of exertion and, as such,
an amendment was submitted to allow the analysis
of these data. We gained approval to include the
pre-AT OMNI data collected
Approved after final
progress report
submitted
n/a NRES Committee
East of England –
Cambridge South
CTIMP, clinical trial of an investigational medicinal product; GP, general practitioner; n/a, not applicable; NRES, National
Research Ethics Service; SAR, serious adverse reaction; SUSAR, suspected unexpected serious adverse reaction; VAS, visual
analogue scale.
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Appendix 2 Topic guide for participants and
parents/guardians
       
 
TOPIC GUIDE: PARTICIPANTS / CARERS 
 
Welcome and context-setting 
• Introduce yourself 
• Remind the participant and their parent / guardian, ‘I work for the University research 
team, not for the hospital’ 
• Tell them, ‘I want to find out what you thought about the hydrotherapy, so that we 
can make it better. And I also want to find out how you felt being in the research study so that 
we can make our next research study really good.’ 
• ‘The interview won’t last much more than half an hour’ 
• Explain that, ‘to help us with this study, we are going to make a recording of what we 
all say today, but nobody will be able to identify you from that recording other than me’. 
• …There are no right or wrong answers 
• … ‘Most of the questions are for you [name child], but [parent or guardian] please do 
chip in if you want and I’ve got some questions for you at the end’ 
• Check that everyone is happy to continue and ask if there are any questions. 
 
[To the child]  
1. How did you find the hydrotherapy?  
Can you tell me what you liked about it? 
Can you tell me what you didn’t like about it? 
How long were the sessions? Was that okay? 
What did you think of the people who helped you in the pool? 
 
2. How did you feel after each session?      [Probe: Tired? Pain?] 
 
3. If you could go to hydrotherapy twice a week, how would you feel about that?  
 
4. How do you feel now it’s the end of the course? 
 
5. How did you hear about this study?  
How did you feel about being approached to participate in the study?  
How did you feel about letting a computer decide whether you were going to get the 
hydrotherapy or not? 
 
[To parent and child] 
 
6. One of the people at the hospital sometimes asked you some questions to complete 
some questionnaires.  
What did you think about the number of questions you were asked? 
Did you have any trouble answering any of the questions? 
We use those questions to find out whether hydrotherapy is good for you and how it makes 
you feel. Were of any questions good at finding out how hydrotherapy made you feel? 
 
[To parent] 
5. How did you feel about the hydrotherapy? Probe: Benefits? Downsides? Were the 
staff okay? 
6 How did you find balancing the hydrotherapy with other things. Probe: School? 
7. How did you get to the hydrotherapy sessions? 
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How long did it take? 
[If using a car] What kind of distance did you have to drive, there and back again for each 
session?  
[If travelling by public transport] Do you mind telling us what you spent getting there and 
back again for each session?  
 
[To parent and child] 
 
8. Is there anything else either of you would like to say? 
 
Thank you 
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Appendix 3 Topic guide for health professionals
         
  
TOPIC GUIDE: HEALTH PROFESSIONALS 
 
Section 1. Normalisation Process Theory for implementing interventions
‘I’m going to ask you some questions about the hydrotherapy intervention and the service 
here’ 
 
Coherence (meaning and sense-making by professionals): 
Is the intervention easy to describe when you’re talking to patients and professionals? 
Is it clearly distinct from other interventions? 
Does it have a clear purpose for patients and professionals? 
Do you think patients and professionals have a shared sense of its purpose? 
What benefits do you think the intervention will bring; to whom? 
Are these benefits likely to be valued? 
Does the intervention fit with the overall goals and activity of your organisation? 
 
Cognitive participation (commitment and engagement by professionals) 
Do patients and professionals think the hydrotherapy service is a good idea? 
Do they see the point of the hydrotherapy service? 
Are patients and professionals prepared to invest time, energy and work in it? 
 
Collective action (the work professionals and patients do to make the intervention function) 
How has the hydrotherapy service affected your work; 
What effect has it had on your consultations and communication with patients and carers? 
How does it impact on the way that health professionals in the unit relate to each other? 
How compatible is the trial with existing work practices? 
Does it seem to be the right thing to be doing? 
It is perceived as valid…. as useful?  
Who needs to be involved in hydrotherapy? 
How do we get them informed them and link up with them?  
Does rolling out a hydrotherapy service mean health professionals learning new skills or 
doing things differently? 
Do all individuals involved in hydrotherapy have the right set of skills? 
What impact does the hydrotherapy service have on: 
the division of labour in your unit 
resources 
responsibility between different professional groups? 
Does a rigorous protocol for hydrotherapy challenge professional autonomy over working 
practices?  
Does the hydrotherapy service impact on case load and allocation of work? 
Who has the power to make the hydrotherapy service happen? 
Do you think the system wants the hydrotherapy service to happen? 
Do we need to and, if so, how can we divert resources to the hydrotherapy service? 
 
Reflexive Monitoring (professionals reflect on or appraise the intervention) 
How are users likely to perceive the intervention once it’s been on-going for a while? 
Is it likely to be perceived as advantageous for patients or staff? 
Will it be clear what effects the intervention has had? 
Can patients and professionals contribute feedback about study procedures? 
Can the intervention procedures be adapted/improved on the basis of experience? 
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‘Thank you, is there anything else you want to say about the hydrotherapy service?’ 
 
Section 2. Normalisation Process Theory for optimisation of trial parameters 
‘I’m going to ask you some questions about the trial and its procedures now’ 
‘First of all, do you have any general comments about the trial?’ 
 
Coherence (meaning and sense-making by professionals): 
Is the trial easy to describe when you’re talking to patients and professionals? 
Is it clearly distinct from other trials? 
Does it have a clear purpose for patients and professionals? 
Do you think patients and professionals have a shared sense of its purpose? 
What benefits do you think the trial will bring; to whom? 
Are these benefits likely to be valued by professionals and patients who might take part in the 
main trial? 
Does the trial fit with the overall goals and activity of your organisation? 
 
Cognitive participation (commitment and engagement by professionals) 
Do patients and professionals think the trial is a good idea? 
Do they see the point of the trial easily? 
Are they prepared to invest time, energy and work in it? 
 
Collective action (the work professionals and patients do to make the trial function) 
How do the trial procedures affect your work; do they promote or impede it? 
What effect has the trial had on your consultations? 
Does participation in the trial require extensive training for staff involved? 
How compatible is the trial with existing work practices? 
What impact does it have on division of labour, resources, power, and responsibility between 
different professional groups? 
 
Reflexive Monitoring (professionals reflect on or appraise the trial) 
How are users likely to perceive the trial once it’s been on-going for a while? 
Is it likely to be perceived as advantageous for patients or staff? 
Will it be clear what effects the study has had? 
Can users/staff contribute feedback about study procedures? 
Can the study procedures be adapted/ improved on the basis of experience? 
 
‘Thank you, have you got any other comments you’d like to make?’ 
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